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Cell migration plays a significant role in carcinoma metastasis in which cancer cells 
move from the primary site and establish tumours at a secondary location. During 
tumour progression cancer cells can assume a migratory phenotype which is 
characterised by cell-cell dissociation and single cells adopting a migratory 
morphology. Hepatocyte growth factor (HGF) signalling is known to induce cell-cell 
dissociation and is associated with prostate carcinoma progression.  
 
HGF-induced cell-cell dissociation and migration require the activity of the Rho family 
GTPases RhoA, Rac1 and Cdc42 and their effector proteins, p21-activated kinases 
(PAKs), which are a family of mammalian serine/threonine protein kinases. PAK6, a 
PAK family member, is over-expressed in prostate cancer but little is known about its 
function in cells. This project investigated the potential role of PAK6 downstream of 
HGF in DU145 colony-forming prostate cancer cells. These cells exhibit prominent 
epithelial-cadherin (E-cadherin)-associated cell-cell junctions and ‘scatter’ upon HGF 
stimulation.  
 
Studies described here show that HGF addition increases PAK6 autophosphorylation 
and that PAK6 depletion inhibits HGF-induced DU145 cell scattering where these cells 
retain junctional E-cadherin. Moreover, PAK6 over-expression induces cell elongation 
and colony escape in unstimulated DU145 cells and PAK6 localises to E-cadherin 
positive cell junctions. Functional studies identified IQ motif containing GTPase 
activating protein 1 (IQGAP1) as a PAK6 binding partner in DU145 cells. Furthermore, 
PAK6 interacts with IQGAP1 in an HGF-dependent manner and both proteins act 
synergistically to induce cell colony escape. Additional studies suggest a complex 
relationship between IQGAP1, PAK6 and E-cadherin during HGF-induced junctional 
disassembly where IQGAP1 mediates PAK6 activity. 
 
The work presented here demonstrates that PAK6 has an important function during 
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Chapter 1 – Introduction 
1.1 Cell migration 
1.1.1 The importance of cell migration 
Cell migration is a dynamic process that is required during various physiological 
activities such as morphogenesis (Vasilyev et al., 2009; Zhang et al., 2011), wound 
healing (Krawczyk, 1971; Ortonne et al., 1981; Schneider et al., 2010) and immune 
responses (Tomura et al., 2010; Tomura et al., 2008). Moreover, cell movement is 
involved in several diseases including atherosclerosis (Prescott et al., 1989; Vogt et al., 
2008) and rheumatoid arthritis (McInnes et al., 1996; Shadidi et al., 2002). Cell 
migration also plays a significant role in carcinoma metastasis (Chaffer and Weinberg, 
2011).  
 
1.1.2 The role of the actin cytoskeleton during cell migration 
During cell migration, the ability to re-organise the actin cytoskeleton is a fundamental 
requirement as the actin cytoskeleton is responsible for the changes in cell shape and the 
generation of forces that are required for cells to migrate (Hall, 1998). Actin filament 
turnover is important for the regulation of the actin cytoskeleton. Actin exists in two 
forms, a monomeric form, termed globular actin (G-actin), and a polymeric form known 
as filamentous actin (F-actin) (Straub, 1943). The G-actin monomer acts as a position of 
nucleation to generate F-actin filaments in a process termed polymerisation 
(Mommaerts, 1952). The F-actin generated by polymerisation is in a head-to-tail 
orientation (Wegner, 1976). Furthermore, the nucleation of G-actin monomers occurs 
more readily at the ‘barbed’ end of actin filaments (Pollard and Borisy, 2003). Thus the 
actin filaments exhibit polarity and are arranged with their fast-growing ends pointing 
towards the plasma membrane and this enables directed actin extension (Small et al., 
1978).  
 
Lamellipodia and filopodia are both products of this actin dependent protrusion and 
contribute to cell motility (Ridley, 2011). Lamellipodia can be characterised by their flat 
and broad morphology; in contrast, filopodia are recognised as finger-like projections 
(Small et al., 2002). In the body of the cell actin filaments are arranged as anti-parallel 
fibers, termed stress fibers; these fibers create the contractile forces that are required 
during cell movement (Katoh et al., 2001). Indeed, experiments using photoactivatable 
15 
 
caged-fluorescent actin demonstrated the rapid turnover of actin subunits within the 
lamellipodium of migrating cells (Theriot and Mitchison, 1991). More recently, 
fluorescence localization after photobleaching (FLAP) was employed as a novel method 
to monitor actin localisation and dynamics at the leading edge of migrating cells (Dunn 
et al., 2002). Fluorescence recovery after photobleaching (FRAP) studies have also been 
used to show that actin and actin-related protein 2/3 (Arp2/3) complex turnover both 
occur at the lamellipodial tip of motile cells (Lai et al., 2008). The Arp2/3 complex is 
important in facilitating the extension of actin and the production of branched actin 
filaments at the front of a migrating cell (Mullins et al., 1998). To achieve prolonged 
cell migration the actin-rich membrane protrusions that are created in the direction of 
movement must be stabilised by attachment of the cell to the underlying extracellular 
matrix (ECM) at the leading edge (Friedl and Wolf, 2003; Ridley, 2011). These 
adhesions then go on to generate sites of cell contraction which propel the cell forward 
(Ridley et al., 2003). In conjunction, to allow translocation, cell-ECM adhesions must 
be disrupted at the rear of the cell (Lauffenburger and Horwitz, 1996).   
 
1.1.2.1 The role of cell-substratum adhesions during cell migration 
Integrin-mediated signalling plays an important role in cell attachment to the ECM 
during cell migration (Huttenlocher and Horwitz, 2011). Integrins are cell surface 
receptors for ECM proteins, such as collagen I (Di Lullo et al., 2002; Mizuno et al., 
2000) and fibronectin (Garćia and Boettiger, 1999), as well as collagen V (Ruggiero et 
al., 1994) and laminins (Kikkawa et al., 2000). Integrins are ubiquitously expressed 
(Virtanen et al., 1990) and the aberrant expression and behaviour of integrins has been 
associated with carcinoma metastasis including that of the breast (Taherian et al., 2011), 
prostate (Gorlov et al., 2009; McCabe et al., 2007) and pancreas (Hosotani et al., 2002).  
 
1.1.3 Carcinoma metastasis 
Although many biological processes require cell migration, this study is focussed on the 
movement of prostate cancer cells. Human cancers are mainly found to be epithelial in 
origin and this is true of prostate cancer; where the majority of prostate cancers manifest 
from the peripheral region of the prostate gland (McNeal, 1969) (figure 1.1A) and are 
predominantly adenocarcinoma in type, originating from the glandular epithelial tissue 
(figure 1.1B) (Shen and Abate-Shen, 2010). Cancer cell migration is a pre-requisite for 

































Figure 1.1 The architecture of the prostate gland. A) Schematic illustrating the 
different regions within the prostate gland which can be divided into four main regions 
termed the peripheral zone, transitional zone, central zone and the anterior 
fibromuscular zone as indicated (McNeal, 1988; Timms, 2008). The location of the 
bladder, seminal vesicles and urethra in relation to the prostate are also marked. The 
prostate gland is adjoined to the upper portion of the urethra. This figure is adapted 
from (www.harvardprostateknowledge.org/prostate-basics). B) The prostate gland is 
composed of different types of epithelial cells. Basal cells rest on the underlying 
basement membrane, beneath columnar luminal cells (Long et al., 2005). 
Neuroendocrine cells are interspersed within the epithelium with predominant incidence 






cancer (Jemal et al., 2008). Metastasis is a multi-stage process, as illustrated in figure 
1.2. At the primary site following oncogenic transformation, cancer cells proliferate 
aberrantly (Fidler, 2003). The growing tumour expands and eventually requires support 
from a new capillary network developed from pre-existing vasculature in a process 
termed angiogenesis (Folkman, 1971; Folkman et al., 1963; Greene, 1941). Within the 
primary tumour, a selective group of tumour cells may undergo an epithelial to 
mesenchymal transition (EMT)-like process (Gabbert et al., 1985); EMT involves the 
loss of intercellular adhesivity and the dissociation of cells from the primary tumour 
mass, where these cells subsequently adopt a motile phenotype (Yilmaz and Christofori, 
2009). Cells that have undergone EMT are then able to cross the basement membrane, 
migrate through the stroma and subsequently enter into the lymphatic or the vascular 
systems in a process termed intravasation (Wyckoff et al., 2000). Those cancer cells that 
survive the hostile environment of the circulatory system then exit into the surrounding 
tissue, in a process termed extravasation (Cameron et al., 2000; Luzzi et al., 1998). 
These cells must then instigate and sustain growth to produce micrometastases (Luzzi et 
al., 1998).  
 
The location of distal metastasis is often defined by the site of the primary tumour and 
in patients with prostate cancer there is a predominance of skeletal metastases 
(Bubendorf et al., 2000). Indeed, numerous reports have shown that bone marrow 
secondary micrometastasis is favoured by prostate cancers (Ellis et al., 2003; Pantel et 
al., 1995; Pantel et al., 1997; Tsingotjidou et al., 2001). The metastatic cascade is 
actually rather inefficient and only a small proportion of disseminating cells have the 
capacity to proliferate and generate a macroscopic tumour (Cameron et al., 2000; Luzzi 
et al., 1998). Nevertheless, metastasis is still incurable and deadly (Duffy et al., 2008) 
and thus it is important to establish the mechanisms involved in this process for the 
development of future anti-metastatic therapies.  
 
1.1.4 Differences in 2-Dimensional and 3-Dimensional cancer cell migration  
There are two principle methods by which cancer cells are observed to migrate in vivo; 
collective cell migration and single cell migration (Friedl and Gilmour, 2009). 
Collective migration can be characterised by the collective movement of cell clusters 


















Figure 1.2 The different stages involved in carcinoma metastasis. 1) In situ cancer is 
supported by the underlying basement membrane. 2) Changes in cell-cell adhesions and 
cell-matrix adhesions, re-organisation of the actin cytoskeleton and basement membrane 
degradation instigate tumour cell movement from the primary site. 3) The dissociated 
tumour cells can then disseminate via the lymphatic system or 4) the blood vasculature. 
5) The circulating tumour cells exit the circulation into the surrounding tissue 
(extravasation). 6) Occult micrometastases may develop and 7) gradually form 








has been implicated in many invasive forms of cancer (Alexander et al., 2008; Friedl et 
al., 1995; Hegerfeldt et al., 2002; Iwanicki et al., 2011; Nabeshima et al., 2000). The 
migration of individual cancer cells has been extensively studied in vitro using 2-
Dimensional (2D) substratums, and more recently in 3-Dimensional (3D) matrices. 
Numerous studies have now established that there is variation in cancer cell behaviour 
between 2D and 3D substratums (Sahai, 2007). For example, cells can present different 
morphologies; PC3 prostate carcinoma cells are observed as single cells when seeded 
onto 2D surfaces (Bright et al., 2009) but these cells form spheroids when grown in a 
3D matrix (Härmä et al., 2010; Ivascu and Kubbies, 2006). In addition, changes in 
cancer cell polarity and morphogenesis (Itoh et al., 2007), gene expression (Ghosh et al., 
2005), tumour cell growth (Liu et al., 2004) and variations in the effects of growth 
factor stimulation (Brinkmann et al., 1995) have also been reported between 2D 
substratums and 3D matrices. 3D studies have also revealed that within single migration 
populations, cancer cells exhibit either an amoeboid motility where cells are 
phenotypically rounded or a mesenchymal mode of migration where cells are elongated 
in appearance; furthermore, cancer cells can switch between these two forms of motility 
(Sahai and Marshall, 2003). Such studies have highlighted the need for more 3D models 
of cell migration and invasion.  
 
In prostate cancer, a number of different cell lines have been routinely used to monitor 
migration in 2D including DU145 (Bright et al., 2009) and PC3 (Ahmed et al., 2008) 
cells. Moreover, more recently efforts have been made to develop 3D model systems. A 
3D model system was implemented to demonstrate that matrix metalloproteinases can 
change the morphology of LNCaP prostate cancer cells from multi-cellular structures to 
possessing a fibroblast-like phenotype (Cao et al., 2008), but there was no evidence of 
active migration. DU145 cells have been reported to migrate through a 3D matrix 
(Zaman et al., 2006) and following the studies presented here a recent publication 
demonstrated that DU145 cells can be stimulated to form elongated ‘sprouts’ in a 3D 








1.2 Growth factor-stimulated cell migration in cancer 
1.2.1 Growth factor signalling in cancer 
Growth factor signalling is known to be involved in the aberrant regulation of cell 
migration that is characteristic of invasive cancer cells (Alper et al., 2001; Jeffers et al., 
1996; Lu et al., 2001). Specifically, epidermal growth factor (EGF) has been implicated 
in promoting cell movement in prostate carcinomas (Zhou et al., 2006) and the invasive 
potential of DU145 cells increases downstream of EGF (Turner et al., 1996). Other 
growth factors, such as hepatocyte growth factor (HGF), are also involved in cancer 
progression (Fujiuchi et al., 2003). 
 
1.2.2 HGF 
HGF is a multi-functional polypeptide that has both mitogenic (Clark, 1994; Gmyrek et 
al., 2001) and motogenic (Cantley et al., 1994; Niranjan et al., 1995) properties and was 
identified as a ligand for c-Met, a tyrosine kinase receptor (Bottaro et al., 1991; 
Nakamura et al., 1989). The binding of HGF to c-Met triggers receptor kinase activation 
and in turn initiates various signal transduction pathways that can affect, for example, 
cell adhesion status (Trusolino et al., 2000) and re-organisation of the actin cytoskeleton 
(Ridley et al., 1995; Royal et al., 2000; Wells et al., 2005). HGF is also involved in 
oncogenic signalling as illustrated in figure 1.3 (Peruzzi and Bottaro, 2006). Early 
studies indicated that HGF was important for liver regeneration in hepatocytes 
(Hamanoue et al., 1992; Ishii et al., 1995). Indeed, HGF knockout mice are embryonic 
lethal (Schmidt et al., 1995). Initial investigations implicated HGF in cell migration; 
HGF was originally termed as scatter factor for its ability to induce cell-cell dissociation 
in colony-forming epithelial cells, as well as promoting the migration potential of single 
cells (Stoker, 1989; Stoker et al., 1987; Stoker and Perryman, 1985).  
 
HGF elicits the scattering and invasion of pancreatic and bladder carcinoma cells into 
collagen gels (Weidner et al., 1990). A similar result was observed for Caco-2 colon 
carcinoma cells; these cells exhibited an increased ability to invade matrigel upon HGF 
addition (Kermorgant et al., 2001). It has also been demonstrated that HGF increases 
the invasiveness of breast cancer cells (Trusolino et al., 2000). In addition, HGF has 














Figure 1.3 HGF and its receptor c-Met in oncogenic signalling. Oncogenic signalling 
through c-Met is associated with altered paracrine HGF levels and subsequent c-Met 
over-expression (Peruzzi and Bottaro, 2006). Signalling can also occur though the 
generation of autocrine HGF; pathway stimulation contributes to invasion, metastasis 
and tumour progression (Peruzzi and Bottaro, 2006). Tyrosine phosphorylation of 
residues Y1349 and Y1356 is required for the biological function of c-Met and mediates 
the interaction of multiple substrates with the receptor (Lai et al., 2009). This figure is 








1.2.2.1 HGF signalling in prostate carcinoma 
Oncogenic signalling via c-Met commonly occurs through paracrine (Knowles et al., 
2009) or autocrine (Toiyama et al., 2011) HGF-induced activation of c-Met (figure 1.3). 
Moreover, c-Met is over-expressed in prostate cancer cells (van Leenders et al., 2002). 
More recently, it has been shown that an increase in the percentage of c-Met-expressing 
prostate cancer cells significantly correlates with the development of bone metastases 
(Colombel et al., 2011).  
 
HGF stimulation increases the proliferation of prostate cancer cells (Gmyrek et al., 
2001) and their ability to invade through a matrix (Fujiuchi et al., 2003; Nishimura et 
al., 1999; Parr et al., 2001). It has also been shown that HGF promotes the migration 
potential of prostate cancer cells (Ahmed et al., 2008; Parr et al., 2001). This growth 
factor has also been implicated in inducing cell scattering and migration in DU145 cells 
(Davies et al., 2004; Miura et al., 2001; Wells et al., 2005). 
 
1.2.2.2 HGF-induced cell scattering 
HGF-induced cell scattering requires the disruption of cell-cell junctions. Cell-cell 
contact disassembly is a process that occurs as a consequence of the re-organisation of 
the actin cytoskeleton and subsequent cell spreading (Ridley et al., 1995). A group of 
proteins, known as Rho GTPases, are activated by HGF and are pivotal in mediating the 
actin re-modelling that is required for the cell-cell dissociation in response to HGF 
(Royal et al., 2000). The binding of HGF to its receptor c-Met triggers a loss of stress 
fibres and a reduction in prominent actin filaments in colony-forming cells (Wells et al., 
2005). HGF-induced activation of c-Met also promotes the formation of filopodia and 
lamellipodia mediated by the Rho GTPases Cdc42 and Rac1, respectively (Royal et al., 
2000). These actin-rich protrusions are required for cell spreading, a process that 
precedes, and is important for, cell-cell junction disassembly (Ridley et al., 1995; Royal 
et al., 2000). 
 
It has also been demonstrated that c-Met co-localises with E-cadherin (Kamei et al., 
1999), a junctional protein central to the stabilisation of cell-cell adhesions (Gumbiner 
et al., 1988), at cell-cell contact sites in Madin-Darby Canine Kidney (MDCK) cells in 
the absence of HGF stimulation (Kamei et al., 1999). Upon HGF addition, cell-cell 
junction disassembly in these cells was coupled with the endocytosis of both c-Met and 
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E-cadherin and this process was mediated, in part, by phosphatidylinositol 3-kinase 
(PI3K) (Kamei et al., 1999). Similarly, other studies have shown that PI3K is required 
during HGF-induced cell spreading and subsequent cell-cell junction breakdown in 
MDCK cells (Potempa and Ridley, 1998; Royal et al., 2000; Royal and Park, 1995). 
Thus the re-modelling of the actin cytoskeleton, in addition to the localisation of c-Met 
and E-cadherin, are important factors during HGF-induced cell-cell adhesion disruption. 
 
Cell scattering can be characterised by the loss of cell-cell junctions and resultant cell-
cell dissociation, where cells that have escaped the cell colony are elongated and 
migratory in morphology (Clark, 1994; Stoker, 1989; Stoker et al., 1987; Stoker and 
Perryman, 1985). Cell scattering also involves the loss of junctional localisation of cell 
adhesion proteins (Bellovin et al., 2005; Miura et al., 2001). Since the cell scattering 
studies of Stoker and Perryman (Stoker and Perryman, 1985), a number of groups have 
reported that DU145 prostate cancer cells display these characteristics in response to 
HGF stimulation (Bright et al., 2009; Humphrey et al., 1995; Miura et al., 2001; Wells 
et al., 2005). Cell scattering as a result of HGF stimulation has also been reported in 
colony-forming HT29 colon adenocarcinoma cells (Herrera, 1998). The HGF-induced 
cell scatter assay is therefore a useful model that can be used to study cell-cell 
dissociation and cancer cell migration in response to HGF.  
 
1.3 Cell-cell dissociation in cancer metastasis 
During cell-cell dissociation and dissemination some cancer cells may exhibit properties 
reminiscent of EMT (Greenburg and Hay, 1982). EMT is important during normal 
development; for example, in vertebrates it is well established that EMT is necessary 
during neural crest cell migration (Ahlstrom and Erickson, 2009) and gastrulation 
(Nakaya et al., 2008).  
 
Non-transformed epithelial cells can be characterised by their non-motile phenotype 
combined with strong cell-cell adhesions and cell-substratum adhesions (Chaffer and 
Weinberg, 2011). It is thought that when these cells become transformed during cancer, 
apical-basal polarity is lost and intercellular cell-cell adhesion sites are weakened 














Figure 1.4 A selection of cancer cells undergo an EMT-like process during 
carcinoma progression. 1) Initiating factors such as growth factors instigate the 2) and 
3) weakening of cell-cell junctions and the loss of cell polarity. 4) Degradation of the 
basement membrane and changes in cell-ECM adhesions allows 5) tumour cell escape 










requires the disassembly of junctions between neighbouring cells and this is mediated, 
in part, by the re-organisation of junctional complexes.  
 
1.3.1 Adherens junctions  
Intercellular junctions are important in the maintenance of epithelial tissue structure; 
these junctional formations include tight junctions, adherens junctions (AJs) and 
desmosomes (Farquhar and Palade, 1963). AJs were initially identified in mammalian 
tissues using electron microscopy (Farquhar and Palade, 1963) and are responsible for 
cell adhesions between neighbouring epithelial cells (Gumbiner et al., 1988). Several 
reports have demonstrated that AJs are dynamic structures when examined in vitro and 
in vivo (Cavey et al., 2008; de Beco et al., 2009; Fujita et al., 2002; Pilot et al., 2006). 
The modulation of AJs is important during development (Shimamura and Takeichi, 
1992; Vestweber and Kemler, 1984) and during disease processes such as carcinoma 
metastasis (Ceteci et al., 2007; Perl et al., 1998). 
 
1.3.2 Structure of adherens junctions 
The type I transmembrane proteins of AJs, cadherins, were originally identified as 
molecules required for the formation of adhesive cell-cell contacts (Gallin et al., 1983; 
Takeichi, 1977; Tanihara et al., 1994; Yoshida and Takeichi, 1982). The cell surface 
protein epithelial-cadherin (E-cadherin), an extensively studied member of the cadherin 
family, is the principle component of AJs in epithelial cells (Boller et al., 1985; 
Gumbiner et al., 1988). The loss of E-cadherin expression has been linked to cancer 
progression (Birchmeier and Behrens, 1994). Early studies tracking the movement of E-
cadherin green fluorescent protein (GFP) fusion proteins using time-lapse microscopy 
and photobleach recovery analysis shed light on the steps thought to be required in 
epithelial cell-cell adhesion formation (Adams et al., 1998). This multi-stage process 
was shown to involve the assembly and development of E-cadherin clusters at adjoining 
cell membranes of adjacent cells, followed by the rapid re-organisation of actin and 
these E-cadherin clusters, thereby inducing tight cell colony formation (Adams et al., 
1998).  
 
E-cadherin possesses extensive intra- and extracellular domains and it has been 
established that the extracellular domain of one E-cadherin molecule associates with the 
extracellular domain of another E-cadherin molecule on an adjacent cell (Gumbiner et 
26 
 
al., 1988; Nose et al., 1988). In contrast, the cytoplasmic portion of E-cadherin interacts 
with cytosolic proteins such as catenins (Kemler and Ozawa, 1989). E-cadherin 
interacts with beta-catenin (β-catenin) (Aberle et al., 1994) and β-catenin sequentially 
binds to alpha-catenin (α-catenin) (Herrenknecht et al., 1991). Therefore, β-catenin acts 
as a linker between E-cadherin and α-catenin (Jou et al., 1995). α-catenin interacts with 
actin directly via its C-terminal region (Rimm et al., 1995) or indirectly via actin-related 
proteins such as alpha-actinin (α-actinin) (Knudsen et al., 1995), thereby linking E-
cadherin to the actin cytoskeleton. However, more recent studies have shown that α-
catenin is incapable of interacting with actin filaments whilst bound to the E-cadherin-
β-catenin complex (Drees et al., 2005; Yamada et al., 2005), even when α-actinin is 
present (Yamada et al., 2005). Thus it has been suggested that α-catenin possesses a 
dual mode of action in cell-cell adhesion dynamics (Drees et al., 2005). 
 
A third member of the catenin family, p120 catenin, also binds to E-cadherin (Daniel 
and Reynolds, 1995; Jou et al., 1995; Shibamoto et al., 1995) through the 
juxtamembrane domain within the cytoplasmic tail of E-cadherin (Ohkubo and Ozawa, 
1999; Reynolds et al., 1996; Thoreson et al., 2000; Yap et al., 1998). p120 catenin is 
thought to mediate the stabilisation of cadherin complexes; indeed, p120 depletion in 
A431 human cervical cancer colony-forming cells resulted in E-cadherin degradation 
and the loss of cell-cell adhesivity (Davis et al., 2003). The expression levels of α- and 
β-catenin were also diminished in p120 catenin depleted cells; p120 catenin is therefore 
required for the maintenance of E-cadherin-mediated adhesion (Davis et al., 2003). 
Moreover, when the interaction between E-cadherin and p120 catenin is uncoupled, 
p120 catenin no longer localises to cell-cell junctions (Thoreson et al., 2000). p120 
catenin modulates the strength of E-cadherin-mediated adhesions (Thoreson et al., 
2000) and knockdown of p120 catenin in prostate cancer cells leads to cell-cell junction 
dissolution (Kümper and Ridley, 2010). In contrast however, it has also been reported 
that p120 catenin may negatively modulate intercellular adhesiveness (Aono et al., 
1999; Ohkubo and Ozawa, 1999). The structure of adherens junctions encompassing E-
cadherin, β-catenin, α-catenin and p120 catenin is illustrated in figure 1.5.  
 
It is evident that the E-cadherin-catenin complex is important in the maintenance of 
AJs; aberrant expression or function of these proteins has been implicated in cancer cell 








Figure 1.5 The structure of adherens junctions. This schematic illustrates the dimeric 
association of E-cadherin and its interactions with the cytosolic proteins α-catenin, β-
catenin and p120 catenin to form an adhesive structure. It is historically thought that α-
catenin links the E-cadherin-β-catenin complex to the actin cytoskeleton. However, a 
recent study has shown that α-catenin is unable to bind β-catenin and actin 
simultaneously (Drees et al., 2005; Yamada et al., 2005). This figure is adapted from 







epithelioid in appearance express E-cadherin and are typically non-invasive forms of 
cancer, whilst the loss of E-cadherin expression correlates with invasiveness and a 
fibroblastoid cell morphology (Frixen et al., 1991). In the presence of low forces that 
mimic those found in the lymphatic system, E-cadherin-negative cancer cells exhibit an 
increased propensity to dissociate from cell aggregates when compared to E-cadherin-
positive tumour cells (Byers et al., 1995). These results suggest that the absence of E-
cadherin would promote cell-cell dissociation from a tumour mass in the presence of 
forces that are characteristically detected in the lymphatic system (Byers et al., 1995). 
The loss of E-cadherin, β-catenin and α-catenin expression is thought to contribute to 
the development of breast carcinoma (de Leeuw et al., 1997) and the stabilisation of E-
cadherin and catenins at cell-cell contact sites reduces the invasiveness of cancer cells 
(Swaminathan and Cartwright, 2011). Whilst the assembly and disassembly of AJs is 
important during the cell-cell dissociation process, actin cytoskeletal re-organisation is 
also required for the detachment of adjacent cells and their subsequent ability to 
migrate. Both the re-organisation of the actin cytoskeleton associated with junctional 
disruption and the actin cytoskeletal dynamics associated with cell migration are known 
to be mediated by the activity of Rho family GTPases. 
 
1.4 Rho family GTPases are central to cell migration dynamics 
RhoA (Madaule and Axel, 1985), Rac1 (Didsbury et al., 1989) and Cdc42 (Munemitsu 
et al., 1990) are ~ 21 kDa small GTPase proteins of the Ras superfamily that act as 
‘molecular switches’ capable of regulating downstream signal transduction pathways by 
modulating their effector proteins (Ellenbroek and Collard, 2007). These proteins have 
been implicated in various cellular processes including cell growth and proliferation 
(Qiu et al., 1997), cytoskeletal re-organisation (Nobes and Hall, 1995; Ridley et al., 
1992), as well as adhesion and migration (Nobes and Hall, 1999; Zhao et al., 2000). In 
addition, these GTPases are also known to be regulated by HGF stimulation (Royal et 
al., 2000; Wells et al., 2005) and have been implicated in HGF-induced cell migration 
(Ridley et al., 1995; Wells et al., 2005). 
 
In initial Rho GTPase studies, Swiss 3T3 cells microinjected with activated RhoA 
exhibited changes in cell morphology where elongated protrusions from the cell body 
were observed (Paterson et al., 1990). Subsequently it was revealed that active mutants 
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of RhoA and Rac1 instigate the generation of stress fibers (Ridley and Hall, 1992) and 
lamellipodia (Ridley et al., 1992) respectively, in fibroblasts. Further investigations 
revealed a role for Cdc42 in the induction of filopodia (Kozma et al., 1995; Nobes and 
Hall, 1995). RhoA, Rac1 and Cdc42 are thus central in actin remodelling during cell 
movement. As cell migration is a pre-requisite for cancer cell progression, these Rho 
GTPases have been implicated in cancer invasion and metastasis (Ellenbroek and 
Collard, 2007).  
 
Rac1 is responsible for lamellipodial protrusion at the leading edge of the cell (Nobes 
and Hall, 1999) and for focal adhesion formation (Nobes and Hall, 1995), which are 
both required for cell movement. More recently, the fluorescence activation indicator 
for Rho proteins (FLAIR) system (Chamberlain et al., 2000; Kraynov et al., 2000) was 
used to show that active Rac1 also accumulates at the rear of motile neutrophils 
(Gardiner et al., 2002) and is required for retraction of the trailing edge in addition to 
the already established role of Rac1 at the leading edge of the cell (Gardiner et al., 
2002). Cdc42 induces filopodia generation at the front of a migrating cell (Nobes and 
Hall, 1995). The expression of dominant-negative Cdc42 disrupts chemotaxis, the 
directional sensing of a cell, in macrophages (Allen et al., 1998). It was originally 
thought that RhoA promoted the contractility of the motor protein myosin to induce the 
generation of stress fibers and cell-ECM adhesions at the rear of the cell 
(ChrzanowskaWodnicka and Burridge, 1996). Activated RhoA promotes detachment of 
the trailing edge of the cell by the modulation of these integrin-based cell-ECM 
adhesions (Alblas et al., 2001). However in recent biosensor studies active RhoA was 
detected at the protruding edge of moving cells (Heasman et al., 2010; Kurokawa and 
Matsuda, 2005; Pertz et al., 2006). In addition, RhoA, Rac1 and Cdc42 all accumulate 
in lamellipodia during protrusion of the cell (Machacek et al., 2009). It was postulated 
that RhoA functions in protrusion generation at the leading edge of motile cells by 
instigating actin polymerisation, whilst Rac1 and Cdc42 contribute to protrusion 
extension by modulating cell adhesion (Machacek et al., 2009). Figure 1.6 depicts the 
cell migration process regulated by Rac1, RhoA and Cdc42.  
 
1.4.1 GDP/GTP cycle  
Ligand-activated cell surface receptors can initiate Rho GTPase activation; G-protein 

















Figure 1.6 RhoA, Rac1 and Cdc42 during single cell migration. Dashed arrows 
represent recent studies indicating that active Rac1 also localises and functions at the 
cell rear (Gardiner et al., 2002) and that active RhoA has been detected at the leading 
edge of a migrating cell (Heasman et al., 2010; Kurokawa and Matsuda, 2005; 
Machacek et al., 2009; Pertz et al., 2006). This figure is adapted from (Raftopoulou and 











are known to be involved in this process (Parri and Chiarugi, 2010). Intracellularly, 
RhoA, Rac1 and Cdc42 switch between being bound to guanosine triphosphate (GTP) 
which renders them active or bound to guanosine diphosphate (GDP) which renders 
them inactive (Heasman and Ridley, 2008) (figure 1.7). In contrast to these typical Rho 
GTPases, Rnd proteins (Fiegen et al., 2002; Foster et al., 1996; Garavini et al., 2002; 
Nobes et al., 1998), RhoV (Aspenström et al., 2007) and RhoH (Li et al., 2002; 
Schmidt-Mende et al., 2010) are not regulated by a GDP/GTP switch.  
 
In the instance of RhoA, Rac1 and Cdc42, when signals are lacking from either the 
exterior or interior of the cell, these Rho GTPases are retained in their inactive GDP-
bound form in the cytoplasm by guanine nucleotide dissociation inhibitors (GDIs) 
(Tcherkezian and Lamarche-Vane, 2007). Receptor activation induces the release of the 
GTPases from GDIs, which in turn allows Rho GTPase translocation from the cytosol 
to the plasma membrane (DerMardirossian and Bokoch, 2005). Proximity to the 
membrane allows GDP/GTP exchange by guanine nucleotide exchange factors (GEFs) 
and triggers the association of activated RhoA, Rac1 and Cdc42 with their effector 
proteins (Rossman et al., 2005). A third group of proteins, GTPase activating proteins 
(GAPs), have the ability to accelerate the inherent GTPase activity of Rho family 
proteins resulting in the cessation of signal transduction (Bernards and Settleman, 
2004). In addition to their roles in cell motility, Rac1, Cdc42 and RhoA also have 
established roles in the modulation of AJs. 
 
1.4.2 Activity of Rho GTPases at cell-cell junctions 
1.4.2.1 Assembly and maintenance of junctions 
It is well established that Rac1 is involved in the assembly of E-cadherin-mediated cell-
cell adhesion sites (Ehrlich et al., 2002; Hoshino et al., 2004; Kovacs et al., 2002a; 
Kovacs et al., 2002b). RhoA has also been implicated in cell-cell junction formation; it 
was recently reported that RhoA depletion in neural progenitor cells induced the 
disruption of AJs (Katayama et al., 2011). The inhibition of RhoA by C3 transferase, a 
known inhibitor of endogenous Rho proteins, impaired the maintenance of E-cadherin-
based cell-cell adhesions in MDCK cells (Takaishi et al., 1997). The over-expression of 
a dominant-negative Rac1 mutant decreases the prevalence of E-cadherin and β-catenin 
at cell-cell junctions, whilst an activated Rac1 mutant elicits the opposite effect 









Figure 1.7 The GDP/GTP cycle. (Y represents the effector protein) (1) Binding of Rho 
GTPases releases intramolecular autoinhibition. Rho GTPase effectors regulated by 
autoinhibition include PAKs, WASP and Dia proteins. However, not all Rho GTPase 
effectors are regulated by an autoinhibitory mechanism. (2) GTP hydrolysis renders the 
effector inactive. (3) The effector may be modified by a phosphorylation event that 
stabilises effector activity even after the GTPase is removed. (4) The effector is 
inactivated through the removal of the modification thus rendering the effector inactive. 










adhesion formation in human keratinocytes (Braga et al., 1997). In MDCK II cells, 
active Cdc42 increases E-cadherin and β-catenin levels at cell-cell junctions and inhibits 
HGF-induced disruption of intercellular junctions (Kodama et al., 1999).  
 
1.4.2.2 Disassembly of junctions 
There are several reports that implicate Rho GTPases in cell junction disassembly. 
Activation of Rac1 and Cdc42 abolished the multi-cellular organisation of T47D breast 
carcinoma cells in a 3D collagen matrix (Keely et al., 1997) and active Rac1 disrupts 
cell-cell adhesions in human keratinocytes (Braga et al., 2000) and pancreatic 
carcinoma cells (Hage et al., 2009). The induction of EMT in human proximal tubular 
epithelial cells, characterised by reduced E-cadherin expression and the adoption of a 
fibroblastic morphology, was dependent on RhoA, Rac1 and Cdc42 signalling (Patel et 
al., 2005). In contrast, it has been reported that the level of active Rac1 diminishes 
following HGF stimulation which is thought to be important during MDCK II cell-cell 
junction disassembly and cell-cell dissociation induction (Fukata et al., 2001; Palacios 
and D'Souza-Schorey, 2003). The discrepancy in the role of Rho GTPases in the 
assembly and disassembly of junctions indicates the complex nature of junctional 
dynamics. Nevertheless, Rac1 and Cdc42 are both known to interact with isoform 1 of 
the IQ motif containing GTPase activating protein (IQGAP) family of proteins (Kuroda 
et al., 1996), which has already been shown to play a role in cell-cell junction 
disassembly downstream of HGF (Fukata et al., 2001). 
 
1.5 IQGAP1 
1.5.1 IQGAP family of proteins 
The IQGAP group of proteins have been isolated in various organisms, such as yeast 
(Epp and Chant, 1997; Lippincott and Li, 1998), Xenopus (Yamashiro et al., 2003) and 
mammals (Weissbach et al., 1994) where they possess distinct functions. To date, three 
variants of human IQGAP have been identified – IQGAP1, IQGAP2 and IQGAP3; 
IQGAP1 was the first to be defined in 1994 (Weissbach et al., 1994), followed shortly 
by the discovery of IQGAP2 (Brill et al., 1996). IQGAP3 was the last to be described in 
2007 (Wang et al., 2007). The function of IQGAP1 in humans has been extensively 




1.5.2 Domain structure of IQGAP1 
Human IQGAP1 is a large multi-domain protein (figure 1.8) that is 1657 amino acids 
(approximately 189 kDa) in size (Weissbach et al., 1994). This protein has numerous 
binding partners including extracellular receptor kinase 1 and 2 (ERK1 and ERK 2), 
mitogen- activated protein kinase/extracellular signal-regulated kinase kinase 1 and 2 
(MEK1 and MEK2) (Roy et al., 2004; Roy et al., 2005) and the EGF receptor (EGFR) 
(McNulty et al., 2011). 
 
IQGAP1 is composed of an N-terminal calponin homology domain (CHD), followed by 
a large coiled coil domain (Johnson et al., 2009). Downstream of the large coiled region 
is a polyproline interacting domain (WW domain) and an IQ domain, composed of four 
concurrent repeats of the IQ motif (Briggs and Sacks, 2003). The N-terminal region of 
IQGAP1 is thought to aid the homo-dimerisation of this protein (Ren et al., 2005). The 
GAP-related domain (GRD) is located downstream of the IQ region and encompasses 
the Cdc42 binding site (Mataraza et al., 2003a). It has been reported that IQGAP1 
interacts with both Cdc42 (Hart et al., 1996) and Rac1 (Kuroda et al., 1996). The most 
C-terminal region of IQGAP1 contains a RasGAP_C-terminus (RGCt) domain that is 
known to interact with a diverse range of proteins (White et al., 2011) including E-
cadherin (Kuroda et al., 1998; Li et al., 1999) and β-catenin (Kuroda et al., 1998). 
Although this domain is considerably similar in sequence to the catalytic region of Ras-
GAPs (Weissbach et al., 1994), IQGAP1 does not function as a traditional GTPase- 
activating protein; in fact in vitro studies have shown that IQGAP1 stabilises Cdc42 in 
its GTP-bound active conformation (Ho et al., 1999; Swart-Mataraza et al., 2002).  
 
1.5.3 IQGAP1 in cancer  
Changes in the localisation of IQGAP1, as well as elevated expression levels, have been 
documented in numerous cancer tissues and tumour cell lines (Johnson et al., 2009). 
IQGAP1 over-expression has been detected in colorectal (Nabeshima et al., 2002) and 
hepatocellular (Chen et al., 2010) cancer cells, as well as in head and neck squamous 
cancer cells (Patel et al., 2008). In addition, the highly metastatic MDA-MB-231 human 
breast cancer cells displayed a 2.7 fold elevation in IQGAP1 levels, when assessed 
against the less invasive MCF7 breast cancer cells (Jadeski et al., 2008). DNA array 









Figure 1.8 The domain structure of IQGAP1. Schematic illustrating the multi-
domain structure of IQGAP1 and some of the binding partners identified for this 











were associated with the development of metastasis (Clark et al., 2000). As well as 
increased expression of IQGAP1 in cancer, several studies have implicated IQGAP1 
specifically in cancer cell migration. In MCF7 breast cancer cells, the interaction 
between IQGAP1 and Cdc42 elevates the level of active Cdc42 (Mataraza et al., 
2003b). Furthermore, increased expression of IQGAP1 promotes cell motility and this 
event is reliant on Cdc42 and Rac1 (Mataraza et al., 2003b). IQGAP1 accumulates at 
the leading edge of HGF-stimulated cells (Hu et al., 2009) and depletion of this protein 
inhibits the migration of glioma (Hu et al., 2009), breast cancer (Mataraza et al., 2003b) 
and ovarian cancer (Bourguignon et al., 2005; Dong et al., 2008) cells. However, the 
role of IQGAP1 in prostate cancer cell migration has yet to be elucidated. 
 
1.5.4 IQGAP1 in cell junction modulation 
Studies have shown that IQGAP1 plays a significant role in the stability and integrity of 
AJs by its interaction with E-cadherin. Indeed, IQGAP1 co-localises with E-cadherin at 
cell junction sites in MCF7 breast cancer cells and is involved in the impairment of E-
cadherin-mediated adhesion (Li et al., 1999) and in cell junction dissociation 
downstream of HGF (Fukata et al., 2001). IQGAP1 also induces cell-cell dissociation in 
mouse L fibroblasts stably expressing E-cadherin (EL cells); in these cells, IQGAP1 
was shown to bind to β-catenin and displace α-catenin from the functional E-cadherin-
β-catenin junctional complex (Kuroda et al., 1998). It was therefore speculated that 
IQGAP1-mediated displacement of α-catenin resulted in a loss of intercellular 
adhesivity (Kuroda et al., 1998). Indeed, GTP-bound Cdc42 and Rac1 negatively 
regulate IQGAP1 function by inhibiting its interaction with β-catenin and in turn 
obstructing α-catenin dissociation (Fukata et al., 1999). However, more recently, 
evidence has emerged to suggest that the displacement of α-catenin from β-catenin 
might not be associated with junctional disruption (Drees et al., 2005). The role of the 
β-catenin-α-catenin interaction during junctional disassembly is therefore not fully 
elucidated. However others have shown that in the absence of functional α-catenin, 
mouse F9 teratocarcinoma cells exhibit a scattered phenotype (Maeno et al., 1999). 
 
In contrast to the proposed role of IQGAP1 in promoting cell-cell junction disassembly, 
it has also been shown that IQGAP1 actually enhances cell-cell adhesion in cells by its 
ability to cross-link actin filaments in the presence of high levels of Rac1/Cdc42 activity 
(Noritake et al., 2004); furthermore, the authors proposed a model for IQGAP1-
37 
 
mediated cell junction stabilisation as illustrated in figure 1.9. Thus the role of IQGAP1 
in junctional dynamics is still not clearly understood and furthermore, IQGAP1 activity 
downstream of HGF has yet to be investigated in colony-forming prostate cancer cells. 
 
Recently, a member of the p21-activated kinase (PAK) family, PAK6, was identified as 
a putative IQGAP1 binding protein (Kaur et al., 2008). PAKs are effectors of the Rho 
family GTPases Rac1 and Cdc42 (Manser et al., 1994). As such, these proteins have 
been implicated in the regulation of both cancer cell adhesion and migration (Whale et 
al., 2011).  
 
1.6 PAKs 
PAKs are a group of highly conserved mammalian serine/threonine protein kinases 
(Eswaran et al., 2008). To date, six human isoforms of PAK have been documented and 
these have been separated into two groups centred around their structure and function 
(Arias-Romero and Chernoff, 2008). PAKs 1–3 have been classified as group I and 
PAKs 4-6 constitute group II (Jaffer and Chernoff, 2002). PAKs are involved in various 
cellular events such as gene transcription (Stanley, 2007), hormone signalling (Holm et 
al., 2006; Lee et al., 2002; Rayala et al., 2006; Schrantz et al., 2004), cell morphology 
changes (Manser et al., 1997; Qu et al., 2001; Zeng et al., 2000), programmed cell death  
(apoptosis) (Cotteret et al., 2003; Huang et al., 2009) and cell migration (Ahmed et al., 
2008; Bright et al., 2009). 
 
1.6.1 Expression of PAKs 1-6 in cancer 
In human tissue, PAK expression has been observed in many different tissue types. 
PAK1 and PAK3 expression has been detected in the brain and PAK2 is ubiquitously 
expressed (Manser et al., 1995; Manser et al., 1994; Martin et al., 1995; Teo et al., 
1995). PAK4 is expressed in various tissues including that of the spleen, ovary, colon 
and prostate (Abo et al., 1998). PAK5 is highly expressed in the brain (Dan et al., 2002; 
Pandey et al., 2002) and PAK6 is found in the prostate, testis and brain, as well as in the 
kidney and placenta (Callow et al., 2002; Kaur et al., 2008; Yang et al., 2001). Altered 
expression of the group I PAK, PAK1, has been documented in many types of cancer 
including that of the brain (Aoki et al., 2007), breast (Bostner et al., 2007), liver (Ching 












Figure 1.9 A proposed model for the modulation of intercellular adhesion strength 
involving IQGAP1. This figure illustrates the potential function of IQGAP1, Rac1 and 
Cdc42 in conferring strong or weak cell-cell adhesions at junctional sites. IQGAP1 is 
thought to stabilise junctions by its actin cross-linking ability which is enhanced by its 
interaction with activated Rho GTPases. The actin cross-linking function of IQGAP1 
was postulated to link the E-cadherin-β-catenin complex to the actin cytoskeleton via α-
catenin. A reduction in activated Rac1 or Cdc42 levels releases IQGAP1 and allows this 
protein to bind to the E-cadherin-β-catenin complex. This triggers the release of α-
catenin from the complex, leading to weak cell-cell adhesions and subsequent cell-cell 





(Ito et al., 2007) and ovary (Davidson et al., 2008). Recently, elevated phospho-PAK2 
expression was reported in tumours of the ovary (Siu et al., 2010). Increased PAK4 
levels has been documented in various cancer cell lines including those of the breast and 
prostate (Callow et al., 2002). PAK5 over-expression has been observed in colorectal 
cancer (Gong et al., 2009). An increased level of PAK6 expression has been detected in 
both breast and prostate cancer cells (Kaur et al., 2008). In contrast, low PAK6 staining 
was reported in non-cancerous prostate epithelium (Kaur et al., 2008). 
 
The expression of PAK6 has been linked to prostate cancer-associated pathways. For 
example, the aberrant expression of PAK6 enhances the survival of prostate cancer cells 
which suggests that PAK6 may be involved in the modulation of apoptosis (Li et al., 
2005a), similar to other PAKs including PAK2 (Vilas et al., 2006), PAK4 (Gnesutta et 
al., 2001) and PAK5 (Cotteret et al., 2003). In addition, the suppression of PAK6, in 
conjunction with irradiation, reduces the survival of PC3 and DU145 prostate cancer 
cells (Zhang et al., 2009). PAK6 inhibition induces a decrease in the phosphorylation of 
a pro-apoptotic member of the B-cell lymphoma 2 (Bcl-2) family, bcl-2 antagonist of 
cell death (BAD), at serine 211, which may contribute to the survival of these cells in a 
PAK6 knockdown background (Zhang et al., 2009). In contrast, PAK6 may act as a 
tumour suppressor in prostate cancer (Wang et al., 2005) as the PAK6 gene was found 
to be hyper-methylated (Wang et al., 2005); hyper-methylated genes are frequently 
associated with the inhibition of tumour growth (He et al., 2003). Furthermore, in 
knockout studies, no defects were noted for PAK6 knockout mice, and PAK5/PAK6-
double-knockout mice were unaffected in their viability and fertility (Nekrasova et al., 
2008). However, these double-knockout mice were impaired in their learning and 
memory capabilities (Nekrasova et al., 2008). 
 
1.6.2 Structure of PAKs 1-6 
It is well established that PAKs 1-3 possess a distinctive N-terminal region that 
encompasses a conserved p21-binding domain (PBD) and an autoinhibitory domain 
(AID) (Burbelo et al., 1995; Manser et al., 1995; Manser et al., 1994; Teo et al., 1995). 
PAKs 1-3 are highly similar in sequence; they exhibit approximately 88% sequence 
homology in their PBD regions when compared to one another, whilst their kinase 
domains are over 90% identical in sequence (Jaffer and Chernoff, 2002). It has been 
shown that the AID overlaps with the PBD and is important in the regulation of basal 
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kinase activity for the group I proteins (Lei et al., 2000). Active Cdc42 and Rac1 are 
known to bind to the PBD (Bagrodia et al., 1995; Sells et al., 1997; Zhao et al., 1998) 
which increases PAK autophosphorylation and kinase activity (Manser et al., 1994; 
Martin et al., 1995). The N-terminal regulatory domain of PAKs 1-3 characteristically 
holds a number of proline-rich motifs, which act as binding sites for proteins that 
contain src-homology 3 (SH3) domains; for example, the motif located at the extreme 
N-terminal region of PAK1 promotes the binding of the adaptor protein Nck (Bokoch et 
al., 1996). The second proline-rich region is capable of interacting with growth-factor-
receptor-bound-protein 2 (Grb2) (Puto et al., 2003). PAK1 also interacts with the PAK-
interacting exchange factor (PIX) (Manser et al., 1998) which is thought to mediate the 
translocation of a PAK1-Nck complex to the plasma membrane upon receptor activation 
(Lu et al., 1997).  
 
Group II PAKs possess a C-terminal kinase domain and an N-terminal PBD domain, 
similar to group I PAKs (Abo et al., 1998; Dan et al., 2002; Lee et al., 2002). However, 
the sequences vary between the two groups. For example, the kinase region of PAK6 
resembles that of PAKs 1-5, whilst the homology of this protein to PAK1 is only 50% 
when compared to 80% with its group member, PAK4 (Lee et al., 2002). PAK6 and 
PAK4 are structurally different from group I PAKs and do not appear to have an 
identifiable AID (Jaffer and Chernoff, 2002). In contrast, PAK5 has been shown to 
possess an inhibitory region that is approximately 120 amino acids in size (Ching et al., 
2003).  
 
Whilst PAK6 and its group II family members do not possess any SH3 binding domains 
in their N-terminal regulatory region that is characteristic of PAKs 1-3 (Lee et al., 
2002), group II PAKs do possess a number of proline-rich regions between the PBD and 
the kinase domain of the protein (Wells and Jones, 2010). PAK4 possesses a GEF 
interacting domain via which GEF-H1 interacts (Callow et al., 2005). This GEF is able 
to promote GDP to GTP exchange for Rac1 and RhoA but not Cdc42 (Ren et al., 1998). 
Whilst a GEF interacting domain has not been identified in PAK6, this kinase is unique 
from PAKs 1-5 in that it possesses a FXXMF motif which associates directly with the 
androgen receptor (AR) ligand binding domain (LBD) (van de Wijngaart et al., 2006). 
Whilst PAK6 (Lee et al., 2002), similar to PAK1 (Wang et al., 2002), binds to the alpha 
isoform of the estrogen receptor (ER-α), PAK6 is the only PAK family member that 
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interacts with the AR (Yang et al., 2001). The AR is important in the differentiation of 
epithelial prostate cells (Donjacour and Cunha, 1993) and has been implicated in the 
development of prostate cancer (Han et al., 2005; Massie et al., 2011). The similarities 
and differences between the structures of group I and II PAKs are demonstrated in 
figure 1.10. 
 
1.6.3 Regulation of PAK activity 
It has been established that the kinase activity of PAKs 1-3 is enhanced by the binding 
of the active form of the Rho GTPases, Rac1 and Cdc42 to the PBD (Manser et al., 
1994; Martin et al., 1995). Group I PAKs exist as a dimer in an autoinhibited inactive 
state where the AID from one PAK molecule is bound to the catalytic domain of the 
other PAK within the dimer (Lei et al., 2000). The binding of active Cdc42 or Rac1 to 
the PBD relieves this autoinhibitory conformation and induces a number of 
conformational changes that trigger the release of the AID from the catalytic region, 
rendering the kinase active (Lei et al., 2000; Parrini et al., 2002). Group I PAKs can also 
be activated through pathways that do not require GTPases, for example by interacting 
with the lipid sphingosine (Bokoch et al., 1998).  
 
In contrast to group I PAKs, the mechanism of regulation for group II PAKs has yet to 
be fully elucidated. PAKs 4-6 preferentially interact with the active form of Cdc42, but  
kinase activity is not thought to be enhanced by this association (Abo et al., 1998; Dan 
et al., 2002; Lee et al., 2002); although there is one report that activated Cdc42 can 
increase the autophosphorylation levels of glutathione S-transferase (GST) tagged 
PAK5 (Ching et al., 2003). As the interaction between PAK6 and the GTP-bound form 
of Cdc42 does not increase PAK6 kinase activity (Schrantz et al., 2004), it is possible 
that this association modulates PAK6 localisation as observed for PAK4 (Abo et al., 
1998) and Xenopus PAK5 (X-PAK5), the Xenopus PAK4 homologue (Cau et al., 
2001). It has been reported that PAK6 interacts with the atypical Rho GTPase family 
member, RhoV (Shepelev and Korobko, 2012), which has 52% sequence homology to 
Cdc42 (Aronheim et al., 1998). However, RhoV does not change PAK6 
phosphorylation levels at the predicted autophosphorylation site, serine 560 (Schrantz et 
al., 2004; Shepelev and Korobko, 2012). Moreover, full-length PAK6 exhibits less 
kinase activity in comparison to a truncated version of PAK6 containing only the 












Figure 1.10 The domain structure of Group I and II PAKs. PAKs 1-6 have been 
divided into two groups based on their sequence homology. All PAK isoforms possess 
an N-terminal PBD and C-terminal kinase domain. There is variation in structure in the 
region between the PBD and kinase domain of PAKs. This figure is adapted from 









PAK6 kinase activity can also be regulated by the p38 mitogen activated protein kinase 
(MAPK) signalling cascade (Kaur et al., 2005). Phosphorylation by p38 MAPK and 
mitogen activated protein kinase kinase 6 (MKK6) activates PAK6; furthermore 
autophosphorylation of PAK6 at serine 560 is required for MKK6-facilitated activation 
(Kaur et al., 2005). In addition, the results obtained from kinase activity studies suggest 
that the AR may also play a part in regulating PAK6 kinase activity (Lee et al., 2002).  
 
1.6.4 PAKs and cancer cell migration 
Group I PAKs were initially implicated in cell movement as a consequence of their 
aptitude to induce membrane ruffling (Sells et al., 1997) as well as the inhibitory effect 
on cell migration induced by a dominant-negative PAK1 mutant (Kiosses et al., 1999). 
PAK1 also phosphorylates cytoskeletal-associated proteins such as actin-related protein 
2/3 complex 41 kDa (p41-Arc), a component of the Arp2/3 complex which contributes 
to breast cancer cell migration (Vadlamudi et al., 2004).  
 
PAK1 has been shown to promote cell migration in colon cancer (Huynh et al., 2010). 
More recently, PAK1 was found to be over-expressed in gastric cancer cells and its 
presence enhances cell motility in these cells whilst the depletion of PAK1 inhibits this 
phenotype (Li et al., 2012). Group I PAKs have also been implicated in cancer cell 
motility downstream of growth factor stimulation. DU145 cell motility is inhibited in 
PAK1, but not PAK2, short interfering RNA (siRNA) knockdown cells upon HGF 
stimulation (Bright et al., 2009). In ovarian cancer cells, PAK1 and PAK2 are over-
expressed and cell motility is enhanced by their presence (Siu et al., 2010). In contrast, 
whilst it has been recently suggested that PAK3 somatic mutations may contribute to 
cancer tumourigenesis (Greenman et al., 2007), very little is known on the function of 
PAK3 in cancer cell migration. 
 
There is extensive evidence that supports a role for PAK4 in cancer cell motility. For 
example, PAK4 depletion reduces the velocity of migrating DU145 cells stimulated 
with HGF (Wells et al., 2010). In PC3 prostate carcinoma cells, PAK4 depletion 
induced a similar effect on cell motility upon HGF stimulation (Ahmed et al., 2008). 
Whilst PAK5 has been implicated in promoting neurite outgrowth downstream of Rho 
GTPases (Dan et al., 2002), and has also found to be localised in filopodia (Wu and 
Frost, 2006), the knowledge on PAK5 function in cancer cell migration is limited. 
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Nevertheless, PAK5 somatic mutations have been detected in a human cancer genome 
screen (Greenman et al., 2007) and increased PAK5 expression in colorectal cancer 
cells impairs cell adhesivity and promotes cell migration on collagen I (Gong et al., 
2009).  
 
PAK6 binds RhoV (Shepelev and Korobko, 2012), a protein that has been implicated in 
the modulation of cytoskeletal dynamics (Aronheim et al., 1998). Interestingly, HGF 
induces a reduction in RhoV gene expression in DU145 cells (van Leenders et al., 
2011); thus it could be speculated that RhoV may be involved in HGF signalling. There 
is also one report in the literature that PAK6 interacts with IQGAP1 in breast cancer 
cells (Kaur et al., 2008). Whilst these PAK6 binding proteins have been implicated in 
cancer cell migration, the role of PAK6 in this process has yet to be investigated. 
Nevertheless, PAK6 has been implicated in other cancer-related phenotypes. For 
example, prostate cancer progression and invasiveness was inhibited in PAK6 siRNA-
treated PC3, DU145 and LAPC4 prostate cancer cell lines (Wen et al., 2009). 
Furthermore, prostate cancer cell growth in vivo was suppressed upon PAK6 depletion; 
this effect was increased in the presence of the anti-tumour compound, docetaxel (Wen 
et al., 2009). As docetaxel acts as a microtubule stabilising agent (Altmann and Gertsch, 
2007), it was proposed that PAK6 may be involved in the modulation of cytoskeletal 
dynamics (Wen et al., 2009). Moreover, MKK6 activates PAK6 (Kaur et al., 2005) and 
the increased expression of MKK6 is associated with invasiveness in osteosarcoma 
(Nakano et al., 2003). Whilst there is emerging evidence for the involvement of PAK6 
in cancer, its role in cancer cell dissemination has yet to be defined.  
 
1.6.5 PAKs in cell junction modulation 
Whilst the role of group I PAKs in cancer cell migration has been studied extensively, 
their role in cell-cell dissociation has not been examined in such depth. However, it has 
been reported that activated group I PAKs can re-localise to cell-cell junctions 
(Stockton et al., 2004). PAK1 is thought to be an essential component in the modulation 
of E-cadherin integrity and junctional stabilisation downstream of Rac1 in keratinocytes 
(Lozano et al., 2008). PAK1 phosphorylates β-catenin and facilitates the disruption of 
the E-cadherin-β-catenin interaction (He et al., 2008). In addition, it has been shown 
that the presence of PAK1 kinase dead and constitutively active mutants can stimulate 
MDCK cell scattering (Zegers et al., 2003), a process that requires the dissolution of 
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intercellular adhesions. It has also been postulated that PAK1 is required for the 
intercellular breakdown of junctions downstream of HGF in DU145 cells (Bright et al., 
2009). 
 
Recent work has implicated group II PAKs in intercellular junction modulation. PAK4 
was found to be required for the maturation of nascent apical junctions in human 
bronchial epithelial cells (Wallace et al., 2010). Moreover, PAK4 accumulated at sites 
of cell contact and this junctional localisation was reliant on the presence of Cdc42 
(Wallace et al., 2010). It has been shown that the activated form of mushroom bodies 
tiny (Mbt), the Drosophila homologue of group II PAKs, is localised at AJs and is 
involved in the cell-cell dissociation process during eye maturation (Menzel et al., 2008; 
Menzel et al., 2007; Schneeberger and Raabe, 2003). Mbt activation interfered with the 
interaction between β-catenin and E-cadherin and thereby reduced intercellular adhesion 
in Drosophila (Menzel et al., 2008). In addition, X-PAK5 also localises at cell junction 
sites and modulates cell adhesion (Faure et al., 2005). A recent report has also 
demonstrated that PAK4 interacts with β-catenin, implicating this kinase in β-catenin 
re-localisation and signalling (Li et al., 2011). Additionally, an interaction with p120 
catenin and group II PAKs has been documented; this association was more pronounced 
with PAK5 when compared to PAK4 and PAK6 (Wong et al., 2010). Furthermore, p120 
catenin was phosphorylated by PAK4 and PAK5 both in vitro and in vivo, however the 
ability of PAK6 to phosphorylate p120 catenin was not tested (Wong et al., 2010). It has 
also been reported that the PAK6 binding protein RhoV (Shepelev and Korobko, 2012) 
modulates E-cadherin localisation at cell junctions in zebrafish (Tay et al., 2010). Thus 
whilst PAK6 interacts with proteins associated with the modulation of AJs, the potential 
role of PAK6 in this process has yet to be explored.  
 
It is known that PAK6 exhibits abundant localisation in the mitochondria (Cotteret et 
al., 2003). Additionally, intracellular localisation of PAK6 has been detected in the 
cytoplasm and at the plasma membrane of HeLa cells (Lee et al., 2002), as well as in the 
nucleus of prostate cells (Yang et al., 2001). It was recently shown that over-expressed 
PAK6 localises at punctate cytoplasmic structures in HeLa B and NCI-H1299 lung 





PAK6 is over-expressed in prostate cancer and this kinase interacts with IQGAP1, a 
scaffold protein implicated in cancer cell-cell dissociation and cell migration. 
Furthermore, PAKs have been implicated in cancer cell migration downstream of HGF 
stimulation. Thus it was hypothesised that PAK6 is involved during HGF-induced 
prostate cancer cell migration. 
 
1.8 Aims of the project 
The aim of this project is to investigate the importance of PAK6 downstream of growth 
factor-induced cell-cell dissociation and migration in prostate cancer cells. To facilitate 
studies of PAK6 biology, a 2D scatter assay will be optimised and subsequently 
developed into a 3D scatter assay. The effect of PAK6 over-expression and depletion on 
growth factor-induced prostate cancer cell-cell dissociation and migration will then be 
monitored using the scatter assay. In parallel, PAK6 interacting partner(s) which are 
relevant to cell-cell dissociation and migration will be isolated using GST pulldown 
assays and immunoprecipitation (IP) protocols. Finally, the relationship between PAK6 
and identified interacting partner(s) will be characterised and explored in the context of 
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Chapter 2 – Materials and Methods 
2.1 Materials 
2.1.1 General materials 
2-Amino-2-hydroxymethyl-propane-1,3-diol (Tris)-Base/ 
Hydrochloric acid (HCL) (Sigma-Aldrich, UK) 
3-N-morpholino propane sulfonic acid (MOPs) (Sigma-Aldrich, UK) 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Hepes) (GIBCO®, Invitrogen, 
UK) 
4’, 6-diamidino-2-phenylindole (DAPI) (Sigma-Aldrich, UK) 
Acrylamide (30%) (Severn Biotech Ltd, UK) 
Adenosine triphosphate (ATP) (Millipore, UK) 
Agarose (Invitrogen, UK) 
Alexa Fluor® 488 goat anti-mouse (Invitrogen, UK) 
Alexa Fluor® 568 goat anti-mouse (Invitrogen, UK) 
Alexa Fluor® 633 Phalloidin (Invitrogen, UK) 
Ammonium persulfate (APS) (Sigma-Aldrich, UK) 
Ampicillin (Sigma-Aldrich, UK) 
Aprotinin (Sigma-Aldrich, UK) 
BD Matrigel
TM
 Matrix (BD Biosciences, UK) 
Beta (β)-mercaptoethanol (Sigma-Aldrich, UK) 
Bovine serum albumin (BSA) (VWR International, UK) 
Bromophenol blue (Bio-Rad, UK) 
Calcium phosphate transfection kit (Invitrogen, UK) 
Carbenicillin (Sigma-Aldrich, UK) 
Control siRNA oligonucleotide (non-silencing) (Qiagen Ltd, UK) 
Dimethyl sulfoxide (DMSO) (Sigma-Aldrich, UK) 
Dithiothreitol (DTT) (Sigma-Aldrich, UK) 
DNA ladder (New England Biolabs, UK) 
Dulbecco's modiﬁed Eagle's medium (DMEM)+GlutaMAXTM (GIBCO®, Invitrogen, 
UK) 
Dulbecco's phosphate-buffered saline (DPBS) (GIBCO®, Invitrogen, UK) 
EGF (Recombinant Human) (R&D systems, USA) 
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Enhanced chemiluminescence (ECL) Plus western blotting detection system 
(Amersham Biosciences, UK) 
Ethidium bromide (Thermo Fisher Scientific, UK) 




Reagent (Calbiochem, UK) 
Foetal bovine serum (FBS) (GIBCO®, Invitrogen, UK) 
FuGene HD (Roche, UK) 
Fuji Medical X ray film, Super RX (Fuji Film, Japan) 
Gateway
TM
 LR and BP Clonase
TM
 Enzyme Mix (Invitrogen, UK) 
Gentamicin (Sigma-Aldrich, UK) 
Glutaraldehyde (Sigma-Aldrich, UK) 
Glutathione Sepharose
TM
 4 Fast Flow beads (Amersham Biosciences, UK) 
Glycerol (Sigma-Aldrich, UK) 
Glycine (Sigma-Aldrich, UK) 
Hepes, free acid, ULTROL grade (Calbiochem, UK) 
HGF (Recombinant Human) (R&D systems, USA) 
HiPerfect (Qiagen Ltd, UK) 
Histone H1 (Millipore, UK) 
Kanamycin (Invitrogen, UK) 
L-Arabinose (Sigma-Aldrich, UK) 
Leupeptin (Sigma-Aldrich, UK) 
Lipofectamine 2000 (Invitrogen, UK) 
Lithium chloride (LiCl) (Fisons Scientific Apparatus, UK ) 
Luria-agar (L-agar) (Sigma-Aldrich, UK) 
Luria-broth (L-broth) (Invitrogen, UK) 
Magnesium acetate (Sigma-Aldrich, UK) 
Magnesium chloride (MgCl2) (Sigma-Aldrich, UK) 
MAX Efficiency® DH5αTM Competent Escherichia coli (E. coli) Cells (Invitrogen, UK) 
Molecular biology enzymes (New England Biolabs, UK) 
Nitrocellulose membrane (Perkin Elmer, USA) 
Octylphenoxypolyethoxyethanol/Nonidet
TM





One Shot® BL21-AI Competent E. coli Cells (Invitrogen, UK) 
One Shot® TOP10 Chemically Competent E. coli Cells (Invitrogen, UK) 
OptiMEM (GIBCO®, Invitrogen, UK) 
PAK6 siRNA oligonucleotide 1 (Oligo 1) (Ambion, USA) 
PAK6 siRNA oligonucleotide 2 (Oligo 2) (Thermo Scientific Dharmacon, UK) 
Paraformaldehyde (PFA) (Sigma-Aldrich, UK) 
pDEST
TM
15 (Invitrogen, UK) 
pDONOR
TM 
207 (Invitrogen, UK) 
Penicillin/Streptomycin (Sigma-Aldrich, UK) 
Phenylmethylsulfonylfluoride (PMSF) (Sigma-Aldrich, UK) 
Phosphate buffered saline (PBS) tablets (Oxoid Limited, UK) 
Phusion enzyme (Finnzymes, UK) 
Pierce® ECL western blotting substrate (Thermo Scientific, USA) 
Protein G Sepharose
TM
 4 Fast Flow beads (Amersham Biosciences, UK) 
Protein marker (Biorad, USA) 
Purelink
TM
 Hi Pure Plasmid mini-prep kit (Invitrogen, UK) 
QIAGEN HiPerfect transfection reagent (Qiagen Ltd, UK) 
QIAGEN Plasmid maxi-prep kit (Qiagen Ltd, UK) 
QIAquick gel extraction kit (Qiagen Ltd, UK) 
QuikChange
TM 
Site-Directed mutagenesis Kit (Stratagene, USA) 
Rat tail collagen, Type I (BD Biosciences, UK) 
Roswell Park Memorial Institute (RPMI)-1640 medium (GIBCO®, Invitrogen, UK) 
Sodium chloride (NaCl) (Sigma-Aldrich, UK) 
Sodium dodecyl sulphate (SDS) (Sigma-Aldrich, UK) 
Sodium fluoride (NaF) (Alfa Aesar, UK) 
Sodium orthovanadate (Na3VO4) (Sigma-Aldrich, UK) 
Sodium pyrophosphate (BDH Chemicals, UK) 
Sucrose (Sigma-Aldrich, UK) 
Super optimal broth with catabolite repression (SOC) media (Invitrogen, UK) 
Tetramethylrhodamine isothiocyanate (TRITC)-Phalloidin (Sigma-Aldrich, UK) 
Tris-base (Sigma-Aldrich, UK) 
Triton X-100 (VWR International, UK) 
Trypsin/EDTA (GIBCO®, Invitrogen, UK) 





Construct Vector backbone Source 
GFP-PAK6 wild-type (WT) pEGFP-C1 (Clontech, UK) 




Kerry Shea, King’s College 
London) 
Generated by the 
author 




Kerry Shea, King’s College 
London) 
Generated by the 
author 
Myc-PAK6 wild-type  pCMV6-Myc Kind gift from 
Jonathan Chernoff, 
Fox Chase Cancer 
Center, Philadelphia, 
USA 
GST-PAK6 wild-type  pDEST
TM
15 (Invitrogen) Generated by the 
author 
GFP-PAK6 Kinase active 
(S531N) 
pEGFP-C1 (Clontech, UK) 




Kerry Shea, King’s College 
London 
Generated by the 
author 
GFP-PAK6 Kinase dead 
(K436A) 
pEGFP-C1 (Clontech, UK)  




Kerry Shea, King’s College 
London 
Generated by the 
author 
GFP-PAK6 predicted 
autophosphorylation site mutant 
(S560E) 
pEGFP-C1 (Clontech, UK)  




Kerry Shea, King’s College 
London 
Generated by the 
author 
HA-Cdc42-V12 pCMV5  Kind gift from Maddy 
Parsons, King’s 
College London 
GFP-IQGAP1 wild-type pEGFP-C1 Kind gift from David 
Sacks, Department of 
Laboratory Medicine, 
NIH, Bethesda, USA 




Kerry Shea, King’s College 
London) 
Generated by the 
author 
RFP-PAK6 N-terminal mutant pDEST
 




Kerry Shea, King’s College 
London) 






pcDNA3 Kind gift from David 
Sacks, Department of 
Laboratory Medicine, 
NIH, Bethesda, USA 
Myc-IQGAP1 C-terminal 
mutant 
pcDNA3 Kind gift from David 
Sacks, Department of 
Laboratory Medicine, 
NIH, Bethesda, USA 
GFP-PAK6 C-terminal mutant pEGFP-C1 (Clontech, UK)  




Kerry Shea, King’s College 
London 
Generated by the 
author 
GST-IQGAP1 (amino acids 
717-863) 
pGEX4T Kind gift from David 
Sacks, Department of 
Laboratory Medicine, 
NIH, Bethesda, USA 
GST-IQGAP1 (amino acids 
162-671) 
pGEX4T Kind gift from David 
Sacks, Department of 
Laboratory Medicine, 
NIH, Bethesda, USA 
GFP-IQGAP1 dominant- 
negative  
pEGFP-C1 Kind gift from David 
Sacks, Department of 
Laboratory Medicine, 
NIH, Bethesda, USA 




Antibody Company Source Application Dilution 
Anti-c-Met (C-12) 
Cat# sc-10 
Santa Cruz Rabbit Western Blotting 1: 500 
Anti-c-Myc (9E10) 
Cat# sc-40 
















a) 1: 500 



















Millipore Mouse Western Blotting 1: 20000 
Anti-GFP 
Cat# 11814460001 








Mouse Western Blotting 1: 10000 
Anti-HA (Y-11) 
Cat# sc-805 




























Rabbit Western Blotting 1: 2000 
Anti-PAK6  
Cat# ST1108 







































Mouse Western Blotting 1: 1000 





 Table 2.3 Secondary antibodies 
 
2.1.4 Buffers 
Blocking solution: 5% w/v milk powder or 5% w/v BSA in Tris buffered saline (TBS)-
Tween  
 
DNA loading buffer: 40% w/v sucrose, 0.25% w/v bromophenol blue 
 
Freeze down buffer for GST protein beads: 50% v/v glycerol, 20 mM Tris-HCL pH 7.6, 
100 mM NaCl, 1 mM DTT 
 
NP-40 lysis buffer: 0.5% v/v NP-40, 30 mM sodium pyrophosphate, 50 mM Tris-HCL 
pH 7.6, 150 mM NaCl, 0.1 mM EDTA and protease inhibitor cocktail 
 
Protease inhibitor cocktail: 50 mM NaF, 1 mM Na3VO4, 1 mM PMSF, 10 µg/ml 
leupeptin, 1 µg/ml aprotinin and 1 mM DTT 
 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) running 
buffer (10x): 250 mM Tris-base, 1.92 M Glycine, 1% w/v SDS. Dilute to 1x with 
distilled water (dH2O) 
 
SDS-PAGE transfer buffer (10x): 250 mM Tris-base, 1.92 M Glycine. Make up 1x 
transfer buffer fresh on the day by diluting to 1x and adding methanol to a final 
concentration of 20% v/v. 
 
SDS-PAGE sample buffer (2x): 100 mM Tris-HCL pH 6.8, 4% w/v SDS, 20% v/v 
glycerol, 0.2% w/v bromophenol blue, 1: 50 β-mercaptoethanol 
 





Dako Goat 1: 1000 - 1: 10000 
HRP-conjugated 
anti rabbit 
Dako Goat 1: 1000 - 1: 2000 
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Tris acetate EDTA (TAE) buffer (1x): 40 mM Tris acetate, 1 mM EDTA 
 
TBS-Tween: 25 mM Tris-HCL pH 7.6, 50 mM NaCl, 0.1% v/v Tween 20 
 
PBS-Tween: PBS, 0.1% v/v Tween 20 
 
Stripping buffer: 25 mM glycine pH 2, w/v 1% SDS 
 
Coomassie blue stain: 50% v/v methanol, 10% v/v acetic acid, 0.025% w/v coomassie 
blue 
 
Coomassie destain: 12.5% v/v isopropanol, 10% v/v acetic acid 
 
Kinase buffer: 50 mM Tris-HCL pH 7.5, 10 mM MgCl2, 1 mM DTT 
 
LiCl buffer: 0.5 M LiCl, 20 mM Tris pH 8 
 
Kinase cocktail solution: 2.5 mM Hepes pH 7.4 (Calbiochem, UK), 50 mM magnesium 
acetate, 0.5 mM ATP 
 

















2.2.1 Molecular biology  
Transformation of Escherichia coli cells 
The heat shock method was used to transform DH5α and Top10 strains of E. coli with 
DNA plasmids. These competent E. coli cells, typically stored at -80
o
C, were allowed to 
thaw out on ice prior to transformation. 1 µl of plasmid DNA was then added to the 
bacteria and this transformation mixture was placed on ice for 30 minutes, followed by 
incubation at 42
o
C for exactly 20 seconds or 30 seconds for DH5α or Top10 cells, 
respectively. The transformed bacteria were then placed on ice for a further 2 minutes, 
supplemented with 950 µl of SOC media (supplied with the competent cells) and 
incubated in a shaking incubator at 37
o
C for one hour. Subsequently, the transformed 





Purification of plasmid DNA 
Plasmid DNA was isolated and purified from E. coli cells using the QIAGEN maxi-prep 
kit and the Purelink
TM 
mini-prep kit. L-broth supplemented with the appropriate 
antibiotic was inoculated with transformed bacteria and incubated in a shaking 
incubator overnight at 37
o
C. The concentrations of antibiotic used were typically 7 
µg/ml for gentamicin, 30 µg/ml for kanamycin and 100 µg/ml for ampicillin. Mini-prep 
kits were employed to purify up to 20 µg plasmid DNA from 5 ml L-broth. Maxi-prep 
kits were utilised to purify up to 500 µg plasmid DNA from 200 ml L-broth. The 
plasmid DNA was eluted in water and stored at -20
o
C for future use.  
 
Restriction digests of plasmid DNA 
A restriction digest reaction typically contained 0.5–1 µg of plasmid DNA, 10–20 units 
of restriction endonuclease (New England Biolabs (NEB)) and 1x NEB buffer in a total 
volume of 15 µl. The reaction was then incubated for one hour at the optimum 
temperature for the restriction endonuclease being used. 2 µl of DNA loading buffer 
was used to terminate the reaction. The restriction digest products were then resolved on 





Resolving DNA fragments on an agarose gel 
A 1% w/v TAE agarose gel supplemented with 0.5 µg/ml ethidium bromide was used to 
resolve DNA fragments. DNA loading buffer was added to the DNA products and 10–
20 µl of sample was loaded, alongside a DNA marker, into a well of the agarose gel. 
The gel was covered with 1x TAE buffer and the DNA was migrated through the gel at 
140V. The DNA marker was used to verify the size of the DNA fragments present and 
these fragments were visualised under ultraviolet (UV) light. 
 
Generation of tagged PAK6 constructs 
Polymerase chain reaction (PCR)  
The Gateway
TM
 Technology system (Invitrogen, UK) was used to generate tagged 
PAK6 constructs. Myc-PAK6 wild-type plasmid was used as the DNA template in the 
production of PAK6 DNA flanked by attB sequences; the addition of attB sequences 
was required to allow for subsequent cloning into Gateway
TM
 vectors. PAK6 DNA 
flanked by attB sequences was produced by PCR amplification (see Appendix 1 for 
primer sequences). The PCR reaction was performed using Phusion DNA polymerase in 
the supplied reaction buffer. Each reaction was set up using 500 ng template DNA, 5% 
v/v DMSO, 0.2 mM of each deoxyribonucleotide triphosphate (dNTP) and 300 nM of 
forward and reverse primers (primers were ordered from Thermo Fisher Scientific, 
Germany). The total reaction volume in a 0.2 ml PCR tube was 50 µl. The specific 
conditions used for the PCR reaction for DNA amplification are displayed in table 2.5.  
 
Cycle(s) Process Conditions  
1 Pre-incubation 95ºC, 5 minutes 
35 Denaturation 95ºC, 1 minute 
Annealing 48ºC and 55ºC, 1 minute 
Extension 74ºC, 1 minute 30 seconds 
1 Final Extension 74ºC, 10 minutes 
Table 2.4 Conditions for PCR amplification of PAK6 
 
PAK6 mutants were generated using the same conditions shown in table 2.5; however 
the extension times were varied depending on the size of the PAK6 region being 
amplified. PCR amplification was also used to generate GFP tagged C-terminal PAK6 
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and mRFP1 tagged N- and C-terminal PAK6 mutant constructs as appropriate (see 
Appendix 1 for primer sequences).  
 
Gel purification of DNA fragments 
PCR products were resolved on a 1% w/v TAE agarose gel supplemented with 0.5 
µg/ml ethidium bromide and the DNA was visualised under low intensity UV light.  
The fragment of interest was excised from the gel with a razor and the DNA purified 
from the agarose using a QIAquick gel extraction kit. The purified DNA was eluted in 
water and then stored at -20°C for subsequent use. 
 
Construction of PAK6 entry clone 
In order to generate a PAK6 entry clone, a Gateway
TM
 BP recombination reaction was 
conducted between the pDONR
TM 
207 vector and the attB sequence flanked PAK6 PCR 
product in accordance with the manufacturer’s instructions. The BP reaction was 
incubated for 1 hour at room temperature. Subsequently, proteinase K was added and 
the reaction mixture was incubated at 37 ºC for 10 minutes to terminate the reaction. 
The BP reaction mixture was then transformed into TOP10 E. coli cells and the bacteria 
were plated onto L-agar supplemented with the appropriate antibiotic and incubated 
overnight at 37
o
C. Colonies were then selected and the plasmid DNA was purified. The 
presence of PAK6 in individual colonies was verified by restriction digest. PAK6-
positive clones were subsequently sequenced by Eurofins MWG Operon using primers 
that anneal to the gateway sequence upstream of the PAK6 gene (primers 19 and 20, 
primers were ordered from Thermo Fisher Scientific, Germany, see Appendix 1 for 
primer sequences). An internal primer was also generated to sequence the entirety of 
PAK6 (see Appendix 1 for primer sequence). 
 
Construction of PAK6 expression clone 
In order to generate GST, GFP and RFP-PAK6 expression plasmids, a Gateway
TM 
LR 
recombination reactions were performed between the pENTR (PAK6) entry clone and 
pDEST
TM
15 (Invitrogen, UK), modified pEGFP-C1 (Clontech, UK) (for use in the 
Gateway
TM 
Technology system) and pDEST (mRFP1/RFP) in accordance with the 
manufacturer’s instructions. The LR reaction was incubated for 1 hour at room 
temperature. Subsequently, proteinase K was added and the reaction mixture was 
incubated at 37 ºC for 10 minutes to terminate the reaction.  The reaction was then 
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transformed into TOP10 E. coli cells as described in previously. The plasmid DNA 
purified from the individual colonies was then sequenced by Eurofins MWG Operon 
using sequencing primers (primers were ordered from Thermo Fisher Scientific, 
Germany, see Appendix 1 for primer sequences). 
 
Purification of GST-fusion proteins 
E. coli BL21-A1 cells were transformed with GST expression plasmids. The 
transformed bacteria were cultured in L-broth to which 100 µg/ml of ampicillin was 
added. The cultures were incubated overnight in a shaking incubator at 37ºC. The 
following day, the bacterial cultures were diluted 1 in 100 into 200 ml of L-broth and 
grown for approximately 2 hours for the optical density to reach 0.6. The bacterial 
cultures were subsequently induced overnight at 20ºC with the appropriate % of L-
Arabinose. The overnight cultures were then centrifuged at 6000 revolutions per minute 
(rpm) for 15 minutes to pellet the bacteria. The pelleted bacteria were re-suspended in 
15 ml of a PBS: protease inhibitor cocktail. Sonication was used to disrupt the cells and 
this was followed by the removal of cell debris using centrifugation (4800 rpm for 10 
minutes). GST beads were pre-washed three times with a PBS: protease inhibitor 
cocktail and added to the supernatant prior to incubation for two hours at 4ºC. The 
beads were then pelleted by centrifugation at 500 x gravity (x g) for 5 minutes and 
washed three times in a PBS: protease inhibitor cocktail at 2000 rpm for 2 minutes per 





Site-Directed mutagenesis was used to construct potential kinase active (S531N and 
S560E) mutants and a kinase dead (K436A) mutant of PAK6. Mutagenic primers were 
designed using the Stratagene QuikChange® Site-Directed mutagenesis primer design 
programme (see Appendix 1 for primer sequences). 
 
The PCR reactions were performed using 1 μl of PfuTurbo DNA polymerase (2.5 U/μl) 
in the supplied reaction buffer. Each PCR reaction was performed using 100 ng of 
template DNA (PAK6 entry clone), 0.2 mM of each dNTP and 300 nM of mutagenic 
forward and reverse primers. The total reaction volume in a 0.2 ml PCR tube was 





Cycle(s) Conditions  
1 95ºC, 30 seconds 
18 95ºC, 30 seconds 
55ºC, 1 minute 
68ºC, 1 min/ kilobase (kb) 
of plasmid length 
             Table 2.5 Conditions for Site-Directed mutagenesis PCR 
 
Following thermocycling, 1 µl of Dpn 1 restriction enzyme (10 U/µl) was added to the 
PCR reaction and mixed thoroughly. The reaction was then immediately incubated at 37 
ºC for 2 hours to digest the parental supercoiled double-stranded DNA. 1 µl of the 
Dpn1-treated DNA was transformed into separate 50 µl aliquots of XL1-Blue 
supercompetent cells. The XL1-Blue supercompetent cells, typically stored at -80
o
C, 
were thawed out slowly on ice prior to transformation. 1µl of plasmid DNA was then 
added to the bacteria and this transformation mixture was placed on ice for 30 minutes, 
followed by incubation at 42
o
C for exactly 45 seconds. The transformed bacteria were 
then returned to the ice for a further 2 minutes. 500 µl of SOC media was added to the 
transformed bacteria and incubated at 37
o
C with shaking for one hour. The bacteria 
were then plated onto L-agar containing the appropriate antibiotic and incubated at 37
o
C 
overnight. The plasmid DNA purified from the individual colonies was sequenced using 
sequencing primers (primers were ordered from Thermo Fisher Scientific, Germany, see 
Appendix 1 for primer sequences). DNA from positive colonies was then used to 
perform a Gateway
TM 
LR recombination reaction between the mutagenic pENTR 
(PAK6) entry clone and the pEGFP-C1 (Clontech, UK) destination vector, modified for 
use in the Gateway
TM 
Technology system, according to manufacturer’s instructions.  
 
2.2.2 Mammalian cell culture 
DU145 human prostate cancer cells (obtained from Claire Wells, King’s College 
London) and DU145 enhanced GFP (EGFP) cells (a kind gift from Yolanda Calle, 
King’s College London) were cultured in 10% FBS, 90% RPMI-1640 with L-
Glutamine and penicillin-streptomycin. HT29 human colon cancer cells and HEK293 
human embryonic kidney cells, both obtained from Claire Wells, King’s College 





streptomycin, 4.5 g/L D-Glucose, 25 mM Hepes media. All media were warmed before 
use to 37
o
C. All cell lines were cultured at 37
o
C in a tissue culture incubator with 
humidified air, supplemented with CO2 to 5% over atmospheric levels. Cells were 
passaged and maintained at sub-confluent levels. During cell passaging the growth 
medium was removed and the cells were washed with 5 ml PBS prior to incubation with 
1 ml trypsin/EDTA at 37
o
C until the adherent cells had detached. 4 ml of 10% FBS in 
RPMI-1640 or 10% FBS DMEM+GlutaMAX
TM 
media (as appropriate) was then added 
to the cells. Cells were pelleted by centrifugation at 1000 rpm for 5 minutes. The media 
was carefully removed and the cell pellet re-suspended in 10% FBS media. An 
appropriate dilution of these cells was subsequently added to 10% FBS media in a fresh 
tissue culture flask to give a total volume of 10 ml. 
 
2.2.3 Transient transfection 
FuGene HD 
Cells were plated at an appropriate density the day before transfection (table 2.7) in 
10% FBS media. A transfection reaction was set up by the addition of a specific 
concentration of DNA to serum-free OptiMEM media and then incubated at room 
temperature for 5 minutes. Following this, typically three times the volume of FuGene 
HD to DNA was added. To allow for complex formation, the mixture was then 
incubated for 30 minutes at room temperature, in accordance with the manufacturer’s 
instructions. The serum-containing media was replaced with serum-free OptiMEM. 
After 30 minutes, the DNA: FuGene HD complexes were added to the cells. Following 




Cells were plated at an appropriate density the day before transfection (table 2.7) in the 
appropriate 10% FBS media. To set up a transfection reaction, 3 µl of lipofectamine 
2000 was diluted in 100 µl serum-free OptiMEM media. In a separate eppendorf, 3 µg 
of DNA was added to 100 µl serum-free OptiMEM media. The mixtures were left at 
room temperature for 5 minutes. Following this, the lipofectamine 2000: OptiMEM mix 
was added dropwise to the DNA: OptiMEM mix and then incubated at room 
temperature for 15 minutes. Prior to the addition of the DNA: lipofectamine 2000 
complexes to the cells, serum-containing media (10% FBS) was replaced with serum-
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free media. The cells were then incubated with the transfection reagents for seven hours 
























1: 3  









































All tagged constructs 
transfected into 
HEK293 cells 
   Table 2.6 Optimised transient transfection protocols  
 
Calcium phosphate transfection 
Cells were seeded at a density of 1x10
5 
/ml (table 2.7) and then incubated at 37°C for 
24 hours. The medium was changed 3-4 hours prior to transfection. The transfection 














10cm tissue culture dish 
(10 ml) 
2cm tissue culture dish  
(2 ml) 
To tube A add: 
 
36 µl 2M CaCl2 
20 µg DNA 
Make volume to 300 µl 
with sterile water 
 
To tube B add: 
 
300 µl 2x Hepes buffered 
saline (HBS) 
 
To tube A add: 
 
7.2 µl 2M CaCl2 
4 µg DNA 
Make volume to 60 µl 
with sterile water 
 
To tube B add: 
 
60 µl 2x Hepes buffered 
saline (HBS) 
 
                       Table 2.7 Calcium phosphate transfection conditions 
 
The calcium chloride (CaCl2), DNA and water mixture was added dropwise to the 2x 
HBS with aeration until depleted. The transfection complex was then incubated at room 
temperature for 30 minutes. The transfection mix was then added dropwise to the cells, 
dispersed and incubated at 37°C overnight. The medium was then replaced with fresh 
medium and incubated for 24 hours.  
 
HiPerfect for siRNA transfections  
Cells were plated at an appropriate density the day before transfection (table 2.9) in 
10% FBS media. To set up a transfection reaction, 75 nM (for PAK6 siRNA oligo 1) or 
225 nM (for PAK6 siRNA oligo 2) was diluted in serum-free OptiMEM media to give a 
total volume of 100 µl (see Appendix 2 for siRNA target sequences). Equal 
concentrations of control siRNA as PAK6 siRNA were used. To this, 12 µl of HiPerfect 
was added. The transfection mix was then incubated at room temperature for 30 
minutes. The transfection mix was subsequently added dropwise to the cells and 










    Table 2.8 Optimised HiPerfect transfection protocol for siRNA transfections 
 
2.2.4 Cell lysis 
Cells were washed twice in PBS and lysed on ice in 0.5% NP-40 lysis buffer 
supplemented with a protease inhibitor cocktail for 10 minutes. The whole cell lysates 
were then scraped and centrifuged for 10 minutes at 13000 x g for 10 minutes to remove 
cell debris. The supernatant was removed and placed in a fresh tube for storage. 10 µl of 
2x SDS Gel sample buffer (GSB) was added to the lysates and the samples boiled at 
90ºC for 3 minutes. 
 
2.2.5 Immunoprecipitation 
Typically 5 µl of the appropriate IP antibody was added to the lysis supernatant (see 
section 2.2.4) and incubated overnight at 4ºC on a rotating wheel. The following day, 
protein G beads were washed three times in lysis buffer. The beads were re-suspended 
in an appropriate volume of lysis buffer prior to adding 30 µl of bead slurry to each IP 
sample. The samples were then incubated for 1 hour on a rotating wheel at 4˚C.  Each 
IP, and untransfected (UT) control, was pulse spun following incubation and washed 
three times with lysis buffer. 2x GSB was added to each sample and boiled at 90°C for 
3 minutes. 
 
2.2.6 Gel electrophoresis and immunoblotting 
Proteins were loaded onto appropriate % gels and electrophoresed. Proteins were then 
blotted onto nitrocellulose membranes. The blots were then blocked in 5% milk or 5% 
BSA/TBS-Tween as appropriate for one hour at room temperature and incubated with 
primary antibodies overnight at 4°C. Blots were then washed for three 10 minute 




























































washes with 0.1% TBS-Tween. Blots were then incubated with HRP-conjugated 
secondary antibodies for one hour at room temperature. Blots were then subjected to a 
further three 10 minute washes with 0.1% TBS-Tween. If re-probing was required, the 
blots were incubated in stripping buffer for 15 minutes which was then removed and 
replaced with fresh stripping buffer for a further 15 minutes. The blots were then 
washed with 0.1% PBS-Tween for 5 minutes. Subsequently the blots were blocked for 1 
hour in 5% milk or 5% BSA/TBS-Tween as appropriate and incubated overnight with 
primary antibodies at 4°C.  
 
2.2.7 In vitro kinase assay 
The immune complexes were prepared as described in section 2.2.5, washed three times 
with lysis buffer, once with lithium chloride wash buffer and once with a kinase buffer 
wash. A kinase cocktail solution was diluted 1:1 with dH2O. 10 µl per sample of this 
was transferred to a separate eppendorf. To a new eppendorf, 10 µl per sample of dH2O, 
5 µl of histone H1 and 5 µl of 5x reaction buffer per sample was added. 1.25 µl of 
gamma-phosphorus 32-labelled ([γ-32P]) ATP per sample was then added to the kinase 
cocktail: dH2O mix. 10 µl per sample from this was transferred to the reaction buffer: 
histone H1: dH2O mix, resulting in the complete kinase reaction mix. To each sample 
25 µl of the complete kinase reaction mix was added. The samples were then incubated 
at 30°C for 30 minutes with gentle mixing every 10 minutes. 10 µl of 2x GSB was 
added to each sample to stop the reaction and the samples were boiled at 100°C for 3 
minutes. Histone H1 or XFP-tagged immunoprecipitated proteins were used as 
substrates as appropriate. 
 
2.2.8 GST pulldown assays  




in each 10cm tissue culture dish and were grown in 10% 
FBS RPMI-1640 for 48 hours. Cells were then lysed with 1 ml lysis buffer (0.5% NP-40 
lysis buffer supplemented with a protease inhibitor cocktail) per 10cm tissue culture 
dish or serum-starved in 0.5% FBS RPMI-1640 for 24 hours prior to lysis. They were 
either unstimulated or stimulated with HGF (500 ng/ml) for specific time points as 
required before lysis. GST beads, pre-washed with the lysis buffer: protease inhibitor 
cocktail, were used to pre-clear the lysates for one hour prior to incubation with GST 
purified protein beads (also pre-washed in the lysis buffer: protease inhibitor cocktail) 
for two hours at 4ºC on a rotating wheel. Subsequently, the unbound fractions were 
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discarded and the beads were washed three times in the lysis buffer: protease inhibitor 
cocktail prior to the addition of 25 µl of 2x SDS sample loading buffer. The samples 
were then boiled for 10 minutes at 90ºC and loaded onto the appropriate % 
polyacrylamide gels and were immunoblotted (WB). 
 
For GST pulldown assays in the presence of over-expressed XFP-tagged constructs 
cells were seeded at 1x10
5 
/ml in each 10cm tissue culture dish and were grown in 10% 
FBS media for 24 hours and each dish was transfected with the appropriate XFP-tagged 
construct using the calcium phosphate transfection kit (see section 2.2.3). Following 24 
hours the media was replaced and incubated for a further 24 hours. Cells were then 
lysed as usual.  
 
Typically 5 µl of the GST alone expression plasmid or 200 µl of GST fusion proteins 
were used per sample in the GST pulldown assays. 
 
2.2.9 Immunofluorescence 
Preparation of coverslips 
13 mm diameter No. 1 glass coverslips were placed in a solution containing 40% of 1 M 
HCL and 60% of 96% ethanol overnight, gently rinsed three times in dH2O and then 
boiled. The coverslips were then rinsed a further six times with dH2O. Excess water was 
drained and the coverslips were incubated in an oven at 150°C overnight for sterilisation 
before being used.  
 
a. Rat tail collagen type I coated coverslips 
A 50 μg/ml solution of rat tail collagen type I (hereafter referred to as collagen I) was 
prepared in 20 mM acetic acid under sterile conditions. 100 µl of the mix was added to 
each 13 mm coverslip and incubated at room temperature for 1 hour. The coverslips 
were then washed twice with sterile PBS and were then ready for use. 
 
b. Fibronectin coated coverslips 
10 µl of fibronectin was added to 1 ml sterile PBS. 100 µl of the mix was added to each 
13 mm coverslip and incubated at room temperature for 45 minutes. The coverslips 




c. 2D matrigel coated coverslips 
Matrigel was allowed to thaw on ice. A 1 in 100 dilution of the matrigel in serum-free 
media was set up. 100 µl of the mix was added to each 13 mm coverslip and incubated 
at 37°C for 1 hour. The coverslips were then washed twice with sterile PBS and were 
then ready for use. 
 
Immunofluorescent labelling 
Cells were fixed with 4% PFA in PBS at room temperature for 20 minutes and washed 
three times with PBS before being permeabilised with 0.2% Triton X-100/PBS for 5 
minutes. Cells were then washed three times with PBS. For F-actin alone (this includes 
XFP-tagged expressing cells), cells were incubated at room temperature for 1 hour with 
TRITC-Phalloidin (1 in 1000 dilution in 3% BSA-PBS) or Phalloidin 633 (1 in 200 
dilution in 3% BSA-PBS). The coverslips were then washed twice with PBS and once 
with dH2O before being mounted in 10 µl FluorSave
TM 
Reagent on glass slides.  
 
For Paxillin or E-cadherin staining, cells were blocked in 3% BSA-PBS for 30 minutes. 
They were then washed three times with PBS and incubated at room temperature for 2 
hours with an anti-paxillin antibody (1 in 50 dilution in 3% BSA-PBS) or with an anti-
E-cadherin antibody (1 in 50 dilution in 3% BSA-PBS). Cells were then washed three 
times with PBS and incubated with Alexa Fluor® 488 or 568 goat anti-mouse antibody 
(1 in 200 dilution in 3% BSA-PBS) in addition to TRITC-Phalloidin (1 in 1000 in 3% 
BSA-PBS) or Phalloidin 633 (1 in 200 dilution in in 3% BSA-PBS). Coverslips were 
then washed and mounted as described for F-actin staining alone. Images were collected 
on an Olympus IX71 inverted microscope, or a Carl Zeiss LSM510 META laser 
scanning confocal microscope. 
 
2.2.10 Time-lapse microscopy 
Cells seeded into six-well plates and supplemented with 20 mM Hepes (Invitrogen, UK) 
were placed on the automated and heated stage of an Olympus IX71 microscope. Cell 
images were collected using a Retiga SRV CCD camera, where a frame was captured at 
5 minute intervals over 24 hours from each of the six wells using Image-Pro Plus 
software (supplied by MAG, UK). Following acquisition, the time-lapse sequences were 
displayed as a movie and saved as AVI files. These files could then be used to manually 
track cells for the whole of the time-lapse sequence using Motion Analysis software 
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(ANDOR IQ Technology, Belfast, UK). This resulted in the generation of a sequence of 
position co-ordinates corresponding to each cell in each frame which was subsequently 
saved as Cel files. A total of 30-60 cells were tracked over 3 independent films per 
condition. The Cel files were then subjected to mathematical analysis using 
Mathematica 6.0™ notebooks developed in-house by Prof. G. Dunn and Prof. G. Jones 
to obtain the mean migration speed and statistical significance, which was accepted for 
P ≤ 0.05. 
 
2.2.11 Cell scatter assay in a 3D matrix 
The Lab-Tek® chambered #1.0 8 chamber borosilicate coverglass system (Nunc, USA) 
was used. 100 µl of matrigel was added to the bottom of all 8 wells. This was allowed to 
set at 37ºC for 1 hour. 2 µl of matrigel and 98 µl of collagen I was mixed with 2.4x10
4
 
DU145 cells in a 100 µl suspension. This was left to set at 37ºC overnight. Once set, 
chamber wells were supplemented with 100 µl 10% FBS RPMI-1640 media and 
subsequently every other day. Following one week, media was removed and cells were 
fixed with 4% PFA and 0.25% glutaraldehyde in PBS at room temperature for 20 
minutes and washed three times with PBS before being permeabilised with 0.2% Triton 
X-100/PBS for 5 minutes. Cells were then washed three times with PBS and incubated 
at room temperature for 1 hour with TRITC-Phalloidin diluted 1 in 1000 in 3% BSA-
PBS for F-actin staining. For DAPI staining, cells were incubated with 3 µm DAPI 
diluted in PBS and left at room temperature for 5 minutes and washed three times with 
PBS. Images were collected on a Carl Zeiss LSM510 META laser scanning confocal 
microscope. 
 
For live-cell imaging of cells, the chamber was set up as described above. Following a 
week, the chamber wells were washed 3 times with PBS and serum-starved with 0.5% 
FBS RPMI-1640 media. Following 24 hours, cells were stimulated with HGF (500 
ng/ml) and left at 37ºC for a further 48 hours. Unstimulated cells were serum-starved 24 
hours prior to filming. The cells were then filmed for 24 hours using the set up 
described in section 2.2.10.  
 
2.2.12 HGF-and EGF-induced cell scatter assay on 2D substratum 
Cells were seeded onto coverslips at a density of 0.5x10
4 
/ml and allowed 48 hours to 
form colonies. Cells were serum-starved with 0.5% FBS media 24 hours. The media 
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was not changed prior to growth factor stimulation. Cells were then fixed with 4% PFA 
after 24 hours. 
 
HGF-induced cell scattering quantification 
Cells were counted and cell counts of starved versus starved plus HGF stimulation were 
compared. The % of scattered cells per experiment was calculated using the following: 
 
Unscattered + attempted scatter + scattered = n  
Scattered/n x 100 = % of scattered cells 
 
The % of attempted scatter cells per experiment was calculated using the following: 
Unscattered + attempted scatter + scattered = n  
Attempted scatter/n x 100 = % of attempted scatter cells 
 
2.2.13 Data analysis 
Image processing and cell shape analysis 
Image J software was used to elucidate the morphology of each cell by manually 
drawing around individual cells and then processing the data to give elongation ratios 
and cell spread areas. In order to determine the elongation ratio of a cell, Image J shape 
analysis software divides the shortest cell diameter by the longest. Therefore, the ratio 
for an elongated cell morphology generated by Image J is a small numerical value. 
Hence, in order to aid graphical representation of the results acquired, all elongation 




The autoradiographs were saved as TIF files in Adobe Photoshop CS5 and ANDOR IQ 
Technology software was used to quantify desired protein levels. In this analysis system 
it was assumed that 0 is black and the maximal value is 255 at 8 bits per pixel. These 

















Development of an HGF-induced 3D 




















Chapter 3 – Development of an HGF-induced 3D cell scatter assay  
3.1 Introduction 
It has long been established that growth factors can promote cell migration both in vitro 
and in vivo. Indeed, HGF is known to be a mitogenic (Clark, 1994) and motogenic  
(Cantley et al., 1994; Niranjan et al., 1995) growth factor that is important during 
normal development. HGF signalling is also implicated in prostate carcinoma metastasis 
(Fujiuchi et al., 2003; Gmyrek et al., 2001; Wells et al., 2005) and the HGF receptor c-
Met is known to be over-expressed in prostate cancer (van Leenders et al., 2002).  
 
HGF was found to induce cell scattering in colony-forming MDCK cells and was 
thereafter used as an EMT model (Stoker and Perryman, 1985). Subsequently, other 
cells have been shown to respond to HGF, including DU145 prostate cancer cells 
(Davies et al., 2004; Wells et al., 2005). Cell scattering involves cell-cell dissociation 
and the loss of junctional E-cadherin localisation (Miura et al., 2001). As such, the 
HGF-induced DU145 scatter model has been used in live-cell imaging to show the 
migration of single DU145 cells in response to HGF and to observe and track actin 
cytoskeletal changes, as well as modifications in intercellular adhesions, downstream of 
HGF stimulation (Bright et al., 2009; Wells et al., 2005).  
 
During tumour cell invasion and metastasis, cancer cells must acquire a migratory 
phenotype to move through the 3D environment of the ECM. It has been documented 
that tumour cells exhibit different properties in 2D and 3D substrata (Sahai, 2007). 
Therefore, 3D model systems are being employed to investigate cell migration in an 
environment similar to that found in vivo (Yamazaki et al., 2009; Zaman et al., 2006).  
 
In this chapter, the 2D HGF-induced scatter assay has been further optimised (Fram et 
al., 2011) and an attempt has been made to translate this assay into a 3D model. In 









3.2.1 DU145 cells scatter in response to HGF stimulation 
It has been previously reported that HGF stimulation elicits scattering in colony-
forming DU145 cells (Wells et al., 2005). To confirm the ability of HGF to induce 
DU145 cell scattering, DU145 cells were maintained in low serum prior to HGF 
stimulation for 4 and 24 hours. DU145 cells grew as colonies in serum-starved 
conditions (minus HGF) with tight cell-cell junctions and prominent E-cadherin 
localisation at the junctions (figure 3.1). Following 4 hours HGF stimulation, colony 
edge cells began to dissociate and this was characterised by a change in their cell 
morphology and a reduction in E-cadherin staining localised at the cell-cell junctions 
(figure 3.1, arrows). Twenty four hours after HGF addition, the majority of the DU145 
cells had scattered and exhibited an elongated migratory phenotype with little or no E-
cadherin staining visible at cell-cell boundaries (figure 3.1). These observations were 
consistent with previous reports that E-cadherin re-localises from cell-cell junctions to 
the cytosol upon HGF stimulation (Miura et al., 2001).  
 
3.2.2 Optimal HGF-induced DU145 cell scattering occurs after 2-5 weeks of 
culturing 
A robust HGF-induced scatter assay requires cells that grow as tight colonies in the 
absence of HGF. The efficiency of HGF-induced DU145 cell scattering may be affected 
by continual cell culturing. Therefore, an optimal time window for tight colony 
formation in the absence of HGF, as well as cell scatter induction in the presence of 
HGF, needed to be defined. 
 
DU145 cells were plated at a low density to favour the growth of cell colonies (figure 
3.2A, minus HGF) (see section 2.2.12). Serum-starved DU145 cells were then 
stimulated with HGF to induce cell-cell dissociation and independent migration (figure 
3.2A, plus HGF). This experiment was repeated in exactly the same manner over 7 
weeks using cells from the same population. The efficiency of the DU145 cell scatter 
response to HGF stimulation was found to change with time. The optimum time for 
scattering was defined as the point at which the scattered cell count was at its lowest in 
the low serum conditions and the scatter response was at its highest following HGF 

























Figure 3.1 HGF induces scattering in DU145 cells. Cells were serum-starved (minus 
HGF) for 24 hours prior to 4 hours or 24 hours HGF (10 ng/ml) stimulation (plus HGF). 
Cells were then fixed and labelled for E-cadherin and F-actin. Arrow marks point of 
cell-cell dissociation (plus HGF (4 hours), Actin) and reduction in junctional E-cadherin 
staining (plus HGF (4 hours), E-cadherin). Images shown are representative of 3 





























Figure 3.2 Optimisation of the HGF-induced scattering model in DU145 cells. A) 
The HGF-induced DU145 scatter assay was conducted. Cells were serum-starved for 24 
hours and were either left untreated (minus HGF) or were treated with HGF (plus HGF) 
(10 ng/ml). After 24 hours the cells were fixed and stained for F-actin. Images illustrate 
categorisation of the DU145 cells minus and plus HGF. Unscattered = cells in a colony 
as marked (minus HGF). One cell adjoined to another was also classed as within a cell 
colony, even if these cells were detached from the remainder of the colony. Attempted 
Scatter = cells remain attached to one another but also exhibit an elongated phenotype 
and there is some loss of cell-cell junctions as indicated in centre (plus HGF). Scattered 
= loss of cell-cell junctions and single cells with an elongated migratory phenotype as 
indicated at top right (plus HGF). B) The HGF-induced DU145 scatter assay was 
conducted over 7 weeks and the mean % of scattered cells was calculated. The optimum 







between 2-5 weeks of culturing following cell recovery from cryogenic storage was 
deemed optimal and therefore, was used in all subsequent experiments (Fram et al., 
2011). 
 
3.2.3 Effect of substratum on HGF-induced DU145 cell scattering 
It has been reported that the rigidity of the underlying ECM can affect the migratory 
behaviour of cells (Lo et al., 2000). Matrigel, collagen and fibronectin are commonly 
used in 2D and 3D in vitro cell migration assays to examine tumour cell migration and 
metastasis. The ECM environment of connective tissues is rich in collagen I; thus this 
type of collagen is the most commonly used for in vitro studies (Hooper et al., 2006). 
Matrigel is employed as its composition resembles that of basement membranes and is a 
mixture of various proteins that is particularly rich in collagen V and laminins (Hooper 
et al., 2006). Lastly, fibronectin is a suitable component in migration assays as this 
ECM protein is secreted by a number of cell types (Hershkoviz et al., 1992; Lam et al., 
2003; Peters et al., 1990; Tse et al., 2011). Prior to attempting to establish a 3D scatter 
assay, the effect of matrix composition on HGF-induced cell scattering was quantified 
using serum (glass coverslips placed in 10% FBS media for 48 hours prior to serum-
starving), fibronectin, collagen I and 2D matrigel coated coverslips.  
 
Serum-starved, unstimulated DU145 cells seeded on all the tested substrata possessed 
prominent actin fibers with paxillin-rich cell-substratum adhesion sites around the 
entirety of the cell colony (figure 3.3A). No obvious change in adhesions or 
morphology was visible between the different substrata. All of the tested substrata 
supported cell scattering upon addition of HGF to a significant level, notably on 
collagen I substratum, when compared to the minus HGF control cells (figure 3.3B).  
 
3.2.4 Effect of substratum on DU145 cell speed upon HGF stimulation 
Live-cell imaging was employed to directly examine the migration of single DU145 
cells in response to HGF and to compare the migration speed of these scattering cells on 
the different substrata. The migration paths for HGF-stimulated DU145 cells were 
manually tracked and processed. The migration of individual cell tracks were plotted 
and shifted to an origin of (x0, y0) (figure 3.4A). As a control, serum-starved DU145 
cells were filmed in the absence of HGF for all the substratum tested. In these 
























Figure 3.3 Variation in HGF-induced DU145 cell scattering response on different 
2D substratum. A) DU145 cells seeded onto serum, fibronectin, 2D matrigel and 
collagen I coated coverslips were serum-starved for 24 hours, fixed and then labelled for 
paxillin and F-actin in the absence of HGF addition. B) The HGF-induced DU145 
scatter assay was conducted using serum, fibronectin, 2D matrigel and collagen I coated 
coverslips. Cells were serum-starved for 24 hours prior to HGF (10 ng/ml) stimulation. 
After 24 hours cells were fixed and stained for F-actin. Scattered = loss of cell-cell 
junctions and single cells with an elongated migratory phenotype. Cells were counted 
and cell counts of minus HGF versus plus HGF were compared. The mean % of 
scattered cells and the standard error of the mean were calculated over 3 independent 
experiments for each substratum. Statistical significance compared with minus HGF 























Figure 3.4 Effect of 2D substratum on DU145 cell migration speed upon HGF 
stimulation. A) DU145 cells seeded onto serum, fibronectin, 2D matrigel and collagen 
I coated coverslips were then serum-starved for 24 hours, stimulated with HGF (10 
ng/ml) and filmed for 24 hours at 5 minute intervals using phase-contrast time-lapse 
microscopy. All colony edge cells were then tracked using ANDOR IQ Technology 
software and processed in Mathematica©. Plots of individual cell tracks are displayed 
centered at (x0,y0). B) The mean migration speed and the standard error of the mean 
(SEM) for 3 independent experiments for each substratum were calculated for cells 
tracked in (A). Statistical significance compared with serum substratum was calculated 






hours filming (see movie 1 for representative movie and Appendix 3). DU145 cells 
displayed a significant increase in mean migratory speed following HGF addition on 
fibronectin (0.5 µm/min ± 0.027 SEM), 2D matrigel (0.5 µm/min ± 0.048 SEM) and 
collagen I (0.63 µm/min ± 0.077 SEM) when compared to serum-coated substratum 
(0.35 µm/min ± 0.036 SEM) (figure 3.4B and see movie 2 for representative movie and 
Appendix 3). DU145 cells seeded onto collagen I exhibited a higher mean migration 
speed when compared to all the substrata used, suggesting that collagen I, in the 
presence of HGF stimulation, increases the migration potential of DU145 cells. 
 
3.2.5 DU145 cells scatter in response to EGF stimulation 
EGF signalling is important in the progression of prostate cancer; indeed, the frequency 
of bone metastases was hindered upon the inhibition of EGFR signalling in vivo 
(Angelucci et al., 2006). EGF, like HGF, has been shown to enhance prostate cancer 
cell migration (Zhou et al., 2006). EGF has also been shown to enhance the invasive 
potential of DU145 prostate carcinoma cells (Turner et al., 1996) and, following the 
completion of these studies, this growth factor was reported to induce the disassembly 
of cell-cell boundaries in DU145 cells (Gan et al., 2010). However unlike HGF, EGF 
has not been tested in a prostate cancer cell scatter assay. Prior to performing the 
DU145 scatter assay with EGF, DU145 whole cell lysate was immunoblotted for EGFR 
to confirm its expression in this cell line. EGFR was found to be expressed in DU145 
cells (figure 3.5A).                                       
 
EGF was found to be able to induce cell scattering in DU145 cells (figure 3.5B, plus 
EGF). Serum, fibronectin and collagen I substratum all supported the scattering effect 
when compared to serum-starved control cells (minus EGF) (figure 3.5C). However 
unlike HGF, the addition of EGF was not enough to significantly increase the scattering 
potential of cells on 2D matrigel coated substratum, when compared to serum-starved 
conditions (minus EGF) (figures 3.3B and 3.5C).  
 
3.2.6 HGF induces cell scattering in HT29 cells 
It has been reported that HGF also induces the scattering of HT29 colon 
adenocarcinoma cells; however, this scattering effect induced by HGF was not 
quantified (Herrera, 1998). Therefore, to complement the use of DU145 cells, and to 




















Figure 3.5 EGF induces DU145 cell scattering. A) DU145 whole cell lysate was 
immunoblotted for EGFR. B) The EGF-induced DU145 scatter assay was conducted. 
Cells seeded onto glass coverslips were serum-starved for 24 hours, and were then 
either left untreated (minus EGF) or were treated with EGF (plus EGF) (100 ng/ml). 
After 24 hours the cells were fixed and stained for F-actin. C) DU145 cells were seeded 
onto serum, fibronectin, 2D matrigel or collagen I coated coverslips and treated as 
described in (B). Cells were counted and scattered cell counts of serum-starved versus 
plus EGF stimulation were compared. Scattered = loss of cell-cell junctions and single 
cells with an elongated migratory phenotype as discernible in (B) (plus EGF). The mean 
% of scattered cells and the standard error of the mean were calculated over 3 
independent experiments for each substratum. Statistical significance compared with 






scattering potential downstream of HGF. HT29 cells are morphologically similar to 
DU145 cells in that they form multi-cellular colonies. Expression of the HGF receptor, 
c-Met, was confirmed in the HT29 cell line (figure 3.6A). Initial assays using HGF at a 
concentration of 10 ng/ml induced a minimal scatter response (figure 3.6B). However it 
was evident that the cells were attempting to scatter upon addition of the growth factor 
when the serum-starved (minus HGF) and attempted scatter cell counts were compared 
(figure 3.6B). In order to optimise the HT29 scatter assay, the time of stimulation was 
increased from 24 hours to 48 hours. However no difference was observed when 
compared to 24 hours HGF addition (data not shown). 
 
Closer examination of western analysis revealed that a higher level of c-Met receptor 
expression was present in the HT29 cells when compared to DU145 cells (figure 3.6A). 
Thus it was speculated that an increased concentration of HGF may be required to 
occupy the higher level of c-Met receptor that was detected. Hence a range of HGF 
concentrations were tested for their affect on HT29 cell scattering (figure 3.6C). A P 
value of < 0.05 was obtained, when compared to control cells (0 ng/ml), when 
concentrations of 30 ng/ml and 120 ng/ml HGF were used. Moreover, a more 
significant P value of < 0.0005 following the addition of 60 ng/ml HGF was obtained 
when compared to control cells (0 ng/ml). Thus 60 ng/ml was used for subsequent 
HT29 cell investigations. Morphological changes were induced when HT29 cells were 
stimulated with HGF (60 ng/ml) and the scatter response was represented by cell-cell 
dissociation and independent migration (figure 3.6D, plus HGF). Whilst a higher 
expression level of c-Met was observed in the HT29 cells when compared to DU145 
cells, it could be speculated that the surface level of c-Met is lower on HT29 cells. This 
could in part account for the reduced scattering obsesrved in response to HGF treatment 
in this cell line when compared to DU145 cells. 
 
3.2.7 Effect of substratum on HGF-induced HT29 cell scattering 
Previous work showed that DU145 cell scattering was supported on multiple matrices 
(figure 3.3B). Therefore, the ability of the different matrices to support HGF-induced 
HT29 cell scattering was also tested. Serum-starved, unstimulated HT29 cells seeded on 
serum, fibronectin, 2D matrigel and collagen I coated coverslips all possessed 


















Figure 3.6 Optimisation of HGF-induced HT29 cell scattering. A) DU145 and HT29 
whole cell lysates were immunoblotted for c-Met expression and for β-tubulin as a 
loading control. B) The HGF-induced scatter assay was conducted using HT29 cells. 
Cells were seeded onto glass coverslips and serum-starved for 24 hours prior to 24 
hours HGF (10 ng/ml) stimulation. Cells were then fixed and stained for F-actin. Cells 
were counted and cell counts of serum-starved versus serum-starved plus HGF were 
compared. Attempted Scatter =  cells remain attached to one another but also exhibit an 
elongated phenotype and there is some loss of cell-cell junctions. Scattered = loss of 
cell-cell junctions and single cells with an elongated migratory phenotype. C) The 
HT29 scatter assay was repeated as described in (B) using varying concentrations of 
HGF as indicated. D) Serum-starved (minus HGF) and HGF-stimulated (plus HGF) (60 
ng/ml) HT29 cells were stained for F-actin as described in (B). In (B) the mean % of 
cells and in (C) the mean % of scattered cells and the standard error of the mean were 
calculated over 3 independent experiments. Statistical significance compared with 








cell colony (figure 3.7A). This was consistent with the morphology observed previously 
for DU145 cells (figure 3.3A). Analysis of the HGF-induced scatter assay results 
demonstrated that all substrata tested supported cell scattering, with the most significant 
level of scattering observed on serum and collagen I (figure 3.7B). Interestingly, the 
mean percentage of scattered cells in unstimulated conditions (minus HGF) was 
significantly lower for all the substrata tested using HT29 cells when compared to 
DU145 cells (figures 3.3B versus 3.7B).  
 
3.2.8 Optimisation of the HGF-induced scatter assay in a 3D matrix 
Although 2D cell migration assays can deliver useful characterisation of cell behaviour 
and help to identify key regulatory proteins, 2D assays do not closely reflect the in vivo 
environment. Therefore, to complement the 2D studies conducted, a 3D model of HGF-
induced cell migration was attempted. DU145 cells were chosen for the 3D model 
instead of HT29 cells as DU145 cells were more responsive to HGF in 2D (figure 3.3 
versus figures 3.6 and 3.7). HGF was chosen as the growth factor stimulant as it 
appeared to be a more effective cell scattering inducer than EGF (figure 3.3B versus 
figure 3.5C).  
 
The first objective was to identify a matrix composition that would support the 
formation of cell colonies and allow serum-starvation without significant cell scattering. 
Following matrix composition trials (data not shown), and based on the previous data 
obtained in chapter 3, it was established that a matrix of 98% collagen I and 2% 2D 
matrigel best supported colony growth (figure 3.8A, grow and minus HGF). Cell 
colonies were easily identified by prominent actin staining coupled with multiple DAPI 
stained nuclei in both basal and serum-starved conditions. Sometimes, in 3D matrix 
assays, the cells imaged are actually adhered to the bottom of the well. Therefore, to 
ensure that the cell colonies detected were fully embedded within the matrix, images 
were captured where cell colonies were found to be present across different planes 
within the same 3D matrix field of view (figure 3.8B). Whilst colonies of DU145 cells 
were detected in the 3D matrix, full lumen formation was not observed. DU145 cells are 
metastatic epithelial cells, thus it is possible that these cells have lost properties that are 
typical of non-transformed epithelial cells and have acquired mesenchymal-like 






















Figure 3.7 Variation in HGF-induced HT29 cell scattering response on different 
2D substratum. A) HT29 cells seeded onto serum, fibronectin, 2D matrigel and 
collagen I coated coverslips were serum-starved for 24 hours, fixed and then labelled for 
paxillin and F-actin in the absence of HGF. B) The HGF-induced HT29 scatter assay 
was conducted using serum, fibronectin, 2D matrigel and collagen I coated coverslips. 
Cells were serum-starved for 24 hours prior to HGF (60 ng/ml) stimulation. After 24 
hours cells were fixed and stained for F-actin. Cells were counted and cell counts of 
starved versus starved plus HGF stimulation were compared. Scattered = loss of cell-
cell junctions and single cells with an elongated migratory phenotype. The mean % of 
scattered cells and the standard error of the mean were calculated over 3 independent 
experiments for each substratum. Statistical significance compared with minus HGF 

















Figure 3.8 DU145 cells are able to form colonies and respond to HGF in a 3D 
matrix. A) DU145 cells were grown in a 98% collagen I and a 2% matrigel 3D matrix 
(see section 2.2.11). Following one week, cells were either left in growth conditions 
(Growth) (10% FBS), serum-starved (minus HGF) (0.5% FBS) for 24 hours or serum-
starved 24 hours prior to HGF stimulation (20 ng/ml) for 24 hours. Cells were then 
fixed and stained for F-actin and for cell nuclei. B) DU145 cells were treated as 
described in (A) but were maintained in 10% FBS grow media. Cells were fixed and 
stained for F-actin and for cell nuclei. The images displayed were captured in the same 
field of view but in a different plane in the matrix. In (A) and (B) the images were 
collected as single images using confocal microscopy and are representative of 3 





test this hypothesis, non-transformed epithelial cells could be used as a control in the 3D 
assay (for example, MDCK cells), as well as other metastatic epithelial cancer cell lines.  
 
The second objective was to be able to induce cell scattering within this 3D matrix. 
DU145 cell colonies in the 3D matrix were serum-starved and stimulated with HGF. 
Following 24 hours stimulation with 20 ng/ml HGF, there was some evidence of colony 
breakdown, where the F-actin distribution around the colony periphery was undulating 
in appearance (figure 3.8A, plus HGF). This may correspond to the ruffling of the 
colony edge cells that is known to occur following HGF stimulation in 2D DU145 
HGF-induced scatter assays (Wells et al., 2005). Live-cell imaging was then used to 
attempt to analyse cell migration of DU145 cells embedded in a 3D matrix. However, 
preliminary results were difficult to interpret due to the limitation of only being able to 
film these cells in phase-contrast (data not shown).  
 
3.2.9 HGF increases the migration potential of DU145 cells in a 3D matrix 
To mitigate technical difficulties associated with imaging cell scattering in phase-
contrast, DU145 cells stably expressing EGFP were employed. To confirm that these 
cells had the same morphology and response to HGF as wild-type DU145 cells, the 2D 
DU145 scatter assay was conducted as previously described (see section 3.2.2). In the 
absence of HGF these cells grew in tight colonies (figure 3.9A, minus HGF). Upon 24 
hours HGF stimulation (10 ng/ml), cell-cell contacts were diminished and single cells 
were visible and were exhibiting an elongated phenotype (figure 3.9A, plus HGF). 
Furthermore, there was significant scattering induction by HGF in these cells when 
compared to serum-starved conditions (figures 3.9A and 3.9B). These observations 
were consistent with the results obtained previously for wild-type DU145 cells on 
serum-coated substratum (figure 3.3B).  
 
The DU145 EGFP stable cell line was then used to assess the migration potential of 
DU145 cells in a 3D matrix in the absence and presence of HGF using live-cell 
imaging. Different HGF stimulation time points, as well as different concentrations of 
HGF were investigated in an attempt to induce cell migration in these cells (data not 
shown). The optimal concentration of HGF was found to be 500 ng/ml. In addition, 
DU145 EGFP cells embedded in the matrix were stimulated with HGF for 72 hours 


















Figure 3.9 HGF increases the percentage of migrating DU145 cells. A) The HGF-
induced scatter assay was conducted using DU145 cells stably expressing an EGFP 
lentiviral vector. Cells seeded onto glass coverslips were serum-starved for 24 hours and 
then left untreated (minus HGF) or stimulated with HGF (plus HGF) (10 ng/ml). After 
24 hours cells were fixed and stained for F-actin. B) Cells from (A) were counted and 
cell counts of serum-starved cells versus plus HGF-stimulated cells were compared. 
Scattered = loss of cell-cell junctions and single cells with an elongated migratory 
phenotype as indicated in (A) (plus HGF). C) EGFP lentiviral vector expressing DU145 
cells were seeded into a 98% collagen I and a 2% matrigel 3D matrix and treated in 
preparation for live-cell imaging (see section 2.2.11). Serum-starved cells in the 
absence of HGF were also filmed. A migrating cell was measured by the translocation 
of one cell body and 90 cells for each condition were analysed. In (B) and (C) the mean 
% of scattered cells and the mean % of migrating cells, respectively, were compared 
between minus and plus HGF. The standard error of the mean was also calculated over 
3 independent experiments. Statistical significance compared with minus HGF cells was 







The percentage of migrating cells in the absence and presence of HGF was calculated. 
A migrating cell in the 3D matrix was measured by the translocation of one cell body. 
When compared to minus HGF control cells (figure 3.9C and see movies 3PC and 3G 
for representative movies and Appendix 3), a significantly higher percentage of cells 
stimulated with HGF were migrating (figure 3.9C and see movies 4PC and 4G for 
































In this chapter, the use of cell scatter assays has been further developed. The optimal 
culture time for the HGF-induced DU145 scatter assay has been determined and the 
assay has been extended to investigate different growth factors and a range of matrix 
compositions (Fram et al., 2011). It has been demonstrated that both HGF and EGF 
induce DU145 cell scattering. Moreover, HGF is able to induce cell scattering in the 
colon adenocarcinoma cell line, HT29, on different matrix compositions. Furthermore, 
all the substrata tested supported the HGF-induced cell scatter assay. The optimised 2D 
model system has also been expanded to develop a DU145 HGF-induced cell scattering 
assay in 3D. 
 
Studies described here have shown that serum-starved DU145 cells became more 
scattered over time and displayed a reduction in their ability to form multi-cellular 
colonies; thus a maximum culture time was established. It is possible that prolonged 
culturing of these cells induces the release of endogenous growth factors. This in turn 
may contribute to an increase in the activity of the cells, and hence reduce their ability 
to form cell colonies. In support of this, it has been published that DU145 cells exhibit 
self-sufficiency in growth factors such as EGF which contributes to the activation of 
DU145 cells in vitro (Tillotson and Rose, 1991). In addition, DU145 cells are known to 
possess the ability to secrete quantifiable levels of nerve growth factor (NGF) (Geldof et 
al., 1997), which is a key autocrine signal for cancer growth and metastasis (Dollé et al., 
2003).  
 
There is evidence that the scattering potency of HGF in cells is regulated by the 
extracellular and basement matrices that encompass the cells (Herrera, 1998). A pre-
requisite of the ability of colony-forming cells to induce the morphological 
modifications reminiscent of EMT is their capacity to spread on the underlying ECM 
(Ridley et al., 1995). Cell spreading is known to be modulated by Rho GTPases (Ridley 
et al., 1995) and integrin-mediated signalling (Herrera, 1998). Rho GTPases are 
required for the re-organisation of the actin cytoskeleton during cell movement (Ridley 
et al., 1995) and integrins play an important role in mediating the attachment of cells to 




HGF-induced DU145 cell scattering was maximal on a collagen I substratum. DU145 
cells are known to express a number of matrix interacting integrin proteins including α3, 
α5 and α6 integrin and the subunits β1, β3 and β4, where β1 is the most prevelant 
(Witkowski et al., 1993). Moreover, aberrant expression of integrins has been reported 
in prostate cancer (Bonkhoff et al., 1993; Schmelz et al., 2002). The differences 
observed in DU145 HGF-induced cell scattering may be as a result of varying integrin 
expression. Rabinovitz et al. demonstrated that higher expression levels of the α6 
integrin in DU145 cells elevated the cell migration velocity of these cells on a laminin 
substratum (Rabinovitz et al., 1995). Furthermore, HGF-induced MDCK cell scattering 
increases on collagen I; it was speculated that the integrin α2β1 may facilitate this effect 
(de Rooij et al., 2005; Sander et al., 1998).  
 
The HGF-induced DU145 cell migration speed was highest on collagen I substratum 
when compared to the DU145 cell velocity on serum substratum. A number of factors 
are involved in determining cell migration velocity including ligand and receptor levels 
and their affinity to bind to one another, as well as cytoskeletal interactions 
(Huttenlocher et al., 1996; Palecek et al., 1997). The turnover of integrin-mediated 
adhesions between the cell and ECM is necessary for cell migration to occur 
(Huttenlocher and Horwitz, 2011). It has been proposed that optimal cell migration 
velocity is achieved when integrins and ECM proteins are intermediately expressed, 
resulting in an intermediate level of adhesivity between the cell and ECM (DiMilla et 
al., 1993; Palecek et al., 1997). DU145 cells are known to express the fibronectin 
integrin α5β1 (Witkowski et al., 1993), as well as intermediate levels of the collagen I 
integrin, α2β1 (Patrawala et al., 2007). Therefore, the presence of an intermediate level 
of collagen I and this integrin may account for the maximal migration speed of DU145 
cells on this substratum. 
 
It has been proposed that the efficiency of cell scattering may be linked with cell 
adhesivity rather than the cell migration speed (de Rooij et al., 2005). MDCK cells 
exhibited the highest migration speed but the lowest cell scattering count on laminin 1 
substratum when compared to collagen I and fibronectin (de Rooij et al., 2005). 
However, this does not correlate with the work presented here, where high migration 
speed and increased cell scattering efficiency were both associated with the same matrix 
composition.    
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In order to develop the range of the 2D scatter assay, the scattering potential of the 
growth factor EGF was tested, as EGF is known to increase the invasiveness of DU145 
cells (Turner et al., 1996). All the substrata tested, except for 2D matrigel, supported the 
EGF-induced scatter assay to a significant level in DU145 cells. Indeed, following 
completion of these studies, it was reported that the addition of EGF stimulates cell-cell 
junction disassembly and leads to a reduction in E-cadherin localisation at junctional 
sites (Gan et al., 2010). On 2D matrigel substratum, a higher percentage of single 
DU145 cells were observed under serum-starved conditions when compared to the other 
substrata that were assessed. The matrigel used in the scatter assay was composed of a 
complex mixture of proteins and growth factors. Thus DU145 cells may have been 
activated by these growth signals and hence exhibited a reduced ability to form colonies 
on a 2D matrigel surface. This hypothesis could be tested by using a growth factor 
reduced form of matrigel. Nevertheless, the inability of EGF to induce cell scattering on 
2D matrigel when compared to HGF may suggest that EGF is a less effective cell 
scattering inducer than HGF. 
 
To support this theory, it has been demonstrated that HGF repeatedly elicited a stronger 
migratory response than EGF in primary rat hepatocytes (Stolz and Michalopoulos, 
1994). In addition, EGF-treated cells were morphologically less spread than those 
stimulated with HGF (Stolz and Michalopoulos, 1994). Moreover, HGF was found to 
stimulate the phosphorylation of two specific cytoskeletal-related proteins, whilst EGF 
showed a diminished ability to do so (Stolz and Michalopoulos, 1994). Thus it was 
speculated that in the hepatocyte cytoskeleton HGF and EGF activate different cell 
signalling pathways, and hence exhibit variation in motogenic capabilities (Stolz and 
Michalopoulos, 1994). This may account for the reduction in cell scattering observed 
here between HGF and EGF-treated DU145 cells.  
 
As HT29 cells grow as tight colonies with extensive cell-cell junctions and c-Met 
expression levels are elevated in these cells when compared to DU145 cells, a higher 
concentration of HGF was required to obtain efficient scattering. Consistent with 
DU145 cells, all substrata supported the HGF-induced scatter assay; however HT29 
cells did not scatter as effectively when compared to DU145 cells, possibly due to the 
tightness of these cells in the absence of HGF stimulation. HT29 cells were reported to 
scatter downstream of HGF stimulation on serum and collagen I coated substratum 
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(Herrera, 1998). However HT29 cells were unable to scatter on a laminin surface and 
this was linked to a defect in cell spreading (Herrera, 1998). The addition of phorbol 12-
myristate 13-acetate (PMA) was able to reinstate HT29 cell spreading on this 
substratum, and this process was integrin dependent (Herrera, 1998).  
 
In addition, HT29 cells exhibited the highest scattering potential on collagen I 
substratum, possibly due to an increase in integrin expression on HT29 cell surfaces that 
bind to collagen I. Indeed it has been shown that the highly metastatic form of HT29 
cells, HT29LMM cells express the collagen receptor integrin α2β1 (Rosenow et al., 
2008). In contrast, expression of the fibronectin binding integrin α5β1 was reduced in 
this cell line (Rosenow et al., 2008). 
 
It was demonstrated in this chapter that DU145 cells embedded in a predominantly 
collagen type I 3D matrix form multi-cellular colonies with distinct cell boundaries and 
discernible nuclei within the cell colony. Following completion of these studies, it was 
reported that DU145 cells exhibit similar morphologies in a type I collagen 3D matrix 
to those observed in chapter 3 (Sugiyama et al., 2010). The morphology of colony-
forming MDCK cells has been analysed in 3D gels for many years (McAteer et al., 
1987); moreover, in a recent study, the morphology of MDCK cells embedded in a type 
I collagen 3D matrix (Raghavan et al., 2010) was alike to that observed here for DU145 
cells.  
 
However, in contrast, it has also been shown that DU145 cells grown in a 100% 
collagen I 3D matrix form multi-cellular structures with a fibroblast-like morphology 
(Härmä et al., 2010). This contrast in morphology reported in Hӓrmӓ et al.’s study to the 
work presented here for DU145 cells embedded in a 3D collagen I matrix could be 
accounted for by a number of factors; the manner in which the type I collagen matrix is 
prepared, the concentration used and the conditions implemented for the 3D collagen I 
matrix to polymerise (Artym and Matsumoto, 2010). These factors will dictate how 
cells interact with the 3D matrix and the cell morphology they exhibit (Artym and 
Matsumoto, 2010). In addition, the time period that the cells are left in the 3D matrix 
may also influence their cell morphology. For example, it has been shown that prostate 
cancer PC3 cells in a 3D matrigel matrix form multi-cellular colonies following 9 days 
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incubation in a 3D matrix; however at day 13, these cells developed distinct and 
multiple projections (Härmä et al., 2010). 
 
In this chapter, increasing the concentration of HGF to 500 ng/ml and incubating the 
cells with HGF for up to 72 hours was required to achieve a detectable DU145 cell 
response. However, although cell locomotion could be observed, the magnitude of 
scattering was small. The muted responses in 3D could be due to some of the HGF 
binding to the 3D matrix, as was observed for HGF-stimulated MDCK cells; this would 
delay growth factor transportation through the matrix and subsequently the onset of 
HGF stimulation (Raghavan et al., 2010). Indeed, it has been demonstrated that MDCK 
cell colonies positioned at the bottom of a collagen I gel failed to respond to HGF 
stimulation, even after 72 hours, whilst projections were observed from cell colonies 
embedded in the upper planes of the 3D matrix (Raghavan et al., 2010). Alternatively, 
although serum-starved, DU145 cells embedded in the matrix in chapter 3 were exposed 
to small levels of growth factor from the matrigel. The use of growth factor reduced 
matrigel may have better synchronised the response of these cells to HGF stimulation.  
 
Due to time constraints, the 3D scatter assay could not be fully optimised. In the Zaman 
et al. study, 3D DU145 cell motility assays were conducted where the authors 
methodically changed matrigel and fibronectin concentrations, as well as β1 integrin 
expression levels (Zaman et al., 2006). From these assays it was proposed that the 
equilibrium of adhesion and contractile forces determines DU145 cell migration 
velocity at a certain matrigel density (Zaman et al., 2006). Thus in this chapter, although 
initial investigations have shown that DU145 cells can migrate in a 3D matrix 
downstream of HGF, it may be useful to, for example, examine integrin expression 
levels in relation to the matrix used in order to develop this assay further. 
 
In summary, EGF- and HGF-induced cell scattering models have been developed in 2D 
and an attempt has been made to establish a 3D DU145 cell scattering model 






3.3.1 Future work 
In the future, it would be useful to optimise the 3D migration assay. In order to achieve 
an accurate representation of DU145 cell morphology and their response to HGF 
treatment in a 3D matrix, control cell lines, both metastatic and non-metastatic cells, 
would need to be analysed. In conjunction with this, the effect of changes in matrix 
rigidity on DU145 cell morphology in the absence and presence of HGF could be 
examined. This could be conducted by, for example, changing the pH and temperature 
at which collagen I polymerises; this will influence the thickness of the collagen fibers 
formed and in turn the rigidity of the matrix. 
 
In this chapter, the HGF-induced scatter response was reduced in the HT29 cells when 
compared to DU145 cells. Furthermore, the expression of the HGF receptor c-Met was 
increased in HT29 cells when compared to the level of expression in DU145 cells. Thus 
it could be speculated that whilst HT29 cells express a higher level of c-Met, a large 
proportion of the receptor may be internalised rather than located on the cell surface; 
this could thereby account for the reduced response to HGF treatment in the HT29 cells. 
Therefore, it would be useful to examine and compare the surface levels of c-Met in 
both these cell lines. Techniques such as biotinylation and antibody labelling could be 




































Chapter 4 – PAK6 is required for HGF-induced cell-cell dissociation 
4.1 Introduction 
In chapter 3, in both 2D and 3D assays, HGF was chosen as the migration inducing 
stimulation. HGF is known to activate a variety of intracellular signalling cascades via 
activation of the c-Met receptor; many of which are related to actin cytoskeletal re-
organisation (Ridley et al., 1995). PAKs are known to regulate the actin cytoskeleton 
and it has been reported that some PAK family members are required for HGF-induced 
migration (Ahmed et al., 2008; Bright et al., 2009; Royal et al., 2000; Royal and Park, 
1995). Indeed, PAK1 knockdown but not PAK2 knockdown reduced HGF-induced cell 
scattering in DU145 cells (Bright et al., 2009). However the effect of PAK1 and PAK2 
over-expression on DU145 cell morphology and cell junction integrity was not 
assessed.  
 
PAK4 is also known to be activated upon HGF stimulation in MDCK cells (Wells et al., 
2002) and mediates HGF-induced prostate cancer cell migration (Ahmed et al., 2008). 
Furthermore, PAK4 knockdown blocks HGF-induced DU145 cell scattering (Wells et 
al., 2010). PAK4 knockdown cells were able to dissociate their junctions; however cell 
migration was inhibited due to an increase in the incidence and size of focal adhesions 
(Wells et al., 2010). In addition, the effect of PAK4 over-expression on cell morphology 
in MDCK cells in unstimulated and HGF-stimulated conditions was examined; a kinase 
active PAK4 mutant induced cell shape changes only in the presence of HGF (Wells et 
al., 2002).  
 
PAK6 is known to be expressed in DU145 cells (Wells et al., 2010; Yang et al., 2001). 
Furthermore, increased PAK6 expression has been detected in prostate cancer cells 
(Kaur et al., 2008). PAK6 was first detected in a screen to identify proteins that interact 
with the AR (Yang et al., 2001). In addition, it has been reported that siRNA 
knockdown of PAK6 inhibits prostate cancer growth (Wen et al., 2009). However, the 
role of PAK6 in cancer cell migration and more specifically HGF-induced migration 
has yet to be elucidated.  
 
In this chapter, the aim was to deduce whether PAK6 plays a role in cell migration 
downstream of growth factor stimulation. Wild-type and mutant PAK6 expression 
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vectors were constructed as tools to assay the morphological effects of PAK6 over-
expression in cells, whilst siRNA was used to examine the effects of PAK6 knockdown 



























4.2.1 PAK6 is endogenously expressed in DU145 and HT29 cells 
Previous work had utilised an antibody that recognises both PAK4 and PAK6 to detect 
PAK6 in DU145 cells (Wells et al., 2010). Initial experiments aimed to identify a PAK6 
specific antibody able to efficiently detect endogenous PAK6. A panel of five 
commercial antibodies were screened and tested (data not shown). Of the antibodies 
tested, the anti-PAK4 antibody (Cell Signaling Technology) hereafter referred to as 
anti-PAK4/PAK6, recognised two distinct bands correlating to PAK4 and PAK6. The 
upper band detected with the anti-PAK4/PAK6 antibody was validated as PAK6 using 
Myc-tagged PAK6 over-expressed protein (figure 4.1A). The anti-PAK6 specific 
antibody (Calbiochem) detected one band at the correct size for PAK6 and hence did 
not cross react with PAK4. Both antibodies were selected for future studies.  
 
Both antibodies were utilised to investigate the levels of endogenous PAK6 protein 
expression in DU145 and HT29 cells. In these cell types, PAK6 was found to be present 
at 75 kDa using the anti-PAK4/PAK6 antibody (figure 4.1B). The anti-PAK6 specific 
antibody was able to detect endogenous PAK6 expression in HT29 and DU145 cells 
(figure 4.1C).  
 
4.2.2 HGF but not EGF stimulation increases PAK6 autophosphorylation levels 
PAKs have been implicated as important effector proteins downstream of growth factor 
induced signalling, where they are involved in various cellular processes such as cancer 
cell migration (Bright et al., 2009; Wells et al., 2010). DU145 and HT29 migration 
assays described previously (see sections 3.2.2, 3.2.5 and 3.2.6) rely on HGF or EGF 
stimulation. The effect of HGF and EGF stimulation on PAK6 autophosphorylation 
levels was therefore examined using a phospho-specific antibody from Cell Signaling 
Technology. This antibody detects phosphorylation of PAK6 at serine 560 in the kinase 
domain. This residue in PAK6 is thought to be an autophosphorylation site homologous 
to threonine 423 (T423) in PAK1 (Schrantz et al., 2004) and serine 474 (S474) in PAK4 
(Abo et al., 1998). Using this phospho-specific antibody, endogenous PAK6 
autophosphorylation levels increased upon HGF stimulation in DU145 cells (figure 
4.2A). This antibody also detects phosphorylation of PAK4 at S474 and PAK5 at serine 























Figure 4.1 Testing of PAK6 antibodies for detecting endogenous PAK6. A) (a) 
DU145 whole cell lysate (WCL) was immunoblotted for PAK4/PAK6 expression using 
an anti-PAK4 antibody that recognises PAK6 (anti-PAK4/PAK6 antibody). (b) 
HEK293 cells expressing WT Myc-PAK6 were lysed and the lysate immunoblotted for 
PAK6 expression using an anti-c-Myc antibody. B) Whole cell lysates for the indicated 
cell lines were immunoblotted using the anti-PAK4/PAK6 antibody. C) Whole cell 
lysates for the indicated cell lines were immunoblotted using an anti-PAK6 specific 
antibody. In (B) and (C) lysates were immunoblotted for GAPDH as a loading control. 



























Figure 4.2 HGF stimulation increases PAK6 autophosphorylation levels in DU145 
and HT29 cancer cell lines but EGF stimulation has no effect in DU145 cells. A) 
DU145 cells were seeded at a density that correlated with the HGF-induced scatter 
assay. Cells were serum-starved 48 hours after plating for 24 hours. Cells were then left 
unstimulated (0 minutes) or stimulated with HGF (10 ng/ml) for 5, 15 and 30 minutes 
prior to lysis. Lysates were immunoblotted for levels of PAK6 autophosphorylation at 
serine 560 using a phospho-PAK4/PAK5/PAK6 antibody. Blots were re-probed for total 
PAK6 expression using an anti-PAK4/PAK6 antibody. B) Changes in PAK6 
autophosphorylation levels at serine 560 were quantified from (A). C) DU145 cells 
were treated as in (A) but stimulated with EGF (100 ng/ml). Lysates were also 
immunoblotted for phospho-ERK1/2 levels. D) Changes in PAK6 autophosphorylation 
levels at serine 560 were quantified from (C). E) HT29 cells were seeded and treated as 
described in (A) but stimulated with 60 ng/ml HGF. F) Changes in PAK6 
autophosphorylation levels at serine 560 were quantified from (E). In (B), (D) and (F), 
the mean fold value representing the autophosphorylation of PAK6 in response to HGF 
or EGF stimulation and the standard error of the mean were calculated over 3 
independent experiments. Statistical significance compared with minus HGF (0 















is consistent with previous reports (Wells et al., 2010). The increase in PAK6 phospho 
levels was significant following 5, 15 and 30 minutes HGF stimulation when compared 
to serum-starved cells (0 minutes) (figure 4.2B). Interestingly, a relatively high level of 
PAK6 autophosphorylation was observed under serum-starved conditions (0 minutes) 
when compared to PAK4 autophosphorylation levels (figure 4.2A). 
 
In figure 4.2A, the dublet at 75 kDa was quantified as the total signal for phospho-
PAK6 due to the reduced sensitivity of the densitometry quantification method that was 
used. Thus there are some drawbacks with measuring and comparing the varying levels 
of protein from autoradiographs as was conducted for analysing the western blot data 
obtained in figure 4.2. Firstly, with densitometry analysis, there is a limited dynamic 
range, where protein bands with higher signals can become saturated. This therefore 
leads to inaccuracies in the quantification of the level of protein between different 
samples on the same autoradiograph. In order to more accurately quantify the level of 
protein on the same western blot, digital imaging can be used. For example, a charge-
coupled device (CCD) camera can be implemented. This alternative method of imaging 
allows for a wider linear dynamic range where higher signals are not saturated. Thus, a 
more accurate quantification of the level of protein expression on the same western blot 
can be achieved.  
 
In contrast to HGF, EGF stimulation did not increase endogenous phospho-PAK6 levels 
(figures 4.2C and 4.2D). As a control, the blot was also probed for phospho-ERK1/2, 
which is known to be activated downstream of EGF, to confirm that EGF signalling 
pathways were activated. Due to the lack of PAK6 autophosphorylation in response to 
EGF, as well as the decreased scattering potential of EGF in DU145 cells as described 
in chapter 1 (see section 3.2.5), this growth factor was excluded from future PAK6 
investigations in cell migration. The remainder of the project focussed on PAK6 
function downstream of HGF signalling. 
 
To validate the response of PAK6 to HGF observed in DU145 cells, colony-forming 
HT29 cells were also tested. Endogenous PAK6 phospho levels were significantly 
elevated when compared to serum-starved cells (0 minutes) following 15 and 30 
minutes HGF stimulation (figures 4.2E and 4.2F). This was consistent with the time 
points of increased phospho-PAK6 levels observed upon HGF addition in the DU145 
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cells (figures 4.2A and 4.2B). Whilst it is clear that HGF increases the phosphorylation 
status of PAK6 at serine 560, the identification of PAK6 substrates is lacking in the 
literature; only one study has shown that PAK6 is able to phosphorylate the AR 
(Schrantz et al., 2004).                                                                              
 
4.2.3 Sub-cloning of PAK6 into GFP, mRFP1 and GST expression vectors 
PAK6 is expressed in both DU145 and HT29 cells. Furthermore, PAK6 
autophosphorylation is elevated downstream of HGF in these cell lines. It might 
therefore be speculated that PAK6 plays a role in the cellular response to HGF observed 
in chapter 3. Therefore, to facilitate PAK6 functional studies, fluorophore-tagged PAK6 




Technology system (see section 2.2.1) was utilised to generate GFP, 
mRFP1 and GST PAK6 expression constructs. In order to insert PAK6 DNA into the 
Gateway
TM 
Technology system, WT Myc-PAK6 was used as the DNA template for 
PCR. The PCR was performed using primers possessing a 25 base pair (bp) attB1 
sequence at the 5’ end and an attB2 sequence at the 3’ end of the sequence. The cloning 
of PAK6 and the Gateway
TM
 Technology system used is outlined in figure 4.3A. PAK6 
was successfully amplified by PCR and was visible as a 2046 bp product (figure 4.3B). 
In order to insert the amplified PAK6 PCR product into the pDONOR
TM
 207 entry 
clone, a BP recombination reaction was performed (see section 2.2.1). Restriction 
digest reactions were then carried out using the EcoRV restriction endonuclease to 
verify the presence of PAK6 in the entry clone (figure 4.3C). In addition, the PAK6 
containing entry clone was sequenced to confirm that no mutations had arisen in the 
DNA sequence during the cloning process. PAK6 was then shuttled into GFP and 
mRFP1 expression vectors using an LR recombination reaction as outlined in figure 
4.3A and then sequenced (see section 2.2.1). In addition, the Gateway
TM 
Technology 
cloning system was also used to generate C-terminal GFP and N- and C-terminal 
mRFP1 PAK6 truncated mutant constructs in order to assess the functions of the 
different domains of PAK6 (see Appendix 1 for primer sequences).  
 
Wild-type GST tagged PAK6 (GST-PAK6) was also generated using the Gateway
TM
 
methodology to investigate PAK6 protein-protein interactions in GST pulldown assays. 



















Figure 4.3 Generation of PAK6 constructs using the Gateway
TM 
Technology 
system. A) Schematic representation of the Gateway
TM
 Technology system used to 
construct GFP and GST vectors expressing PAK6. BP and LR recombination reactions 
were used to shuttle the desired DNA into the expression vectors. att = attachment site, 
R 
= resistance. Figure adapted from (Gateway
TM
 Technology instruction manual, 2002). 
B) attB flanked gene specific primers were used to amplify human PAK6 DNA in a 
PCR reaction alongside positive (+) and negative controls (-) and subjected to gel 
electrophoresis. C) Restriction digest reactions were performed using the EcoRV 
restriction enzyme and subjected to gel electrophoresis to confirm the presence of PAK6 
following the BP reaction. This enzyme cuts the vector once to linearise it, and if PAK6 
is present, cuts PAK6 once resulting in the production of 2 fragments (4.4 kb and 1.4 
kb). D) E. coli BL21-A1 cells transformed with the GST and GST-PAK6 expression 
plasmids were grown to mid-log phase and protein expression was induced with 0.2% 
and 0.05% L-Arabinose, respectively, overnight at 20ºC. The gel was stained with 
coomassie blue to visualise the protein bands present. E) Induced GST-PAK6 from (D) 
was electrophoresed against an uninduced bacterial lysate. Blots were immunoblotted 
for detection of GST-PAK6 using a GST specific antibody and an anti-PAK4/PAK6 












PAK6 into a GST expression vector using an LR recombination reaction (see section 
2.2.1). Protein expression was induced for both GST-PAK6 and GST (figure 4.3D). 
Induced GST-PAK6 was also visualised by immunoblotting, with an uninduced 
bacterial lysate as a control (figure 4.3E). 
 
4.2.4 Validation of wild-type, kinase active and kinase dead PAK6 kinase activity  
Kinase mutants are useful tools in characterising proteins that possess kinase activity. 
Thus GFP-PAK6 kinase active and kinase dead mutants were generated using Site-
Directed mutagenesis (see section 2.2.1) and were shuttled into suitable expression 
vectors using Gateway
TM
 Technology (see section 2.2.1). 
 
Three mutant PAK6 constructs were generated; S560E (serine to glutamic acid 
mutation) and S531N (serine to asparagine mutation) as potentially active forms of 
PAK6, and K436A (lysine to alanine mutation), a proposed kinase dead form of PAK6 
(Schrantz et al., 2004). As serine 560 is a predicted autophosphorylation site for PAK6 
(based on homology to PAK1), mutating this residue may induce an increase in PAK6 
kinase activity (Schrantz et al., 2004). The S531N mutation is thought to stabilise the 
catalytic loop region in the kinase domain of PAK6 (Schrantz et al., 2004) and is 
analogous to the PAK4 activation site (S445N) (Qu et al., 2001; Schrantz et al., 2004). 
The K436A residue change is located within the activation loop of the kinase domain 
and is thought to obstruct ATP binding and thereby inhibit PAK6 kinase activity 
(Schrantz et al., 2004). Whilst it has yet to be established, it has been predicted that 
PAK6, alike to its group members, is constitutively active (Kaur et al., 2005; Schrantz 
et al., 2004).     
 
A radioactive in vitro kinase assay confirmed that the kinase dead mutant possessed no 
exogenous or autophosphorylation kinase activity (figure 4.4), as has already been 
documented (Schrantz et al., 2004). The S560E PAK6 mutant construct did not exhibit 
an increase in kinase activity when compared to WT PAK6 (figure 4.4) even though 
this is accepted as the autophosphorylation site. In fact the activity of the S560E PAK6 
mutant was actually lower than WT PAK6. This is consistent with another study (Kaur 
et al., 2005). Interestingly however, autophosphorylation was detected for the S560E 
mutant which suggests that PAK6 possesses other autophosphorylation sites (figure 








Figure 4.4 Kinase activity of PAK6 mutants. HEK293 cells were transfected with the 
indicated full-length GFP-PAK6 mutants. The cells were lysed and PAK6 was 
immunoprecipitated using an anti-GFP antibody (IP) from cell lysates. The kinase 
activity of the PAK6 mutants was determined with an in vitro kinase assay in the 
presence of [γ-32P] ATP and using histone H1 as a substrate. Whole cell lysates (WCL) 
were immunoblotted using an anti-GFP antibody as a loading control. The blots shown 






to phosphorylate histone H1 when compared to WT PAK6 (figure 4.4). This mutant 
also exhibited an increased level of autophosphorylation when compared to WT PAK6, 
as consistent with previous reports (Schrantz et al., 2004). Therefore, the S531N mutant 
was used as the kinase active form of PAK6 and the K436A mutant was used as the 
kinase dead for future investigations. 
 
4.2.5 PAK6 interacts with constitutively active Cdc42  
Cdc42 is known to be activated by HGF (Royal et al., 2000) and the active form of 
Cdc42 is known to bind to PAK6 (Lee et al., 2002). Thus the PAK6 derivatives 
generated were tested for their ability to bind to Cdc42-V12 using an IP protocol. All of 
the PAK6 derivatives were able to bind Cdc42-V12 irrespective of the levels of kinase 
activity (figure 4.5). 
 
4.2.6 DU145 cell morphology is affected by PAK6 over-expression 
Having generated and characterised PAK6 expression constructs, PAK6 was over-
expressed in DU145 cells to monitor the effect on cell morphology. The levels of the 
over-expressed PAK6 mutants were approximately 50% higher than the level of 
endogenous PAK6. WT PAK6 expressing DU145 cells were found to be significantly 
more elongated in phenotype when compared to GFP control cells under serum-starved 
conditions (figures 4.6A and 4.6C). Importantly, GFP control transfected cells were not 
significantly different in shape when compared to untransfected cells (figures 4.6A and 
4.6B). Cells expressing the kinase active form of PAK6, S531N, were also significantly 
more elongated than GFP control cells, although not to the same degree as WT PAK6 
expressing cells (figures 4.6A and 4.6C). However, DU145 cells expressing the kinase 
dead mutant of PAK6, K436A, were not significantly elongated when compared to GFP 
control cells (figures 4.6A and 4.6C). Interestingly, cells expressing WT PAK6 
exhibited a further significant increase in cell elongation after HGF stimulation, when 
compared to WT PAK6 expressing cells in the absence of HGF (figure 4.6A). 
Interestingly, an increased level of active Cdc42 was co-immunoprecipitated with the 
K436A PAK6 mutant when compared to WT and S531N PAK6 (figure 4.5). Given that 
K436A PAK6 expressing DU145 cells did not exhibit an increase in cell elongation 
when compared to GFP control cells, unlike WT and S531N PAK6 (figures 4.6A and 



















Figure 4.5 Over-expressed PAK6 interacts with Cdc42-V12. HEK293 cells were co-
transfected with the indicated GFP-PAK6 mutants and HA-Cdc42-V12. The cells were 
lysed and over-expressed PAK6 was immunoprecipitated using an anti-GFP antibody 
(IP). IPs were immunoblotted using anti-GFP and anti-Cdc42 antibodies as indicated. 
Whole cell lysates (WCL) were immunoblotted using an anti-HA antibody as a loading 




























Figure 4.6 PAK6 over-expression induces morphological changes in DU145 cells. 
A) and B) DU145 cells were transfected with GFP control vector or GFP-PAK6 
mutants as indicated. Untransfected cells (UT) were treated in the same manner. After 
24 hours, cells were serum-starved for 24 hours. Cells were then either left unstimulated 
(minus HGF) or stimulated with HGF (plus HGF) for 5 minutes. Cells were then fixed 
and stained for F-actin. Shape analysis was performed on the cells using Image J to 
determine the elongation ratio and cell spread area as indicated. C) F-actin stained 
DU145 cells transfected as indicated were imaged using confocal microscopy. * = 
S531N PAK6 expressing cell with rounded phenotype. Arrow = S531N PAK6 
expressing cell with elongated phenotype. In (A) and (B) 110 cells over 3 independent 
experiments were analysed. Statistical significance compared with GFP control cells 
(unless otherwise indicated) was calculated using Student’s t-test; *, P < 0.05, *** P < 






This could account for, in part, the difference in cell phenotype observed between the 
PAK6 mutants. In contrast, the cell spread area of WT PAK6 expressing cells was 
significantly reduced when compared to GFP control expressing cells, as was that of 
K436A PAK6 expressing cells (figures 4.6B and 4.6C). S531N PAK6 expressing cells 
also exhibited a decrease in cell spread area, and this effect was more pronounced when 
compared to WT PAK6 over-expression (figures 4.6B and 4.6C). This phenotype 
observed for the S531N PAK6 mutant is consistent with previous reports for the active 
form of PAK4 (Wells et al., 2002).  
 
4.2.7 PAK6 kinase activity is required for efficient cell colony escape 
Having established that WT PAK6 over-expression in DU145 cells induced 
morphological changes, the elongated phenotype of these cells was examined more 
closely. In contrast to GFP control expressing cells, it was discernible that WT PAK6 
expressing cells were detaching from neighbouring cells and were no longer contained 
within the cell colony (figure 4.6C). In order to investigate this observation further, 
untransfected DU145 cells and those expressing GFP control, WT, S531N, and K436A 
PAK6 mutant constructs were scored based on whether they were present in a cell 
colony versus escaping the cell colony. A cell escaping a colony was defined as either 
greater than 50% of the cell body perimeter detached from the neighbouring cell(s), 
cells already escaped from a colony and exhibiting 100% dissociation from the 
neighbouring cell(s) or cells in a different plane to the underlying cell colony (figure 
4.7A). The colony escape phenotype was classed as the same for cells escaping from the 
middle of periphery of the cell colony and they were quantified in the same manner.  
 
In serum-starved cells, GFP control expressing cells remained in colonies to a similar 
level as untransfected cells (data not shown). In contrast, the percentage of WT and 
S531N PAK6 expressing cells retained in colonies was significantly reduced when 
compared to GFP control cells (figure 4.7B). Furthermore, an increase in kinase activity  
was found to correlate with an increase in the induction of cell colony escape. Indeed, a 
greater percentage of WT PAK6 expressing cells were within a cell colony when 
compared to S531N PAK6 expressing cells, the latter being the more active derivative 
of PAK6 (figures 4.4 and 4.7B). Moreover, cells expressing the kinase dead mutant of 

























Figure 4.7 PAK6 induces cell colony escape in DU145 cells. A) Schematic illustrating 
colony escape phenotypes observed upon PAK6 over-expression in DU145 cells. (1) = 
cells escaping a colony defined as greater than 50% of the cell body perimeter detached 
from the neighbouring cell(s). (2) = cells already escaped from a colony defined as cells 
exhibiting 100%  dissociation from the neighbouring cell(s) or cells in a different plane 
to the underlying cell colony. In (1) and (2) cells were quantified in the same manner. 
B) DU145 cells were transfected with GFP control vector or GFP-PAK6 mutants as 
indicated. After 24 hours, the cells were serum-starved for 24 hours and then fixed and 
stained for F-actin. The mean % of GFP expressing cells in colonies was calculated for 
110 cells per condition over 3 independent experiments. Statistical significance 
compared with GFP control cells was calculated using Student’s t-test; *, P < 0.05, **, P 





addition, HT29 cells over-expressing WT PAK6 were also able to induce colony escape 
to a significant level when compared to GFP control cells (figure 4.8). To further 
investigate the cell colony escape phenotype of PAK6 expressing DU145 cells, time-
lapse microscopy was used to perform imaging of WT GFP-PAK6 cells to see if the cell 
colony escape event could be captured in live cells. Following 11 hours, it was 
discernible that a DU145 cell expressing PAK6 was elongated in shape (figure 4.9, 
arrows). Cell colony escape of the PAK6 expressing cell was difficult to detect as the 
majority of non-expressing DU145 cells exhibited a rounded phenotype leading to 
disrupted cell colony morphology. This is most likely due to the sub-optimal 
transfection-induced conditions that these cells were exposed to for a prolonged time 
frame. However, in contrast to non-expressing DU145 cells, the PAK6 expressing cell 
was still elongated and independently migrating 16 hours following transfection (figure 
4.9, arrows and see movies 5PC and 5G for representative movies and Appendix 3).  
 
Subsequently, attempts were made to see if the same effect could be captured using the 
3D assay described in chapter 3. However, whilst WT PAK6 expressing cells were 
successfully embedded in the matrix, no significant cell movement or cell shape 
changes were observed under serum-starved conditions during a 24 hour time-lapse 
movie (data not shown).  
 
4.2.8 HGF-induced cell scattering is inhibited in DU145 and HT29 PAK6 
knockdown cell populations 
HGF-driven cell scattering requires the dissolution of cell-cell adhesions (figure 3.1). 
Given that PAK6 can drive cell-cell dissociation, PAK6 may act downstream of HGF 
during a cell scatter response. Thus it might also be reasoned that a loss of PAK6 would 
hinder this process. Two different siRNA oligonucleotides were employed to 
knockdown PAK6 (figure 4.10). The level of PAK6 was significantly reduced when 
compared to PAK6 levels in control siRNA lysates and did not affect PAK1, PAK2 or 
PAK4 expression (figure 4.10). No significant difference in PAK6 expression levels 
was detected between untransfected mock and control siRNA-treated DU145 and HT29 
cells (figures 4.10B and 4.10D). However, whilst PAK6 knockdown was achieved, this 
was a challenging process that required the optimisation of siRNA concentrations and 




















Figure 4.8 PAK6 induces cell colony escape in HT29 cells. A) HT29 cells were 
transfected with GFP control vector or WT GFP-PAK6. Following 24 hours, the cells 
were serum-starved for 24 hours. The cells were fixed and stained for F-actin. The % of 
GFP expressing cells present within a colony was calculated. A cell escaping a colony 
was defined as either greater than 50% of the cell body perimeter detached from the 
neighbouring cell(s), cells already escaped from a colony and exhibiting 100% 
dissociation from the neighbouring cell(s) or cells in a different plane to the underlying 
cell colony. B) Cells were treated as described in (A) and imaged using fluorescence 
microscopy. In (A) the mean % of GFP expressing cells in colonies was calculated for 
110 cells per condition over 3 independent experiments. Statistical significance 
compared with GFP control cells was calculated using Student’s t-test; ***, P < 0.0005. 




























Figure 4.9 Live-cell imaging of WT GFP-PAK6 in DU145 cells. DU145 cells were 
transfected with WT GFP-PAK6. Cells were immediately filmed for 24 hours at 5 
minute intervals using phase-contrast and GFP fluorescence time-lapse microscopy. 
Still images from the film at varying time points were taken to show a WT GFP-PAK6 
expressing cell elongating (arrows). The images shown are representative of 3 












Figure 4.10 PAK6 siRNA knockdown in DU145 and HT29 cells. A) DU145 cells 
were transfected with PAK6 siRNA (Oligo 1 or 2) or control siRNA (Con siRNA), 
lysed after 72 hours and immunoblotted for PAK6 using a PAK6 specific antibody and 
for GAPDH as a loading control. Lysates were also immunoblotted for PAK4 using an 
in-house affinity purified PAK4 specific antibody and for PAK1 and PAK2 as controls 
for specific knockdown. B) Quantification of blots from (A). C) HT29 cells were 
treated as described in (A). D) Quantification of blots from (C). In (B) and (D) the mean 
fold value and the standard error of the mean were calculated over 3 independent 
experiments. Statistical significance compared between Con siRNA and UT Mock or 









particularly difficult when compared to the HT29 cell line. There are a number of 
reasons that could account for this. Firstly, PAK6 expression at an mRNA level may be 
significantly higher in the DU145 cells; indeed PAK6 protein expression was observed 
to be lower in the HT29 cell line when compared to DU145 cells (figures 4.1B and 
4.1C). Furthermore, it has been proposed that PAK6 has anti-apoptotic functions in 
prostate cancer cells (Zhang et al., 2009). Moreover, PAK6 was classed as a ‘difficult to 
silence’ gene in an siRNA screen where the central region of PAK6 mRNA was found to 
be highly difficult to target using siRNA knockdown (Bergauer et al., 2009).     
 
Control siRNA DU145 cells exhibited a normal degree of cell-cell dissociation upon 
HGF stimulation; however the ability of the PAK6 knockdown cell populations to 
scatter in response to HGF was significantly reduced (figures 4.11A and 4.11B). 
Moreover, PAK6 knockdown cells exhibited similar elongation ratios in the absence and 
presence of HGF (4 hours stimulation) (figure 4.11C), whilst untransfected and control 
siRNA cells were significantly more elongated following 4 hours HGF stimulation 
(figure 4.11C); a characteristic response of DU145 cells to HGF. Thus PAK6 
knockdown cells appeared to possess a defect in cell elongation upon HGF addition. 
Consistent with these findings in DU145 cells, HT29 cells transfected with control 
siRNA scattered upon HGF stimulation (figure 4.11D, Con siRNA). However PAK6 
siRNA-transfected HT29 cells exhibited a significantly diminished ability to scatter in 
response to HGF addition (figures 4.11D and 4.11E). 
 
4.2.9 PAK6 knockdown affects cell-cell junction integrity and E-cadherin 
localisation in DU145 cells 
Closer examination of PAK6 siRNA colonies in the presence of HGF suggested that 
these cells were not disassembling their cell-cell junctions, a normal initial HGF 
response (figure 3.1) (Fram et al., 2011; Wells et al., 2005). E-cadherin is a junctional 
epithelial marker and a key component of cell-cell junction integrity (Gumbiner et al., 
1988). Therefore, its distribution in control siRNA and PAK6 knockdown cells was 
examined downstream of HGF stimulation. 
 
Control siRNA cells were undergoing dissociation after 4 hours HGF stimulation, with 
minimal E-cadherin staining visible at sites of cell-cell contact (figure 4.12A). In 
























Figure 4.11 PAK6 siRNA knockdown reduces HGF-induced cell scattering in 
colony-forming cells. A) DU145 cells were transfected with PAK6 siRNA (Oligos 1 
and 2) or control siRNA (Con siRNA). Following 72 hours, cells were serum-starved 
for 24 hours and stimulated with HGF (10 ng/ml) for a further 24 hours. The cells were 
fixed and stained for F-actin. B) DU145 cells were counted and cell counts of Con 
siRNA versus PAK6 siRNA were compared. Scattered = loss of cell-cell junctions and 
single cells with an elongated migratory phenotype. C) Cells were seeded and treated as 
described in (A) but left unstimulated (minus HGF) or stimulated with HGF for 4 hours 
and were then fixed and stained for F-actin. Cells were subjected to Image J analysis to 
determine the cell elongation ratio. D) HT29 cells were treated as in (A) but stimulated 
with 60 ng/ml HGF. E) Scattered cells were quantified as in (B). In (B), (C) and (E) the 
mean values and the standard error of the mean were calculated over 3 independent 
experiments. Statistical significance compared with Con siRNA cells was calculated 

































Figure 4.12 PAK6 knockdown inhibits the re-distribution of E-cadherin from cell-
cell boundaries to the cytoplasm downstream of HGF in DU145 cells. A) and B) 
DU145 cells were transfected with control siRNA (Con siRNA) or PAK6 siRNA (Oligo 
1) as indicated. Following 72 hours, cells were serum-starved for 24 hours and 
stimulated with HGF (10 ng/ml) for 4 hours and 24 hours as indicated. The cells were 
then fixed and labelled for E-cadherin and F-actin. In (A) and (B) cells were imaged 
using confocal microscopy. The images shown are representative of 3 independent 





E-cadherin staining detected (figure 4.12A). In contrast, the cell borders in PAK6 
knockdown cell populations were E-cadherin-positive, with distinct and extensive 
punctate staining following 4 hours stimulation with HGF (figure 4.12B). At the 24 
hour time point, the cell-cell boundaries in the PAK6 knockdown cell population were 
still E-cadherin-positive, with a distinct localisation pattern similar to that observed 
following 4 hours HGF stimulation (figure 4.12B).  
 
4.2.10 PAK6 localisation in DU145 cells 
Taken together, with the finding that PAK6 over-expression drives the disassembly of 
junctions, it might be speculated that PAK6 is localised at cell junctions. To investigate 
PAK6 localisation within DU145 colony cells, low level expressing WT PAK6 cells 
were imaged as high expressing WT PAK6 cells were already escaping the cell colony. 
PAK6 was found to be specifically localised at cell-cell boundaries with punctate and 
distinct localisation (figure 4.13, arrows) which correlated with the pattern of E-
cadherin localisation detected in these cells (figure 4.13, arrows). Thus, PAK6 can be 
detected at E-cadherin-positive cell-cell junctions. However, it is important to consider 
that there are potential artefacts of examining co-localisation with tagged proteins. For 
example, fluorophore tags such as GFP may potentially influence the localisation of a 
protein. In order to confirm that this is not the case between GFP-PAK6 and E-cadherin, 
the co-localisation between control cells transfected with GFP alone and E-cadherin 
could be analysed and compared to that of GFP-PAK6 expressing cells. Furthermore, Z-
sections could be taken at different focal planes through the cells where GFP-PAK6 and 
E-cadherin appear to be co-localised. This would further help confirm that the co-
localisation observed between GFP-PAK6 and E-cadherin is true.   
 
Subsequently, the localisation of other PAK6 mutants was investigated (figure 4.14). As 
expected, the localisation of GFP control cells was nuclear and cytoplasmic (figure 
4.14). The localisation could not be determined in colony cells expressing the S531N 
PAK6 mutant as even low expressing cells had already escaped from colonies (figure 
4.14). Furthermore, these cells exhibited a rounded phenotype, unlike WT PAK6 
expressing DU145 cells (figure 4.14). Cell rounding can be stimulated by different 











Figure 4.13 Localisation of over-expressed PAK6 in DU145 cells.  DU145 cells were 
transfected with WT GFP-PAK6. After 24 hours, the cells were serum-starved for 24 
hours. Cells were then fixed and labelled for E-cadherin and F-actin. Low level WT 
GFP-PAK6 expression could be detected at E-cadherin-positive cell-cell junctions 
(arrows). Cells were imaged using confocal microscopy and the images shown are 















Figure 4.14 Localisation of PAK6 mutants in DU145 cells. DU145 cells were 
transfected with GFP control vector or GFP-PAK6 mutants as indicated. After 24 hours, 
the cells were serum-starved for 24 hours. Cells were then fixed and stained for F-actin 
and imaged using confocal microscopy. The images shown are representative of 3 




the cell body as well as during mitosis. In addition, cell rounding is characteristic of 
dying cells; this possibility could be excluded by the use of cell viability and 
cytotoxicity assays of S531N PAK6 expressing DU145 cells. 
 
In contrast, the kinase dead mutant of PAK6, K436A, which exhibited a reduced 
efficiency in colony escape induction (figure 4.7B), was diffusely localised in the cell 
cytoplasm (figure 4.14) and was not specifically detected at cell junctions. Taken 




























In this chapter, the potential role of the PAK family member PAK6 in growth factor-
induced cell migration has been investigated using the scatter assay from chapter 3 as a 
model system. It has been shown that PAK6 autophosphorylation levels are increased in 
response to HGF in DU145 and HT29 cells, but not in response to EGF stimulation. 
Moreover, it has been demonstrated for the first time that PAK6 over-expression is able 
to induce cell elongation and cell colony escape in DU145 and HT29 colony-forming 
cells. In addition, siRNA knockdown of PAK6 inhibited HGF-induced cell scattering 
and affected E-cadherin localisation downstream of HGF stimulation. These results 
suggest that PAK6 plays an important role in driving cell-cell dissociation downstream 
of HGF.  
 
PAK6 is known to be highly expressed in the testis and in prostate tissues, as 
demonstrated by Northern blot analysis (Yang et al., 2001). In this study, PAK6 was 
found to be expressed in DU145 prostate cancer cells, as consistent with previous 
reports (Callow et al., 2002; Wells et al., 2010; Yang et al., 2001), as well as in HT29 
colon adenocarcinoma cells. However, PAK6 expression was lower in the HT29 cells 
when compared to DU145 cells. This is consistent with the reported mRNA expression 
levels of PAK6 in HT29 and DU145 cells (Callow et al., 2002). PAK6 is also expressed 
in MCF7, HS578t and MDA-MB-231 breast cancer cells, with highest PAK6 
expression detected in the latter cell type (Kaur et al., 2008). 
 
PAK6 differs from its family members in its ability to bind to the LBD of the AR and 
induce the suppression of AR signalling (Schrantz et al., 2004). In addition, ectopic 
expression of PAK6 is thought to enhance the survival of prostate cancer cells (Li et al., 
2005a). In the literature, PAK6 knockdown was found to inhibit DU145 prostate cancer 
cell growth (Wen et al., 2009). However, the effect of PAK6 siRNA knockdown on cell 
migration has not been assessed. In addition, very little is known on the effect of PAK6 
over-expression and PAK6 localisation in cells.  
 
It is well established that HGF signalling plays a role in prostate cancer metastasis 
(Gmyrek et al., 2001). HGF stimulation significantly increased PAK6 
autophosphorylation in DU145 cells, as well as in HT29 cells. Whilst HGF is also 
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known to induce an increase in both PAK1 and PAK4 phosphorylation levels in DU145 
cells, these PAKs induce distinct functions downstream of HGF stimulation (Bright et 
al., 2009; Wells et al., 2010). Although phospho-PAK6 levels were increased upon HGF 
addition, the elevation in phospho-PAK6 detected was only modest in the DU145 cells. 
Interestingly, it has been shown that the HGF receptor c-Met is distributed on the 
basolateral membrane of polarised multi-cellular MDCK cells (Crepaldi et al., 1994). 
Thus it has been speculated that in colony-forming cells, only cells located at the 
periphery of the colony, and not those within the cell colony, have the ability to respond 
to HGF addition thereby accounting for a muted HGF response (Wells et al., 2002; 
Wells et al., 2010). Hence this theory could potentially account for, in part, the modest 
elevation in PAK6 phospho levels upon HGF stimulation.  
 
The regulation of group II PAK activity and the phosphorylation sites involved has yet 
to be fully discerned. PAK1, the most extensively studied group I PAK, is known to 
have multiple autophosphorylation sites (Chong et al., 2001). Thus it is possible that 
PAK6 is phosphorylated downstream of HGF on residues other than serine 560, which 
has been tested here, and thus these results may not reflect the complete activating 
potential of HGF signalling on PAK6. Indeed, it has been shown here that mutating this 
site does not increase the kinase activity of PAK6, as consistent with previous reports 
(Kaur et al., 2005; Schrantz et al., 2004). In contrast, mutating serine 531 increased 
PAK6 kinase activity as also observed in previous work (Schrantz et al., 2004). In 
addition, whilst serine 560 phosphorylation is known to be required for PAK6 activation 
via MKK6, PAK6 is also directly activated by MKK6 at tyrosine 566 (Kaur et al., 
2005). This supports a hypothesis that the phosphorylation of other residues on PAK6 is 
important for PAK6 activation. This hypothesis could be investigated further by 
designing in-house antibodies to different serine, threonine or tyrosine sites on PAK6. 
 
The potential of EGF to stimulate PAK6 was also investigated due to its ability to 
induce cell-cell junction breakdown in DU145 cells (Gan et al., 2010). In contrast to 
HGF, EGF was unable to induce a phospho-PAK6 response at serine 560 in DU145 
cells. This again may be due to the fact that PAK6 is more responsive to growth factor 





In this chapter, PAK6 over-expression was found to induce morphological and 
phenotypical changes in DU145 cells. HGF stimulation was not required for the cell 
shape changes induced; indeed WT PAK6 expression in serum-starved conditions was 
sufficient to stimulate pronounced morphological effects. The elongated phenotype 
observed for WT PAK6 expressing DU145 cells is novel when compared to cell shape 
analyses of other PAKs. WT PAK4 over-expression exhibited no effects on MDCK cell 
morphology in unstimulated conditions, as well as upon stimulation with HGF (Wells et 
al., 2002). Furthermore, WT PAK4 expression induces no cell shape changes in DU145 
cells (personal communication with Dr. Wells). Consistent with this, WT PAK4 
expression in unstimulated conditions induced no cell shape changes in C2C12 mouse 
myoblast cells (Dan et al., 2001) or NIH 3T3 mouse embryo fibroblast cells (Qu et al., 
2001). The ability of WT PAK6 expressing cells to induce a morphological response 
may be related to the phosphorylation status of WT PAK6 and thus activity levels. WT 
PAK6 may be autophosphorylated under basal conditions, as has been speculated in the 
literature for group II PAKs (Abo et al., 1998; Pandey et al., 2002). Interestingly it has 
been shown here that at the residue serine 560, a predicted autophosphorylation site of 
PAK6, phospho-PAK6 levels are high in serum-starved DU145 cells. 
 
The majority of PAK induced cell shape changes have been detected when the 
constitutively active forms of PAK1, 2 and 4 were utilised (Manser et al., 1997; Qu et 
al., 2001; Zeng et al., 2000). DU145 cells over-expressing the kinase active form of 
PAK6 were predominantly rounded in the absence of HGF. This is consistent with the 
cell rounding reported upon expression of activated PAK4 in mouse embryo fibroblast 
cells in unstimulated conditions (Dan et al., 2001). However HGF stimulation was 
required to induce cell rounding in MDCK (Wells et al., 2002) and DU145 (Wells et al., 
2010) cells. The cell rounding phenotype observed for kinase active PAK6 expressing 
DU145 cells may be due to a defect in cell spreading. Indeed, it has been reported that 
Rat1 fibroblast cells expressing active PAK4 exhibited a diminished ability in cell 
spreading on fibronectin coated substratum (Qu et al., 2001). Moreover, there is 
evidence suggesting that PAKs play a role in cell-substratum adhesion (Manser et al., 
1997; Wells et al., 2002) and cell rounding induction in cells can also be as a 




One of the first characteristics of HGF-induced DU145 cell scattering is that cells 
become more elongated (Fram et al., 2011; Wells et al., 2005). Following HGF 
stimulation, cell elongation becomes more pronounced, thereby inducing cell 
detachment and subsequent cell colony escape (Fram et al., 2011; Wells et al., 2005). 
WT PAK6 was found to induce cell elongation in serum-starved conditions and these 
cells exhibited the ability to escape from a cell colony in the absence of HGF 
stimulation. This colony escape phenotype was dependent on PAK6 kinase activity, as 
the kinase dead mutant failed to induce efficient cell colony escape. In addition, the 
kinase active PAK6 mutant, S531N, induced an increase in the percentage of cells 
escaping a colony, even when compared to WT PAK6 cells. This correlates with the 
kinase activity exhibited for these derivatives of PAK6 as shown in the radioactive in 
vitro kinase assay; the S531N mutant exhibited a substantial increase in 
autophosphorylation and substrate phosphorylation when compared to the kinase 
activity of WT PAK6, whilst the kinase dead PAK6 mutant, K436A, exhibited no 
kinase activity. The kinase activity profiles observed for these mutants are consistent 
with previous reports (Kaur et al., 2005; Schrantz et al., 2004). 
 
Colony escape mechanisms have been reported in epithelial cell colonies during 
epithelial cancer cell outgrowth. In one study, single cells induced to express oncogenes 
translocated out of the epithelial layer (Leung and Brugge, 2012). It was postulated that 
these cells were escaping the hostile environment of a developed epithelium (Leung and 
Brugge, 2012). This in turn allows for aberrant proliferation of these cells and thereby 
induces cancer cell progression (Leung and Brugge, 2012). In a second study, it was 
demonstrated that live epithelial cells are extruded from an overcrowded epithelial 
environment (Eisenhoffer et al., 2012). Moreover, MDCK cells expressing oncogenic 
Ras basally extrude from epithelial cell sheets in a model of tumour cell progression 
(Hogan et al., 2009). 
 
PAK6 knockdown cells were defective in cell junction disassembly downstream of 
HGF stimulation, whilst PAK6 over-expression induced cell colony escape. In addition, 
these phenotypes were reproducible in HT29 cells. This suggests that PAK6 may have a 
similar role in cell-cell dissociation in different colony-forming cancer cell types. Whilst 
HGF-induced cell scattering was also inhibited in PAK4 knockdown DU145 cells, these 
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PAK4-depleted cells did not possess a defect in junction disassembly (Wells et al., 
2010).  
 
PAK1 knockdown cells exhibited a similar phenotype to that of PAK6 in DU145 cells 
downstream of HGF stimulation (Bright et al., 2009) and it was speculated that the 
inhibition of scattering was related to cell-cell adhesion dynamics (Bright et al., 2009). 
In contrast, HGF-induced DU145 cell scattering was not inhibited in PAK2 knockdown 
cells and it was proposed that depletion of PAK2 in fact promoted cell scattering in 
DU145 cells (Bright et al., 2009). Unfortunately, there is significant variation in the 
methods used to measure cell scattering in the Bright et al. study, compared to the 
quantification system used here. Therefore, the inhibition in HGF-induced scattering as 
a result of PAK1 depletion cannot be directly compared to the PAK6 knockdown 
phenotype observed here.  
 
PAK6 knockdown cells retained strong localisation of E-cadherin at cell-cell junctions 
downstream of HGF stimulation. In addition, these cells were still in colonies following 
24 hours HGF stimulation. E-cadherin, a junctional marker (Gumbiner et al., 1988) that 
is commonly associated with cancer progression (van Roy and Berx, 2008), is normally 
re-distributed from cell-cell junctions to the cytoplasm during cell-cell dissociation 
(Miura et al., 2001). In the Bright et al. study, whilst E-cadherin localisation was also 
maintained at PAK1 knockdown cell junctions, these knockdown cells appeared to be 
partially scattered, rather than remaining within a tight cell colony (Bright et al., 2009). 
Thus it could be speculated that the roles of PAK1 and PAK6 during junctional 
disassembly are distinct.  
 
The work presented here suggests a novel role for PAK6 in the disruption of junctions 
that subsequently leads to cell-cell dissociation. Interestingly Mbt, a Drosophila PAK 
protein which shares close homology with human group II PAKs, localises at adherens 
junctions when activated and has been reported to induce the breakdown of these 
junctions during eye maturation (Menzel et al., 2008; Menzel et al., 2007; Schneeberger 
and Raabe, 2003). In addition, the Xenopus PAK4 homologue, X-PAK5, also localises 
at sites of cell contact and has been implicated in the cell-cell dissociation process 
(Faure et al., 2005). In DU145 cells, PAK4 is not required for cell-cell adhesion 
disassembly but is required for subsequent cell scattering (Wells et al., 2010). Thus both 
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of these group II PAKs may be present in the same HGF-induced signalling pathway 
where PAK6 lies upstream of PAK4. Indeed, in the group I PAKs, it has been 
hypothesised that PAK2 may exert its effects through PAK1 to modulate HGF-induced 
DU145 cell scattering (Bright et al., 2009).  
 
In DU145 cells, WT PAK6 was localised to cell-cell boundaries. Very little is known 
about PAK6 localisation in other cell types. However, full-length PAK6 was found to 
be localised predominantly in the cytoplasm of non-colony forming fibroblastic CV-1 
cells but PAK6 can also translocate to the nucleus with AR stimulation (Yang et al., 
2001). This cytoplasmic localisation pattern was similar to that described for the 
localisation of kinase active (S531N) PAK6 and kinase dead (K436A) PAK6 (Schrantz 
et al., 2004) and over-expressed WT PAK6 in HeLa cells, which exhibit a low level of 
cell-cell contact sites (Lee et al., 2002). PAK6 was also found localised at the plasma 
membrane in HeLa cells (Lee et al., 2002). More recent work has shown that over-
expressed PAK6 frequently localises to punctate formations in the cytoplasm of HeLa B 
cells and NCI-H1299 lung cancer cells (Shepelev and Korobko, 2012). The latter cell 
type is colony forming possessing high levels of cell-cell contacts, however PAK6 
localisation at cell-cell junctions was not observed (Shepelev and Korobko, 2012). The 
difference in cell elongation and colony escape phenotypes observed between WT 
PAK6 and PAK6 mutant constructs in this study could potentially be accounted for by 
the intracellular distribution of these mutants, as the kinase dead mutant of PAK6 
exhibited diffuse and cytoplasmic localisation. A junctional localisation for PAK4 in 
lung epithelial cells has also been reported (Wallace et al., 2010), but not in DU145 
cells; however PAK4 has been localised to focal adhesions in these cells (Wells et al., 
2010). 
 
In summary, a novel role for PAK6 in HGF-induced cell scattering has been identified 
using over-expression and knockdown strategies. Indeed, work presented here suggests 







4.3.1 Future work 
Based on the in vitro kinase assay data in this chapter, it seems likely that PAK6 
possesses autophosphorylation sites other than serine 560. Thus it would be interesting 
to deduce the location of these sites within PAK6. This could be achieved by 
performing an in vitro kinase assay using wild-type PAK6 and/or PAK6 mutants and 
conducting mass spectrometry phosphorylation analysis on observed phosphorylation 
band(s). Furthermore, as the AR is the only PAK6 substrate that has been identified 
(Schrantz et al., 2004) it would be interesting to investigate other potential PAK6 
substrates that could potentially be involved in cell-cell junction disassembly signalling. 
Techniques such as mass spectrometry or a yeast two-hybrid screen could be 
implemented.                 
 
In this study, PAK6 knockdown in DU145 and HT29 cells led to a reduction in cell-cell 
junction disassembly. To confirm that this phenotype was PAK6-specific, a rescue 
experiment could be conducted. Furthermore, DU145 cells expressing the kinase dead 
mutant of PAK6, K436A, remained in cell colonies, unlike wild-type PAK6 and the 
kinase active form of PAK6, S531N. The localisation pattern of E-cadherin was similar 
to that of wild-type PAK6. Thus it would be beneficial to compare E-cadherin 
localisation in these cells to the other derivatives of PAK6, as well as to control cells 


































Chapter 5 – PAK6 interaction with IQGAP1 in DU145 cells 
5.1 Introduction 
In cells with reduced PAK6 expression, HGF does not induce cell-cell junction 
dissociation (chapter 4). Moreover, PAK6 over-expression induces cell elongation and 
cell colony escape (chapter 4). These results suggest that PAK6 plays a role in junction 
disassembly. Thus to better understand how PAK6 might regulate cell-cell boundaries, 
potential binding partners were investigated. 
 
There is one report in the literature that PAK6 can interact with IQGAP1 (Kaur et al., 
2008), a protein known to localise to MDCK (Kuroda et al., 1996) and MCF7 (Li et al., 
1999; Swart-Mataraza et al., 2002) cell-cell junctions. This putative interaction was 
detected in a breast cancer cell line using co-immunoprecipitation experiments (Kaur et 
al., 2008), but this finding has yet to be validated in other cell types. IQGAP1 is a multi-
domain protein that is thought to be involved in protein-protein interactions and various 
signal transduction pathways (White et al., 2011). Indeed, IQGAP1 binds to Cdc42 
(Kuroda et al., 1996) and is thought to act as a scaffold protein in the MAPK signalling 
cascade (Ren et al., 2007; Roy et al., 2005). 
 
IQGAP1 has also been implicated in cancer cell motility and siRNA knockdown of 
IQGAP1 significantly decreases cancer cell migration in MCF7 breast epithelial cells 
(Mataraza et al., 2003b). IQGAP1 also binds to junctional-associated molecules 
including actin (Erickson et al., 1997) and E-cadherin (Kuroda et al., 1998) and is 
thought to regulate cell-cell dissociation downstream of HGF in colony-forming MDCK 
II cells (Fukata et al., 2001). Moreover, it has been postulated that the GTP-bound 
forms of Rac1 and Cdc42 are involved in cell-cell dissociation downstream of HGF 
stimulation by modulating the interaction of IQGAP1 with an E-cadherin-containing 
junctional complex (Fukata et al., 2001).  
 
In this chapter, the aim was to further characterise the interaction between IQGAP1 and 







5.2.1 IQGAP1 expression and localisation in DU145 cells 
IQGAP1 is a ubiquitously expressed protein (Weissbach et al., 1994); however its 
expression in prostate cancer cells has not been examined. IQGAP1 was found to be 
expressed in DU145 cells (figure 5.1A). It has been reported that IQGAP1 is enriched 
at cell-cell junctions in colony-forming MDCK II cells (Fukata et al., 2001). Therefore, 
the localisation of WT GFP-IQGAP1 was examined in DU145 cells. Consistent with 
previous reports (Kuroda et al., 1998), over-expressed WT IQGAP1 was detected and 
enriched at E-cadherin-positive junctions (figure 5.1B). Diffuse cytoplasmic expression 
was also discernible as has been observed previously (Fukata et al., 2001).  
 
5.2.2 PAK6 interacts with IQGAP1 
HEK293 cells were used for a structure-function analysis of the reported interaction 
between PAK6 and IQGAP1. IQGAP1 is a large (approximately 189 kDa) multi-
domain scaffold protein (Briggs and Sacks, 2003; Weissbach et al., 1994) that is known 
to have multiple binding partners (Brown and Sacks, 2006). PAK6 is structurally 
similar to its family members and possesses an N-terminal PBD and a C-terminal 
serine/threonine kinase domain (Wells and Jones, 2010). Endogenous (co)-
immunoprecipitation protocols were firstly employed, but these attempts were 
unsuccessful. However, endogenous PAK6 (which is expressed in HEK293 cells 
(figure 5.2A) was co-immunoprecipitated with over-expressed WT GFP-IQGAP1 in 
HEK293 cells (figure 5.2B). 
 
Both PAK6 and IQGAP1 are reported to interact with activated Cdc42 (Hart et al., 
1996; Kuroda et al., 1996; Lee et al., 2002). Thus, the interaction between IQGAP1 and 
PAK6 may not be direct but mediated through a joint interaction with Cdc42. 
Immunoprecipitation studies indicated that full-length WT IQGAP1, Cdc42-V12 and 



























Figure 5.1 IQGAP1 expression and localisation in DU145 cells. A) DU145 whole 
cell lysate was immunoblotted for IQGAP1 expression using an anti-IQGAP1 antibody 
and for ERK1/2 using an anti-ERK1/2 antibody as a loading control. B) DU145 cells 
were transfected with WT GFP-IQGAP1. Cells were fixed and labelled for E-cadherin 
and F-actin and imaged using confocal microscopy. WT GFP-IQGAP1 expression 
could be detected at E-cadherin-positive cell-cell junctions (arrows). In (A) and (B) data 






























Figure 5.2 PAK6 interacts with IQGAP1. A) HEK293 whole cell lysate was 
immunoblotted for endogenous PAK6 using a PAK6 specific antibody and for GAPDH 
as a loading control. B) HEK293 cells were transfected with WT GFP-IQGAP1. The 
cells were lysed and IQGAP1 was immunoprecipitated using an anti-GFP antibody (IP) 
from cell lysates. The samples were immunoblotted for endogenous PAK6 using a 
PAK6 specific antibody and anti-GFP for WT GFP-IQGAP1. The blots in (A) and (B) 




























Figure 5.3 Co-immunoprecipitation of PAK6, IQGAP1 and Cdc42-V12. HEK293 
cells were transfected with WT Myc-PAK6, WT GFP-IQGAP1 and HA-Cdc42-V12 as 
indicated. The cells were lysed and WT Myc-PAK6 was immunoprecipitated using an 
anti-c-Myc antibody (IP) from cell lysates. The samples were immunoblotted for over-
expressed WT GFP-IQGAP1 using an anti-GFP antibody, for WT Myc-PAK6 using an 
anti-c-Myc antibody and for HA-Cdc42-V12 using an anti-HA antibody. Whole cell 
lysates (WCL) were immunoblotted using anti-HA and anti-GFP antibodies as loading 







The limitations of using co-immunoprecipitation techniques to investigate protein- 
protein interactions are that they do not confirm that proteins pulled down together are 
in fact directly interacting. For example, PAK6 may be in a binary complex with 
Cdc42-V12, as may IQGAP1 in figure 5.3. Alternative approaches that are more 
suitable for examining direct protein-protein interactions include protein fractionation, 
fluorescence resonance energy transfer (FRET) and yeast two-hybrid screening. 
 
5.2.3 Full-length IQGAP1 interacts with the N- and C-termini of PAK6 
In order to elucidate whether Cdc42 may mediate the interaction between IQGAP1 and 
PAK6, domain mutants of PAK6 were co-expressed with full-length WT IQGAP1 
(figure 5.4A). Co-immunoprecipitation experiments demonstrated that full-length WT 
IQGAP1 bound to both the N- and C-termini of PAK6 (figure 5.4B). The interaction 
between IQGAP1 and the N-terminal domain of PAK6 may be mediated by Cdc42. 
However, it is also possible that the ability of IQGAP1 to interact with both the N- and 
C-terminal of PAK6 is due to PAK6 and/or IQGAP1 forming homodimers. Indeed it 
has been demonstrated that IQGAP1 self-associates in cells (Ren et al., 2005). 
Nevertheless, the binding of IQGAP1 to the C-terminal region of PAK6 is likely to be a 
direct association. 
 
5.2.4 Full-length PAK6 interacts with the N-terminal region of IQGAP1 
Having established that IQGAP1 can bind to PAK6, the interaction between full-length 
PAK6 and IQGAP1 domain mutants was explored. Domain mutants of IQGAP1 were 
co-expressed with full-length wild-type PAK6 (figure 5.5A). Co-immunoprecipitation 
experiments demonstrated that full-length wild-type PAK6 selectively interacted with 
the N-terminal region of IQGAP1 (figure 5.5B). 
 
Subsequently, the interaction between the C-terminal region of PAK6 and a truncated 
N-terminal mutant of IQGAP1 was investigated. This mutant encompassed amino acids 
717-863 of the N-terminal region of IQGAP1 (IQGAP1
717-863
) (figure 5.6A) and was 
chosen as it included the IQ domain region of IQGAP1 (amino acids 746-856) (Brown 
and Sacks, 2006) but not the Cdc42 binding site (Hart et al., 1996; Mataraza et al., 
2003a). This domain is known to bind a number of proteins and kinases including 
calmodulin (Hart et al., 1996), MEK1 and MEK2 (Roy et al., 2005). Thus the 
IQGAP1
717-863 













Figure 5.4 IQGAP1 interacts with the N- and C-termini of PAK6. A) Schematic 
illustrating full-length PAK6 (amino acids 1–682), N-terminal (amino acids 1–367) and 
C-terminal (amino acids 368–682) PAK6 generated constructs. These constructs were 
used in subsequent experiments. B) HEK293 cells were transfected with N- or C-
terminal RFP-PAK6 mutants and WT GFP-IQGAP1 as indicated. The cells were lysed 
and WT GFP-IQGAP1 was immunoprecipitated using an anti-GFP antibody (IP) from 
cell lysates. The samples were immunoblotted for WT GFP-IQGAP1 using an anti-GFP 
antibody and for N- and C-terminal PAK6 mutants using an anti-RFP antibody 
(arrows). Whole cell lysates (WCL) were immunoblotted using anti-GFP and anti-RFP 
antibodies as loading controls (arrows). The blots shown are representative of 3 





























Figure 5.5 PAK6 selectively binds to the N-terminal region of IQGAP1. A) 
Schematic illustrating full-length IQGAP1 (amino acids 1–1657), N-terminal IQGAP1 
(amino acids 2–863) and C-terminal IQGAP1 (amino acids 864-1657) constructs. These 
constructs were used in subsequent experiments. B) HEK293 cells were transfected 
with N- or C- terminal Myc-IQGAP1 mutants and WT GFP-PAK6 as indicated. The 
cells were lysed and N- and C-terminal IQGAP1 mutants were immunoprecipitated 
using an anti-c-Myc antibody (IP) from cell lysates. The samples were immunoblotted 
for WT GFP-PAK6 using an anti-GFP antibody and for N- and C-terminal Myc-
IQGAP1 mutants using an anti-c-Myc antibody. Whole cell lysates (WCL) were 
immunoblotted using an anti-GFP antibody as a loading control. The blots shown are 


























Figure 5.6 The C-terminal region of PAK6 interacts with amino acids 717-863 in 
the N-terminal region of IQGAP1. A) Schematic illustrating full-length IQGAP1 
(amino acids 1–1657) and the truncated N-terminal mutant of IQGAP1 (amino acids 
717–863). To protein purify GST-IQGAP1 (GST-IQGAP1717-863) E. coli BL21-A1 cells 
were transformed with the expression plasmid and grown to mid-log phase. Protein 
expression was induced with 0.05% L-Arabinose overnight at 20ºC. B) HEK293 cells 
were transfected with C-terminal GFP-PAK6 mutant as indicated. Cell lysates were 






GST was used as a control. The samples were immunoblotted for the C-terminal GFP-





and GST alone (control) using an anti-GST antibody. Whole cell lysate 
samples (WCL) were immunoblotted using an anti-GFP antibody as a loading control. 





PAK6 and this region of IQGAP1.
 
 This truncated IQGAP1 mutant interacted with the 
C-terminal PAK6 mutant (figure 5.6B). In contrast, PAK6 did not interact with a 
truncated N-terminal mutant of IQGAP1 encompassing amino acids 162-671 figure 
5.6B. In summary, the C-terminal half of PAK6 interacts with amino acids 717-863 
within the N-terminal region of IQGAP1. Furthermore, Cdc42-V12 was co-
immunoprecipitated with PAK6 and IQGAP1. A potential structural conformation 
between these 3 proteins is illustrated in figure 5.7.  
 
Having confirmed the interaction between IQGAP1 and PAK6 in HEK293 cells, an 
interaction using DU145 cells was explored. Full-length GST-PAK6 bound to 
endogenous IQGAP1 when using DU145 cells (Figure 5.8). 
 
5.2.5 IQGAP1 induces morphological changes and colony escape when expressed 
alone and when co-expressed with PAK6 in DU145 cells 
PAK6 is localised to cell-cell junctions and PAK6 over-expression induces cell 
elongation in DU145 cells (chapter 4). IQGAP1 is also localised at cell-cell junctions 
(figure 5.1B) and has been found to interact with PAK6 (figure 5.8) in these cells. 
Therefore, the effect of WT IQGAP1 over- expression on DU145 cells was compared to 
the morphological changes already described for PAK6 (figure 4.6). Control cells 
transfected with GFP were not significantly different in shape when compared to 
untransfected cells (figure 5.9A). WT IQGAP1 expressing DU145 cells exhibited 
significantly higher elongation ratios when compared to GFP control cells under serum-
starved conditions (figures 5.9A and 5.9B). This was similar to the cell shape changes 
observed for WT PAK6 expressing cells (figures 4.6A and 4.6C). Moreover, when WT 
GFP-IQGAP1 was co-expressed with WT RFP-PAK6 under these conditions, this 
elongation phenotype was further enhanced to a significant level when compared to 
cells expressing WT GFP-IQGAP1 alone (figures 5.9A and 5.9B). WT RFP-PAK6 
exhibited similar elongation ratios and localisation as that of WT GFP-PAK6 in DU145 
cells (data not shown).  
 
Over-expression of WT PAK6 not only induced cell elongation but also cell colony 
escape (figure 4.7). Having established that WT IQGAP1 also induced cell elongation 










Figure 5.7 Schematic to illustrate the proposed conformation of the interaction 
between PAK6, IQGAP1 and active Cdc42. The C-terminal region of PAK6 interacts 
with IQGAP1 via amino acids 717-863. Cdc42-V12 was co-immunoprecipitated with  
these two proteins. GTP-bound Cdc42 is known to interact with PAK6 (Lee et al., 2002) 
presumably via its N-terminal region, similar to its family members (Abo et al., 1998). 
IQGAP1 interacts with active Cdc42 via its GRD region (amino acids 1025-1238) in the 
C-terminal domain (Hart et al., 1996; Mataraza et al., 2003a). Dashed lines represent 






















Figure 5.8 PAK6 interacts with IQGAP1 in DU145 cells. DU145 cells were cultured 
in 10% FBS serum for 48 hours. Cells were then lysed and subjected to a GST-PAK6 
pulldown assay. GST was used as a control. The samples were immunoblotted for 
endogenous IQGAP1 using an anti-IQGAP1 antibody and for GST-PAK6 and GST 
alone (control) using an anti-GST antibody as indicated. The blots shown are 


































Figure 5.9 IQGAP1 over-expression and co-expression with PAK6 induces 
morphological changes in DU145 cells. A) DU145 cells were transfected with GFP 
control vector or WT GFP-IQGAP1 or co-transfected with WT RFP-PAK6 and WT 
GFP-IQGAP1. Untransfected cells (UT) were treated in the same manner. After 24 
hours, cells were serum-starved for 24 hours. Cells were then fixed and stained for F-
actin. Shape analysis was performed on the cells using Image J to determine the 
elongation ratio. B) F-actin stained DU145 cells transfected with WT GFP-IQGAP1 or 
co-transfected with WT RFP-PAK6 and WT GFP-IQGAP1 from (A) were imaged 
using confocal microscopy. In (A) the mean elongation ratio was calculated for 110 
cells per condition over 3 independent experiments. Statistical significance compared 
with GFP control cells (unless otherwise indicated) was calculated using Student’s t-





significant difference in cell colony escape between untransfected and GFP control 
expressing cells (data not shown). However, reminiscent of WT PAK6 expressing 
DU145 cells (figure 4.7), WT IQGAP1 expressing cells and cells co-expressing WT 
IQGAP1 and WT PAK6 were uncoupled from neighbouring cells and were no longer 
within the cell colony (figure 5.10). Based on the cell shape and colony escape data, 
IQGAP1, like PAK6, may be driving colony escape in DU145 cells. 
 
5.2.6 There is an optimal interaction between PAK6 and IQGAP1 following 4 
hours HGF stimulation 
When cell colonies are responding to HGF, cell-cell dissociation is required (figure 
3.1). Given that PAK6 and IQGAP1 interact in DU145 cells, and that these proteins 
function additively to increase cell-cell dissociation, it might be speculated that PAK6 
and IQGAP1 interact in an HGF-dependent manner.  
 
Endogenous IQGAP1 was pulled down with GST-PAK6 when growing DU145 cells 
were used (figure 5.11A), as previously shown (figure 5.8). Upon serum-starvation, 
this interaction decreased, although not to a significant level (figures 5.11A and 5.11B). 
Earlier studies had shown that PAK6 autophosphorylation at serine 560 was elevated 
following 5, 15 and 30 minutes HGF stimulation (figures 4.2A and 4.2B). Therefore, 
the level of interaction between PAK6 and IQGAP1 was investigated during early HGF 
stimulation time points. Although not significant, a small increase in the level of 
interaction between GST-PAK6 and endogenous IQGAP1 was observed following 30 
and 60 minutes HGF stimulation when compared to serum-starved conditions (figures 
5.11A and 5.11B). However it is important to note that the input protein levels of 
endogenous IQGAP1 may be lower in serum-starved conditions when compared to 
grow conditions. This may influence the level of interaction observed between GST-
PAK6 and endogenous IQGAP1. Furthermore, there are limitations in using 
immobilized GST-PAK6 to detect endogenous protein interactions. Firstly, in contrast 
to endogenous IQGAP1, GST-PAK6 was not exposed to the variation in conditions, for 
example serum-starvation and HGF stimulation. In addition, GST-PAK6 may have 
become saturated with bound endogenous protein which will influence the GST-PAK6-
IQGAP1 binding profiles that were observed. Lastly, the GST-PAK6 used was 
expressed in bacteria and not mammalian cells and thus it could potentially be in quite 























Figure 5.10 IQGAP1 over-expression and co-expression with PAK6 induces colony 
escape in DU145 cells. A) DU145 cells were transfected with GFP control vector or 
WT GFP-IQGAP1 or co-transfected with WT RFP-PAK6 and WT GFP-IQGAP1. After 
24 hours, cells were serum-starved for 24 hours and then fixed and stained for F-actin. 
The % of GFP expressing cells present within a colony for each condition was 
calculated. A cell escaping a colony was defined as either greater than 50% of the cell 
body perimeter detached from the neighbouring cell(s), cells already escaped from a 
colony and exhibiting 100% dissociation from the neighbouring cell(s) or cells in a 
different plane to the underlying cell colony. B) F-actin stained DU145 cells transfected 
with WT GFP-IQGAP1 or co-transfected with WT RFP-PAK6 and WT GFP-IQGAP1 
from (A) were imaged using confocal microscopy. In (A) the mean % of GFP 
expressing cells in colonies was calculated for 110 cells per condition over 3 
independent experiments. Statistical significance compared with GFP control cells 
(unless otherwise indicated) was calculated using Student’s t-test; *, P < 0.05, ***, P < 





























Figure 5.11 PAK6 and IQGAP1 interact downstream of HGF stimulation. A) 
DU145 cells were serum-starved for 24 hours or replenished with 10% FBS media 
(Growth). Cells were then left unstimulated (Starve) or stimulated with HGF (500 
ng/ml) for the indicated time points. Cells were then lysed and subjected to a GST-
PAK6 pulldown assay, using GST as a control. The samples were immunoblotted for 
endogenous IQGAP1 and for GST-PAK6 using an anti-GST antibody as a loading 
control. B) The level of binding between PAK6 and IQGAP1 was quantified using 
ANDOR IQ Technology software. C) DU145 cells were treated as described in (A). D) 
The level of binding was quantified as in (B). In (A) and (C) GST alone controls were 
GST positive as demonstrated in figures 5.6 and 5.8. In (B) and (D), the mean fold 
value representing the amount of bound IQGAP1 was deduced. The standard error of 
the mean was calculated over 3 independent experiments. Statistical significance 








interaction between GST-PAK6 and endogenous IQGAP1. As cell-cell dissociation in 
DU145 cells responding to HGF occurs approximately 4 hours post-stimulation (figure 
3.1), the interaction between PAK6 and IQGAP1 was also examined at later time 
points. A significant increase in the interaction between GST-PAK6 and endogenous 
IQGAP1 was observed following 4 hours HGF stimulation when compared to serum-
starved conditions (figures 5.11C and 5.11D), thereby correlating with HGF-induced 
cell-cell dissociation that occurs after 4 hours stimulation (figure 3.1). Furthermore, 
following 8 hours HGF stimulation, the interaction between these two proteins was 
reduced to near serum-starved levels (figures 5.11C and 5.11D). 
 
5.2.7 There is an optimal interaction between PAK6 and E-cadherin following 4 
hours HGF stimulation 
It has been demonstrated that the interaction between PAK6 and IQGAP1 is optimal 
following 4 hours stimulation with HGF (figures 5.11C and 5.11D) which correlates 
with E-cadherin cell junction disassembly (figure 3.1). IQGAP1 is known to interact 
with E-cadherin (Kuroda et al., 1998), and it has been shown that PAK6 can localise to 
E-cadherin-positive junctions (figure 4.13). Furthermore, E-cadherin is retained at cell-
cell junctions in PAK6 knockdown cells downstream of HGF (figure 4.12B). 
Therefore, the possibility of an interaction between PAK6 and E-cadherin was 
investigated. 
 
In serum-starved conditions, bacterially purified GST-PAK6 bound to endogenous E-
cadherin (figure 5.12A). Following 4 hours of HGF stimulation, where 
characteristically E-cadherin begins to move away from cell-cell junctions in DU145 
cells (figure 3.1) there was a significant increase in the level of interaction between 
GST-PAK6 and endogenous E-cadherin when compared to serum-starved cells (figures 
5.12A and 5.12B). Additionally, the interaction between GST-PAK6 and E-cadherin 
diminished following 8 hours HGF stimulation when compared to 4 hours stimulation 
(figures 5.12A and 5.12B), similar to the interaction trend observed between GST-
PAK6 and IQGAP1 (figures 5.11C and 5.11D). Furthermore, GST-PAK6, endogenous 
IQGAP1 and endogenous E-cadherin were pulled down together using serum-starved 





















Figure 5.12 PAK6 and E-cadherin interact downstream of HGF stimulation. A) 
Serum-starved DU145 cells were left unstimulated (Starve) or stimulated with HGF 
(500 ng/ml) for 4 or 8 hours. Cells were then lysed and subjected to a GST-PAK6 
pulldown assay. GST was used as a control. The samples were immunoblotted for 
endogenous E-cadherin and for GST-PAK6 using an anti-GST antibody as a loading 
control. B) The level of binding between PAK6 and E-cadherin was quantified using 
ANDOR IQ Technology software. C) DU145 cells were treated as described in (A) and 
immunoblotted for endogenous IQGAP1 and E-cadherin and for GST-PAK6 using an 
anti-GST antibody as a loading control. D) DU145 cells were seeded at a density that 
correlated with the HGF-induced scatter assay. Serum-starved DU145 cells were left 
unstimulated (Starve) or stimulated with HGF (10 ng/ml) for 60 minutes and 4 hours 
prior to lysis. Lysates were immunoblotted for levels of PAK6 autophosphorylation at 
serine 560 using a phospho-PAK4/PAK5/PAK6 antibody. Blots were re-probed for total 
PAK6 expression using an anti-PAK4/PAK6 antibody. E) Changes in the levels of 
autophosphorylation at serine 560 in (D) were quantified using ANDOR IQ Technology 
software. In (A) and (C) GST alone controls were GST positive as demonstrated in 
figures 5.6 and 5.8. In (B) the mean fold value representing the amount of bound E-
cadherin and in (E) the changes in the level of PAK6 autophosphorylation at serine 560 
were quantified. The standard error of the mean was calculated over 3 independent 
experiments. Statistical significance compared with serum-starved cells (Starve) was 








no significant change in PAK6 autophosphorylation at serine 560 was detected at longer 
HGF stimulation time points, including after 4 hours (figures 5.12D and 5.12E).  
 
5.2.8 PAK6 phosphorylation levels are elevated in the presence of IQGAP1  
IQGAP1 binds to the C-terminal region of PAK6 which encompasses the kinase domain 
(figure 5.6). Thus, it was hypothesised that IQGAP1 may be a substrate for PAK6. 
Indeed, it has been shown in the literature that IQGAP1 is phosphorylated at serine 
1443, potentially by the serine/threonine kinase protein kinase C (PKC) epsilon, and 
this in turn can alter the function of IQGAP1 (Grohmanova et al., 2004). This 
hypothesis was tested using a radioactive in vitro kinase assay. GST-PAK6 did not 
phosphorylate over-expressed WT IQGAP1 in vitro as incorporated [γ-32P] ATP was 
not detected at the size of WT GFP-IQGAP1 (approximately 220 kDa) or above. 
However, unexpectedly, the presence of WT IQGAP1 induced an increase in the 
phosphorylation levels of GST-PAK6, when compared to the phosphorylation levels of 
GST-PAK6 in the absence of WT IQGAP1 (figure 5.13A). Therefore, this suggests that  
IQGAP1 is not a PAK6 substrate but that the presence of IQGAP1 elevates the levels of 
PAK6 phosphorylation.  
 
IQGAP1 is able to interact with other kinases, such as MEK1 and MEK2, and in turn 
indirectly modulates their activation status (Roy et al., 2005). It has been demonstrated 
previously that PAK6 autophosphorylation levels at serine 560 increased upon HGF 
stimulation (figure 4.2). In addition, phosphorylation at this residue has been reported 
to be required for MKK6-mediated activation of PAK6 (Kaur et al., 2005). Therefore, 
WT or dominant-negative IQGAP1 were over-expressed with WT PAK6 and the levels 
of PAK6 autophosphorylation at serine 560 were examined (figure 5.13B). Dominant-
negative IQGAP1 lacks the GRD domain, where active Cdc42 binds, and thereby 
reduces the level of GTP-Cdc42 bound to IQGAP1 (Swart-Mataraza et al., 2002). 
However, phosphorylation levels at this residue were unaltered in the presence of the 
IQGAP1 constructs tested (figure 5.13B). Thus, the presence of IQGAP1 does not 
affect the levels of autophosphorylation at serine 560 on PAK6, implying that IQGAP1 





















Figure 5.13 IQGAP1 expression increases PAK6 phosphorylation levels. A) 
HEK293 cells were transfected with WT GFP-IQGAP1 as indicated. The cells were 
lysed and IQGAP1 was immunoprecipitated using an anti-GFP antibody (IP) from cell 
lysates and mixed with or without GST-PAK6 as indicated. An in vitro kinase assay 
was performed using [γ-32P] ATP. GST-PAK6 alone was also subjected to the in vitro 
kinase assay and GST was used as a control. Whole cell lysates (WCL) were 
immunoblotted using an anti-GFP antibody as a loading control. B) HEK293 cells were 
transfected with WT Myc-PAK6, or co-transfected with WT Myc-PAK6 and WT GFP-
IQGAP1 or dominant-negative (dom –ve) GFP-IQGAP1. The cells were lysed and WT 
Myc-PAK6 was immunoprecipitated using an anti-c-Myc antibody (IP) from cell 
lysates. The samples were immunoblotted for GFP-IQGAP1 using an anti-GFP 
antibody and also for WT Myc-PAK6 using an anti-c-Myc antibody as a loading 
control. The IP samples were immunoblotted for levels of PAK6 autophosphorylation at 
serine 560 using a phospho-PAK4/PAK5/PAK6 antibody. In (A) and (B) the blots 






In this chapter, an interaction between PAK6 and IQGAP1 has been established in 
DU145 cells for the first time. IQGAP1 was found to induce cell elongation and a cell 
colony escape phenotype in DU145 cells, similar to that observed for PAK6 expressing 
cells in chapter 4.  Endogenous E-cadherin and IQGAP1 were pulled down with PAK6 
and the association between PAK6 and these proteins was maximal following 4 hours 
HGF stimulation. In addition, it was demonstrated that the presence of IQGAP1 
increases PAK6 phosphorylation levels.  
 
IQGAP1 is known to be over-expressed in numerous types of cancer including 
colorectal (Nabeshima et al., 2002), hepatocellular (Chen et al., 2010) and ovarian 
carcinomas (Dong et al., 2006), as well as in breast cancer epithelial cells (Jadeski et al., 
2008); however its expression in prostate cancer cells has not been documented. In this 
study, IQGAP1 was found to be expressed in DU145 cells. 
 
IQGAP1 is known to bind to kinases such as ERK1/2 and MEK1/2 and these 
interactions are important for MAPK signalling (Roy et al., 2005). IQGAP1 also 
interacts with PAK6 in MCF7 breast cancer cells (Kaur et al., 2008); however the 
significance of this association has yet to be elucidated. An interaction between PAK6 
and IQGAP1 was confirmed using an endogenous IP protocol and a GST pulldown 
assay. This association was detected in the absence of HGF stimulation; consistent with 
this, the interaction between IQGAP1 and ERK2 did not require EGF stimulation (Roy 
et al., 2004). However, over-expressed IQGAP1 must associate with ERK2 for the 
regulation of EGF-induced ERK2 stimulation  (Roy et al., 2004). Therefore, it could be 
speculated that whilst IQGAP1 and PAK6 are able to interact in the absence of HGF 
stimulation, the presence of IQGAP1 may be required for HGF-induced PAK6 
activation and/or for the function of PAK6 downstream of HGF. 
 
In the GST pulldown assay, only endogenous IQGAP1, and not GST-PAK6, was 
exposed to serum-starved conditions and to HGF stimulation. The data presented 
indicates an increase in the association of IQGAP1 to GST-PAK6 upon HGF addition 
when compared to serum-starvation. This suggests that HGF may modulate IQGAP1 
and consequently enhance its interaction with GST-PAK6. For example, HGF may 
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modify the conformation of IQGAP1 and thereby make the PAK6 binding site on 
IQGAP1 more accessible. Additionally, the presence of HGF may induce the 
phosphorylation of IQGAP1; indeed EGF has been shown to induce the 
phosphorylation of IQGAP1 at serine 1443 via protein kinase C (McNulty et al., 2011). 
Moreover, phosphorylation of IQGAP1 at this site was also detected upon cell-cell 
junction disassembly (Grohmanova et al., 2004).       
 
Full-length IQGAP1 was found to interact with both the N- and C-terminal regions of 
PAK6. The N-terminal region of PAK6 possesses a PBD domain, to which the activated 
form of Cdc42 is known to interact (Lee et al., 2002). IQGAP1 is also known to interact 
with GTP-bound Cdc42 (Hart et al., 1996; Kuroda et al., 1996). It is likely that the 
association of full-length IQGAP1 with the N-terminal region of PAK6 is mediated by 
Cdc42, rather than a direct interaction. Furthermore, PAK6 may be associated with 
IQGAP1 and Cdc42. More recently, it has been shown that PAK6 interacts with the 
atypical Rho GTPase, RhoV (Shepelev and Korobko, 2012), which shares close 
sequence homology with Cdc42 (Aronheim et al., 1998). Thus, it could also be 
speculated that PAK6 may interact with both RhoV and IQGAP1. Furthermore, RhoV 
has also been implicated in cytoskeletal modulation (Aronheim et al., 1998). 
 
The C-terminal kinase domain containing region of PAK6 interacted with the N-
terminal of IQGAP1; this region of IQGAP1 also binds to the kinase domain of the 
EGFR (McNulty et al., 2011). IQGAP1 modulates the activation of the EGFR and 
subsequent signalling through this association (McNulty et al., 2011). Further binding 
studies in this chapter revealed that the C-terminal half of PAK6 bound to a region 
spanning the IQ domain, similar to the IQGAP1 binding reported for the kinases MEK1 
and MEK2 (Roy et al., 2005). In this interaction IQGAP1 acts as a scaffold where its 
interaction with ERK is speculated to induce a conformational change that triggers an 
increased association with MEK, thereby allowing subsequent MEK-mediated ERK 
activation (Roy et al., 2005). It could be speculated that IQGAP1 might play a similar 
scaffolding role where it allows the interaction between PAK6 and a downstream 
substrate/upstream regulator.  
 
This direct interaction of IQGAP1 is similar to that described for identified binding 
partners of other PAK family members. DGCR6L, a protein implicated in cancer 
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metastasis, is known to bind to the C-terminal region of PAK4 and modulate PAK4-
induced cell migration, via LIM kinase 1 (LIMK1), in gastric cancer cells (Li et al., 
2010). In addition, this association increased PAK4-mediated phosphorylation of 
LIMK1 (Li et al., 2010). In contrast, the intracellular protein nischarin modulates cell 
migration by binding to the C-terminal region of PAK1 in its activated conformation 
(Alahari et al., 2004). This in turn inhibits the ability of PAK1 to phosphorylate other 
proteins (Alahari et al., 2004). Thus interactions via the C-terminal of PAKs are 
important in signal transduction modulation.  
 
Once the interaction between PAK6 and IQGAP1 had been examined, the functional 
significance of the association between these two proteins was assessed. Over-expressed 
WT IQGAP1 was found to induce cell elongation and colony escape in serum-starved 
DU145 cells. Consistent with this cell-cell dissociation phenotype of IQGAP1 
expressing cells, cell-cell dissociation assays have shown that in EL cells the majority 
of IQGAP1 expressing cells were dissociated and visible as single cells (Kuroda et al., 
1998). In contrast, control cells did not dissociate and persisted in aggregates (Kuroda et 
al., 1998). Thus, Kuroda et al. demonstrated that expression of IQGAP1 increased the 
ability of epithelial cells to detach from one another, in the absence of growth factor 
stimulation. This is consistent with the colony escape phenotype observed here. 
IQGAP1 regulates actin dynamics and the over-expression of WT IQGAP1 is also 
known to induce actin microspikes and filopodia in MCF7 breast cancer cells (Swart-
Mataraza et al., 2002). Interestingly, IQGAP1-expressing cells appeared to exhibit a 
colony escape phenotype in the study by Swart-Mataraza et al.; however the authors did 
not comment on nor quantify this phenotype. 
 
In this chapter not only did over-expression of IQGAP1 drive cell colony escape, but 
co-expression with PAK6 increased the level of cell-cell dissociation. Thus there would 
appear to be a synergistic relationship between these two proteins. One possibility is 
that IQGAP1 is a PAK6 substrate. Indeed, phosphorylation of specific residues on 
IQGAP1 can modify its function by altering its association with other proteins, as well 
as its conformation or its dimerisation, and in turn affect its interaction with the actin 
cytoskeleton (Grohmanova et al., 2004; Li et al., 2005b). However, no phosphorylation 
of IQGAP1 was detected in the presence of PAK6 using a radioactive in vitro kinase 
assay. In contrast, the presence of over-expressed IQGAP1 increased the levels of GST-
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PAK6 phosphorylation in this in vitro kinase assay. It is unlikely that this increase in 
PAK6 phosphorylation levels is as a result of a second kinase bound to IQGAP1 in the 
immunoprecipitate as incorporation of radioactivity was not detected anywhere else on 
the blot. Thus, it is likely that the increase in phosphorylation of PAK6 observed in the 
presence of IQGAP1 is as a result of PAK6 phosphorylating itself. In addition, the 
presence of IQGAP1 may alter the conformation of the PAK6 kinase domain. 
Interestingly, a recent report has demonstrated the ability of IQGAP1 to regulate the 
activity of Aurora-A kinase (Yin et al., 2012), a serine/threonine kinase that has been 
associated with human malignancy (Wang et al., 2006). Similar to the results obtained 
here, over-expression of IQGAP1 is thought to increase Aurora-A phosphorylation 
levels (Yin et al., 2012).  
 
Whilst IQGAP1 does not possess the ability to phosphorylate proteins, it is known to 
modulate the activation status of other kinases through its ability to function as a 
scaffold protein, for example in the MAPK signalling pathway (Roy et al., 2005). In this 
pathway, IQGAP1 is able to directly interact with ERK2 and modulate its activity in 
MCF7 cells (Roy et al., 2004). In addition, IQGAP1 plays a pivotal role in regulating 
the activation of MEK1, upstream of ERK1 (Roy et al., 2005). The increased 
autophosphorylation detected in the in vitro kinase assay is unlikely to be focussed on 
serine 560 as co-expression of IQGAP1 and PAK6 does not modulate phosphorylation 
levels at this site. This suggests that there are other autophosphorylation sites on PAK6. 
Indeed, the correlation between serine 560 autophosphorylation and activity is not 
clearly defined. PAK6 autophosphorylation levels at serine 560 increased downstream 
of HGF at early time points as described in chapter 4; however, autophosphorylation 
levels at this residue did not increase to a significant level after 4 hours HGF addition, 
when IQGAP1 and E-cadherin interactions with PAK6 are maximal. Either PAK6 
activity is not regulated by phosphorylation at serine 560 or PAK6 activity is not 
elevated at later time points. Furthermore, an increase in PAK6 activity was not 
detected when point mutating the serine 560 residue (figure 4.4). It is also possible that 
transient phosphorylation of PAK6 via HGF is sufficient for downstream signal 
propagation or that initial serine 560 autophosphorylation induces the phosphorylation 





Both IQGAP1 and PAK6 were found to be localised at E-cadherin-positive junctions in 
DU145 cells. This junctional localisation of IQGAP1 has been reported in different cell 
types including in MDCK cells (Kuroda et al., 1996) and MCF7 cells (Li et al., 1999; 
Swart-Mataraza et al., 2002), as well as its co-localisation with E-cadherin at sites of 
cell-cell contact (Kuroda et al., 1998; Li et al., 1999). Thus, data presented here would 
suggest that PAK6 and IQGAP1 both mediate the dissolution of cell-cell junctions 
downstream of HGF. Indeed, an increased interaction between PAK6 and IQGAP1 was 
detected following HGF stimulation which correlated in time with cell-cell dissociation 
(figure 5.11C and figure 3.1). This provides further evidence that PAK6 and IQGAP1 
are functioning in an HGF-dependent pathway. This is in contrast to EGF, which did 
not modify the association between ERK2 and IQGAP1 (Roy et al., 2004). Moreover, 
the maximal interaction between PAK6 and E-cadherin was also observed within the 
same time frame (figure 5.12A). Furthermore, PAK6 bound to IQGAP1 and E-cadherin 
downstream of HGF stimulation at this time point (figure 5.12C). 
 
Data presented here argue that IQGAP1 binds to and regulates PAK6 and that PAK6 



















5.3.1 Future work 
In this chapter, PAK6 was found to interact with IQGAP1. Cdc42-V12 was also co-
immunoprecipitated with these proteins. However, co-immunoprecipitation does not 
represent direct associations between proteins. An approach that could be implemented 
to directly examine protein-protein interactions includes subcellular fractionation. 
Furthermore, as PAK6 and IQGAP1 both interact with the GTP-bound form of Cdc42 
(Hart et al., 1996; Lee et al., 2002), it would be useful to try and elucidate if this 
interaction is important during the cell-cell dissociation process in DU145 cells.        
   
The presence of IQGAP1 was found to increase PAK6 autophosphorylation levels in 
the in vitro kinase assay that was conducted. However, this assay was performed in 
steady-state conditions; thus it would be useful to perform this experiment in the 
presence of HGF at different time points, particularly following 4 hours HGF 
stimulation, as this was identified as a significant time point during the cell-cell 
dissociation process. Furthermore, the levels of endogenous IQGAP1 and E-cadherin 
bound to GST-PAK6 were elevated 4 hours post-HGF stimulation. Moreover, as 
IQGAP1 is not a kinase, it would interesting to elucidate the mechanism by which 
IQGAP1 induces an increase in PAK6 autophosphorylation.   
 
Whilst PAK6 and IQGAP1 may function together during HGF-induced cell-cell contact 
disassembly, data from this study suggest that IQGAP1 is unlikely to be a PAK6 
substrate. Thus it would be useful to isolate PAK6 substrates that may be involved in 
this process. For example, a potential candidate as a PAK6 substrate is p120 catenin, a 
junctional protein that binds E-cadherin (Daniel and Reynolds, 1995) and is important 
in the maintenance of cell-cell adhesivity (Davis et al., 2003), is known to bind to PAK6 

















































Chapter 6 - Concluding Remarks 
In this study it has been demonstrated that DU145 prostate cancer cells scatter in 
response to HGF stimulation and this is supported on a range of substrata. As a 
consequence, this scatter model was then used to investigate the potential role of PAK6 
in prostate cancer cell dissemination. Depletion of PAK6 expression was found to 
inhibit the HGF-induced cell-cell junction dissolution and subsequent cell scattering. In 
contrast, over-expression of PAK6 drove cell-cell dissemination; a process dependent 
on PAK6 kinase activity. Furthermore, PAK6 was localised at E-cadherin-positive 
junctions. Subsequently, PAK6 was found to interact with the junctional protein 
IQGAP1, in an HGF-dependent manner. Thus, PAK6 and IQGAP1 may collaborate 
downstream of HGF to induce cell-cell dissociation in DU145 prostate cancer cells.  
 
The question is how PAK6 and/or IQGAP1 achieve junction disassembly in DU145 
cells. There is already considerable evidence to suggest a key role for IQGAP1 in 
junction disassembly in other cell types. In gastric cancer cells, junctional localisation 
of IQGAP1 has been linked to a reduction in E-cadherin-mediated cell-cell adhesion 
(Takemoto et al., 2001). IQGAP1 also localises at cell-cell junctions in MCF7 breast 
cancer cells (Swart-Mataraza et al., 2002) and the increased junctional localisation of 
this protein correlates with a reduction in E-cadherin localisation at sites of cell-cell 
contact in breast cancer cells (Li et al., 1999). Moreover, IQGAP1 has been shown to 
negatively modulate cell-cell adhesion in MDCK II colony-forming cells downstream 
of HGF (Fukata et al., 2001).  
 
How IQGAP1 drives junction disassembly is not clearly elucidated. Historically, 
IQGAP1 was thought to contribute to a reduction in cell-cell adhesivity through its 
association with β-catenin (Kuroda et al., 1998). It was proposed that this interaction 
with β-catenin induces α-catenin displacement from the E-cadherin-β-catenin complex 
in vitro and in vivo (Kuroda et al., 1998) and that removal of α-catenin weakens these 
adhesions (Kuroda et al., 1998; Ozawa and Kemler, 1998), thereby inducing cell 
scattering (Fukata et al., 2001). However, more recently α-catenin dissociation from β-
catenin has been linked to junction stabilisation (Benjamin and Nelson, 2008; Drees et 
al., 2005). Nevertheless, several studies have shown that α-catenin expression is lost in 
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gastric and breast scirrhous adenocarcinomas (Ochiai et al., 1994) and in human lung 
adenocarcinoma PC9 cells (Watabe et al., 1994); furthermore, these cell types also 
exhibit a scattered phenotype (Ochiai et al., 1994; Watabe et al., 1994).  
 
Data presented here demonstrate that E-cadherin, IQGAP1 and PAK6 can be pulled 
down together. Thus what needs to be addressed is how PAK6 would fit into an E-
cadherin-IQGAP1 cell-cell junction dissociation model. There is no evidence to suggest 
that IQGAP1 is a PAK6 substrate; however, it could be speculated that β-catenin may 
be a potential substrate for PAK6. PAK1 (Zhu et al., 2011) and PAK4 (Li et al., 2011) 
both phosphorylate β-catenin at serine 675. Moreover, the hyper-phosphorylation of β-
catenin on serine/threonine residues has been shown to induce the loss of cell-cell 
junction sites in human epidermal cells (Serres et al., 1997) and Jun N-terminal kinase 
(JNK) phosphorylates β-catenin at serine 37 and threonine 41, which induces the loss of 
cell-cell contacts (Lee et al., 2009). In contrast, inhibition of JNK kinase activity leads 
to a reduction in the phosphorylation of β-catenin and promotes cell-cell adhesion (Lee 
et al., 2009). 
 
Furthermore, the junctional protein p120 catenin also binds E-cadherin (Jou et al., 1995) 
and is important for the stabilisation of cell-cell junctions (Ireton et al., 2002). Indeed it 
has been demonstrated that siRNA-induced depletion of p120 catenin lead to the rapid 
turnover and degradation of E-cadherin as well as the subsequent loss of cell-cell 
junctions (Davis et al., 2003). Interestingly, group II PAKs were recently reported to 
associate with this catenin family member (Wong et al., 2010). Wong et al. 
demonstrated that p120 catenin interacts with PAK5 with the highest affinity, followed 
by PAK6, whereas p120 catenin bound PAK4 with the lowest affinity (Wong et al., 
2010). However whilst an interaction between PAK6 and p120 catenin was detected, 
the authors only tested the phosphorylating potential of PAK4 and PAK5 (Wong et al., 
2010). Activated PAK4 phosphorylated p120 catenin in vitro and in vivo, as did wild-
type PAK5 (Wong et al., 2010). Thus it cannot be rules out that PAK6 may also 
phosphorylate p120 catenin and the interaction detected between PAK6 and p120 
catenin suggests a functional relationship between these two proteins. In addition to 
serine/threonine phosphorylation of p120 catenin (Wong et al., 2010; Xia et al., 2003) it 
has also been suggested that the N-terminal region of p120 catenin, encompassing the 
phosphorylation domain, confers an inhibitory effect on intercellular adhesivity (Aono 
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et al., 1999). Taken together, it could be speculated that PAK6 phosphorylates p120 
catenin which in turn triggers the degradation of E-cadherin and subsequent cell-cell 
dissociation.        
 
Given the strong link between PAKs, serine/threonine phosphorylation of β-catenin and 
cell-cell dissociation, it might be imagined that during HGF-induced cell scattering 
PAK6 functions as follows (figure 6.1). Stimulation through HGF of cells with strong 
E-cadherin-positive junctions induces serine 560 autophosphorylation of PAK6 (other 
sites on PAK6 may also be phosphorylated as a result of HGF addition). At 4 hours 
post-HGF stimulation, there is an optimal interaction between E-cadherin, PAK6 and 
IQGAP1 which correlates with cell-cell dissociation. During the interaction between 
PAK6 and IQGAP1, PAK6 autophosphorylation levels are increased, which may 
potentially allow for increased substrate phosphorylation. Thus, the interaction between 
PAK6 and IQGAP1 may induce an increase in exogenous PAK6 activity. Given that 
IQGAP1 and E-cadherin both interact with β-catenin (Kuroda et al., 1998), PAK6 may 
also potentially phosphorylate β-catenin. These events may in turn trigger α-catenin 
dissociation from the E-cadherin-β-catenin complex, thereby inducing cell-cell 
dissociation. This model does speculate that PAK6 phosphorylates β-catenin and that 
the phosphorylation of β-catenin leads to junctional breakdown. Moreover, it favours a 
model where IQGAP1-mediated dissociation of α-catenin from β-catenin promotes cell-
cell adhesion disassembly. However, it is important to clarify that the outcome of α-
catenin dissociation from the cadherin complex has yet to be fully established.  
 
PAK6 interacts with the GTP-bound form of Cdc42 (Lee et al., 2002) as does IQGAP1 
(Hart et al., 1996). However, the interaction of active Cdc42 does not enhance the 
activity of PAK6 (Lee et al., 2002), which is required for cell colony escape. GTP-
bound Cdc42 could potentially mediate the localisation of PAK6 at cell-cell junctions; 
indeed it has been reported that active Cdc42 induces the re-localisation of PAK4 (Abo 
et al., 1998) and X-PAK5 (Cau et al., 2001). Thus Cdc42 may be involved in the 
IQGAP1-PAK6-modulated cell-cell dissociation process. However, there are conflicting 
views as to how Cdc42 contributes to cell-cell adhesion strength modulation, which is 
clearly a tightly regulated and complex process (Keely et al., 1997; Kodama et al., 




Figure 6.1 A proposed model for the role of PAK6, acting with IQGAP1, in HGF-
induced cell-cell dissociation in DU145 prostate cancer cells. In the absence of HGF, 
there is a minimal interaction between E-cadherin-PAK6-IQGAP1 at cell-cell junctions. 
α-catenin is bound to β-catenin, which in turn is associated with E-cadherin, leading to 
strong intercellular adhesions. Upon HGF stimulation, PAK6 autophosphorylation 
levels are increased (other PAK6 sites may also be phosphorylated). A maximal 
interaction occurs between E-cadherin-PAK6-IQGAP1 (this interaction may also 
include β-catenin) 4 hours post-HGF stimulation. IQGAP1 increases PAK6 
autophosphorylation activity and PAK6 substrate phosphorylation may also be elevated. 
It has been speculated here that PAK6 phosphorylates β-catenin. These events may 
trigger α-catenin uncouplingthereby leading to the weakening of cell-cell adhesions and 
subsequent cell-cell dissociation. α-catenin is known to dissociate from β-catenin; 
however, the consequence of this dissociation is still unclear. Thus this model 




In future studies, it would be interesting to assess whether there is an interaction 
between PAK6 and β-catenin, as well as whether PAK6 phosphorylates β-catenin. In 
addition, the association between IQGAP1 and the junctional components α-catenin, β-
catenin and E-cadherin in PAK6 knockdown cells and the interaction between IQGAP1 
and kinase active and kinase dead PAK6 mutants could also be investigated. Moreover, 
Cdc42 and PAK6-IQGAP1 interactions downstream of HGF could be examined. This 
would help elucidate the intricacies of the mechanism involving IQGAP1 and PAK6 in 
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Appendix 1 – PCR amplification primer sequences 
 
Full-length PAK6 (amino acids 1–682) 
attB1 Forward primer: 5’-GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTG 
ATG TTC CGC AAG AAA AAG AAG AAA-3’ 
attB2 Reverse primer: 5’-GGGG A CCA CTT TGT ACA AGA AAG CTG GGT C 
TCA GCA GGT GGA GGT CTG CTT TCG-3’ 
 
N-terminal PAK6 mutant (amino acids 1–367) 
attB1 Forward primer: 5’-GGGG ACA AGT TTG TAC AAA AAA GCA GGC TTG 
ATG TTC CGC AAG AAA AAG AAG AAA-3’ 
attB2 Reverse primer: 5’-GGG GAC CAC TTT GTA CAA GAA AGC TGG GTC 
TCA CTG GGG CAG GTA CAG GTT GCT GGT-3’ 
 
C-terminal PAK6 mutant (amino acids 368–682) 
attB1 Forward primer: 5’-GGG GAC AAG TTT GTA CAA AAA AGC AGG CTT 
GGA CCT GGA CCC CAC GGT TGC CAA GGG TGC C-3’ 
attB2 Reverse primer: 5’-GGGG A CCA CTT TGT ACA AGA AAG CTG GGT C 
TCA GCA GGT GGA GGT CTG CTT TCG-3’ 
 
Mutagenic primers 
S560E PAK6 mutant (predicted PAK6 autophosphorylation site) 
Forward primer: 5’-CGT CCC TAA GAG GAA GGA GCT GGT GGG AAC CCC CT-
3’ 
Reverse primer: 5’-AGG GGG TTC CCA CCA GCT CCT TCC TCT TAG GGA CG-
3’ 
 
S531N PAK6 mutant (Kinase active PAK6 mutant) 
Forward primer: 5’-GGG ACA TCA AGA GTG ACA ACA TCC TGC TGA CCC 
TCG-3’ 




K436A PAK6 mutant (Kinase dead PAK6 mutant) 
Forward primer: 5’-CGC CAG GTG GCC GTC GCG ATG ATG GAC CTC AG-3’ 




P19 Forward 5’-GTA ACA TCA GAG ATT TTG AGA CAC-3’ 
P20 Reverse 5’-TCG CGT TAA CGC TAG CAT GGA TC-3’ 
Internal PAK6 5’-CCT AGC CCT AAG ACC CGG G-3’ 
GST GEX-5 Forward 5’-GGG CTG GCA AGC CAC GTT TGG TG-3’ 
GST T7 terminator Reverse Primer provided by Eurofins MWG Operon 
pEGFP-C1 Forward Primer provided by Eurofins MWG Operon 























Appendix 2 - siRNA oligonucleotide sequences 
 
Control siRNA (non-silencing) 
Target sequence: AAT TCT CCG AAC GTG TCA CGT 
 
PAK6 siRNA (Oligonucleotide 1) 
Target sequence: GGC UAU UCC GAA GCA UGU Utt 
 
PAK6 siRNA (Oligonucleotide 2) 


























Appendix 3 - Figure legends for movies 1-5  
 
Movie 1 
DU145 cells were left for 48 hours to form colonies and were then serum-starved for 24 
hours. Cells were then filmed for 24 hours at 5 minute intervals using phase-contrast 




DU145 cells were left for 48 hours to form colonies and were then serum-starved for 24 
hours. Cells were then stimulated with HGF (10 ng/ml) and filmed for 24 hours at 5 
minute intervals using phase-contrast time-lapse microscopy (see section 2.2.10). 
Movie is representative of 3 independent experiments.  
 
Movies 3PC and 3G 
EGFP lentiviral vector expressing DU145 cells were seeded into a 98% collagen I and a 
2% matrigel 3D matrix and left for one week to form colonies. Cells were then serum-
starved for 24 hours prior to filming. Cells were filmed for 24 hours at 5 minute 
intervals. Cells were filmed using phase-contrast (PC) and GFP fluorescence (G) time-
lapse microscopy (see section 2.2.10). Movies are representative of 3 independent 
experiments.  
 
Movies 4PC and 4G 
EGFP lentiviral vector expressing DU145 cells were seeded into a 98% collagen I and a 
2% matrigel 3D matrix and left for one week to form colonies. Cells were serum-
starved for 24 hours and then stimulated with HGF (500 ng/ml) for 48 hours. Cells were 
then filmed for 24 hours at 5 minute intervals using phase-contrast (PC) and GFP 
fluorescence (G) time-lapse microscopy (see section 2.2.10). Movies are representative 
of 3 independent experiments.  
 
Movies 5PC and 5G 
DU145 cells were transfected with WT GFP-PAK6. Cells were immediately filmed for 
24 hours at 5 minute intervals using phase-contrast (PC) and GFP fluorescence (G) 
time-lapse microscopy (see section 2.2.10). Movies are representative of 3 independent 
experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
